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1 Introduction 1
1 Introduction 
1.1 Chirality and biocatalysis 
The biological activity of a chiral compound depends strongly on the stereochemistry of the 
molecule. While one enantiomer has a desired therapeutic effect, the other can have no or 
even an opposite effect. The most well known example for this is the medicine Contergan® 
containing the active substance thalidomide, the (S)-enantiomer of which possesses a 
teratogenic effect. Therefore, a high enantiomeric purity is necessary particularly in the 
pharmaceutical, agrochemical and food industries. There is an increasing trend in these 
industries, to develop products containing enantiomerically pure materials. This trend was 
accelerated by the decision of the American Food and Drug Administration (FDA) in May 
1992. Safety information is now demanded for individual stereoisomers of products submitted 
for approval and although racemates will still be continued to be approved on a case-by-case 
basis, information on each of the enantiomers is required (Peters, 1998). Chiral compounds 
can be produced by either chemical synthesis (which is not necessarily catalytic) or 
biocatalysis (using either whole cells or isolated enzymes). Biocatalysis has been a key focus 
area in white biotechnology (application of nature’s toolset to industrial production) 
(Bachmann, 2003). A recent report of McKinsey predicted that by the year 2010, white 
biotechnology would be a competitive way of producing about a fifth of world’s fine 
chemical segments (Bachmann, 2003). According to another recent study from Frost and 
Sullivan it is expected that biocatalysis will increase its share from 10% in 2002 to 22% in 
2009 of the annual turnover for chiral technologies (Widmer, 2003). This is because of the 
growing use of enzymes as substitutes for conventional chemical catalysts in production 
processes, for example in the detergent industry, food and pharmaceutical industries (Liese 
and Filho, 1999). Biocatalysts offer some advantages over chemical catalysts and these 
include necessity of only mild reaction conditions, avoidance of unwanted by-products (when 
isolated enzymes are used) (Liese and Filho, 1999), and of course a high chemoselectivity, 
regioselectivity and especially stereoselectivity for the production of enantiomerically pure 
compounds that may not be necessarily exhibited by the chemical catalysts. Biocatalytic 
resolutions of racemates make use of the selectivity of the enzymes for one of the enantiomers 
of the chiral molecule, whereby one enantiomer of a racemate remains virtually untouched 
and the other enantiomer is converted into the desired enantiomerically pure 
product/intermediate. As a result of the growth in demand for chiral actives, the market for 
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chiral intermediates is growing fast. This has provided an enormous impetus for the 
development of enantioselective chemical and biochemical transformations, such as the 
reduction of carbonyl compounds and/or oxidation of alcohols. Biocatalytic applications of 
oxidoreductases for such transformations have been an important tool in biotechnology. In 
particular, alcohol dehydrogenases (ADH) are increasingly being used for asymmetric 
synthesis, due to the growing demand for enantiomerically pure pharmaceutical compounds 
(Bradshaw, et al. 1992a; Wong and Whitesides, 1994; Hummel, 1999). 
1.2 Alcohol dehydrogenases 
Alcohol dehydrogenases (EC  1.1.1.1) are enzymes that belong to the first sub-class of the 
oxidoreductase family, which catalyze the oxidation of primary and secondary alcohols and/or 
reduction of carbonyl compounds like aldehydes and ketones. An important characteristic of 
alcohol dehydrogenases (ADH) is their dependence on NADH+H+ and/or NADPH+H+ as 
cofactors.  
 
An important thing to consider when using alcohol dehydrogenase is whether they follow the 
Prelog or the anti-Prelog rule (Prelog, 1964), which states from which side the hydride 
transfer takes place (si- or re- side) so as to determine whether the enantiomer formed is (R) 
or (S) specific. Many alcohol dehydrogenases are available in nature but they vary specially in 
their cofactor dependence, stereospecificity and substrate spectrum. The stereospecific 
reduction of carbonyl compounds is of great interest for the production of intermediates of 
chiral compounds like hydroxy acids, amino acids and alcohol and prochiral intermediates. 
Such products can find direct applications in food or as components in the synthesis of 
therapeutics, herbicides and pesticides.  
1.3 Carbonyl reductase from Candida parapsilosis 
In the year 1992, Peters et al. reported for the first time an oxidoreductase from the yeast 
Candida parapsilosis DSMZ 70125 strain. This novel, strictly NAD(H)-dependent, carbonyl 
reductase (CPCR), has an extremely broad substrate range and high enantioselectivity, 
accepting primary and secondary alcohols, aldehydes, ketoacetals, aliphatic and aromatic 
ketones, cyclic ketones, diketones, halogenated ketones, keto esters and halogenated keto 
esters of variable chain length as substrates (Peters et al., 1992, 1993a; Kula et al., 1996 ). The 
enzyme oxidizes primary and secondary alcohols and is able to differentiate between the 
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enantiomers of 2-butanol, which is difficult with other alcohol dehydrogenases (Keinan et al., 
1986b, 1987). CPCR delivers the pro-(R) hydride of the nicotinamide ring to the re face of the 
carbonyl yielding (S)-hydroxy compounds (Peters et al., 1993b). Thus the stereochemical 
outcome follows Prelog’s rule. The substrate spectrums that had been identified for the CPCR 
were all converted with (S)-configuration and with a very high enantiomeric purity (Peters et 
al., 1993a,b, c; Rissom, 1999). CPCR was successfully applied for the preparation of a range 
of synthetically useful chiral compounds (Peters et al., 1993c, d). 
 
Literature data available regarding the characteristics of this novel enzyme varies widely. 
Initially this enzyme was characterized as a homodimer enzyme with a molecular weight of 
about 135-136 kDa (Kula et al., 1996; Peters et al., 1993a). Later, in newer publications, the 
molecular weight of the native CPCR was described to be approximately 78-79 kDa with 
subunit size of about 40 kDa per subunit (Rissom et al., 1999; Orlich, 2000; Bönitz, 2001; 
Laue, 2001). The enzyme is described to be found in the peroxisomes of the yeast cells. The 
biological function of the described enzyme in C.parapsilosis seems to be the reduction of 
carbonyl compounds due to its kinetic characteristics (Peters et al., 1993a). However, the 
natural substrate of the enzyme is still unknown. The enzyme may be involved in fatty acid 
metabolism and/or regeneration of NAD+ from NADH+H+ (Peters, 1993; Peters et al., 
1993a). The enzyme is characterized by temperature optima between 36 °C to 40 °C 
(reduction) and 50 °C to 56 °C (oxidation), while the pH optima are 7-8.5 and 9-10.5 for 
reduction and oxidation reactions respectively (Peters et al., 1993a, Peters 1993; Kula and 
Peters, 1996; Bönitz, 2001). Very recent characterization of the CPCR showed that the 
temperature optimum for reduction was 48 °C and the pH optimum was 6 instead (Steinsiek, 
2006).  
 
Based on the substrates that had been investigated for CPCR, a hypothetic model of the 
substrate-binding site has been deduced from the kinetic measurements (Peters et al., 1993b; 
Kula et al., 1996). CPCR possibly possesses two hydrophobic substrate-binding sites, which 
differ from one another in volume and affinity towards the alkyl groups. One side chain of the 
keto group has to be a small alkyl group while the other group may be a large hydrophobic 
side chain.  From this model, the substrate spectrum of CPCR was concluded. Very polar 
substances, which do not possess a similar methyl side chain, could not be reduced (Figure 1). 
 
  
1 Introduction 4
The catalytic cycle follows a sequentially ordered bi-bi-mechanism (Cleland, 1986). First the 
cofactor binds to the CPCR enzyme, followed by the binding of the substrate. After the 
substrate is converted, the product is released from the binding site and afterwards, the 
oxidized cofactor is set free.  
 
 
 
Figure 1: Hypothetical structure of the CPCR substrate-binding site. ADPR = Adenosine 5’ diphosphate ribose. 
 
1.4 Versatility of CPCR to other alcohol dehydrogenases 
The CPCR has a wide range of advantages compared to other alcohol dehydrogenases. 
Hummel and Kula (Hummel et al., 1989) discussed different alcohol dehydrogenases and 
their applications. Alcohol dehydrogenases from yeast (YADH) and horse liver (HLADH) 
have several disadvantages, such as instability above 30 °C, sensitivity to organic solvents, 
loss of activity upon immobilization and narrow substrate specificities (Keinan et al., 1986a, 
b; Sih and Chen, 1984). Disadvantages of some alcohol dehydrogenases that were isolated 
from certain thermophilic microorganisms like Sulfolobus solfataricus and 
Thermoanaerobium brockii are moderate specific activity (3.9 U/mg) and NADPH 
dependency respectively. A NADH-dependent alcohol dehydrogenase from Pseudomonas sp. 
(PED) showed broad substrate specificity (Bradshaw et al., 1992a). But one disadvantage of 
this enzyme is the high Km value for the oxidized coenzyme. Both PED and the NADPH-
dependent Lactobacillus kefir alcohol dehydrogenase (LKADH) yield the (R)-enantiomer 
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(Hummel, 1990a, b) while the CPCR produces the (S)-enantiomer and is NADH-dependent. 
The ketopantoyl reductase (Hata et al., 1989) and carbonyl reductase (Hata et al., 1990) 
isolated from another strain of C.parapsilosis are NADPH-dependent enzymes inactive with 
keto acids or esters as substrates. 4-Ketoacids or esters were not reduced by PED. LKADH 
reduces 4-keto esters at much lower rates (Bradshaw et al., 1992b). In contrast, the NADH-
dependent CPCR reduces 4- and 5-keto esters of variable chain length and substitution at high 
reaction velocities and enantioselectivity (Peters et al., 1993a,b). The alcohol dehydrogenases 
from Thermoanaerobium brockii (TBADH) and Pseudomonas sp. (PED and PADH) 
generally require that one of the ketone side chains be a methyl group (Bradshaw et al., 
1992a); whereas CPCR accepts a broad spectrum of side chains, including aromatic and 
cyclic groups as well as halogen-substituted carbon chains. Although the substrate specificity 
of CPCR is partially overlapped with PADH, PED and TBADH, most substrates are reduced 
at higher rates by the CPCR, especially the reduction of synthetic useful acetophenone 
derivatives and 4-chloro-3-oxobutanoate (Peters et al., 1993a). The CPCR showed the 
possibility of converting acetophenone and its derivatives to the corresponding (S)-
phenylethanol in NADH-dependent catalysis, which is especially interesting since up to now 
only the (R) specific transformations could be realized. 
1.5 Secondary alcohol dehydrogenase from Candida parapsilosis 
In the year 1995, Kojima et al. reported for the first time a novel secondary alcohol 
dehydrogenase from the yeast Candida parapsilosis IFO 1396 strain. The gene coding for this 
secondary alcohol dehydrogenase (CpSADH) was isolated, cloned and expressed in the 
Escherichia coli JM109 by the same group. CpSADH catalyzes the NADH-dependent 
reduction of ketones to the corresponding secondary alcohols. The enzyme catalyzes the 
enantioselective oxidation of racemic secondary alcohols and the asymmetric reduction of 
aromatic and aliphatic ketones to their corresponding secondary alcohols with (S) selectivity 
(Yamamoto et al., 1995). Furthermore, the said enzyme preferentially oxidizes (S)-2-butanol 
with the S configuration. The said enzyme has a relative higher activity toward secondary 
alcohols than primary ones. This novel enzyme has very broad substrate specificity, good 
stereoselectivity and utilizes aliphatic alcohols including those with an aromatic substitution 
as its oxidizing substrate as well as aldehydes and ketones with an aromatic substitution. The 
recombinant CpSADH has been extensively used for whole cell biocatalysis for the synthesis 
of several pharmaceutical intermediates for industrial use with a very high enantiomeric 
purity (Matsuyama et al., 1993; Yamamoto et al., 1999; Matsuyama et al., 2001; Matsuyama 
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et al., 2002; Yamamoto et al., 2002). The enzyme is characterized with a temperature 
optimum of 50 °C and pH optima of 5.5-6.5 (reduction) and 8.5-9.5 (oxidation). The values of 
the temperature optimum and the pH optimum for reduction of CpSADH matches exactly to 
what has been described by Steinsiek (2006) for the wild-type CPCR. The apparent molecular 
weight of the enzyme is estimated to be about 40 kDa by SDS-PAGE. 
1.6 Cofactor regeneration  
Due to the high costs of the nicotinamide cofactors, in order to avoid a stoichiometric amount 
of the cofactor, cofactor regeneration is necessary for the economic production of chiral 
compounds with the help of alcodol dehydrogenases so that only catalytic quantities of the 
reduction equivalents can be used. Cofactor regeneration can be carried out with enzymatic 
(biological) or non-enzymatic methods. With the biological method, whole cells or isolated 
enzymes can be used for the regeneration of the cofactors. The non-enzymatic method is 
differentiated into chemical, electrochemical and photochemical methods (Chenault et al., 
1988). The chemical method uses a reducing agent like sodium dithionite and therefore 
suffers from a very low total turnover number of less than 100 (Jones et al., 1972) and the 
reducing agent can also deactivate enzymes (Ramio and Lilius, 1971). The electrochemical 
method uses electricity and the photochemical method uses light energy for the cofactor 
regeneration. The major disadvantages of most electrochemical and photochemical 
regeneration methods are low regioselectivity (Mandler and Willner, 1986; Jones and Taylor, 
1976; Legoy at al., 1980; Julliard et al., 1986), leading to coenzyme/cofactor inactivation, 
occurrence of side reactions, and low total turnover numbers of less than 1000 (Chenault and 
Whitesides, 1987; Chenault et al., 1988). Another disadvantage of the electrochemical 
regeneration method is the fouling of the electrodes by adsorption of the substances from the 
solution. For industrial applications, cofactor regeneration system must fulfill certain 
requirements and these include apart from a high reaction rate and a high conversion, stability 
of the enzyme and the cofactor in the reaction system. The efficiency of such a system is 
determined by the total turnover number (TTN). TTN is defined as the total number of moles 
of product formed per mole of cofactor or enzyme during the course of the entire reaction. For 
an efficient and economic system, generally, a cofactor regeneration method must be capable 
of recycling the cofactor 102-106 times, depending on the initial cost of the cofactor and the 
value of the product synthesized (Chenault and Whitesides, 1987; Donk and Zhao, 2003). The 
application of whole microbial cells with in situ cofactor regeneration for synthetic purpose 
could avoid the above-mentioned problems, but their selectivity is poor (Goubet, et al. 2002; 
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Grizon, et al. 2004), may involve secondary reactions and also substrate or product inhibition 
may occur. For these reasons, often the enzymatic methods with isolated enzymes for the 
cofactor regeneration is used because they are specific for the regeneration of enzymatically 
active cofactor and are mostly compatible with other components of an enzymatic reaction. In 
this way a high TTN is achieved and the cofactor is converted specifically, without causing 
secondary reactions. With the enzymatic method for cofactor regeneration, two general 
concepts are used which are: 
 
1. Substrate-coupled regeneration: In the substrate-coupled approach, the oxidoreductase 
serves not only the substrate reduction but also the oxidation of the cosubstrate and therefore 
both the main reaction and the regeneration of the cofactor are catalyzed by the same enzyme. 
In the case of alcohol dehydrogenases, cheap alcohols like ethanol or 2-propanol are widely 
used as the cosubstrate for the regeneration system. In this process, the cosubstrate is given in 
surplus amount which is oxidized, and the substrate is reduced. With the oxidation of the 
cosubstrate, the reduced form of the cofactors is restored. 
 
ADH
NADH+H+ NAD+
R2R1
OH
O
R1 R2
O
OH
ADH
 
Figure 2: Substrate-coupled cofactor regeneration of alcohol dehydrogenase. 
 
2. Enzyme-coupled regeneration: In the case of enzyme-coupled approach, the reduction of 
the main substrate and the cofactor regeneration reaction are catalyzed by two different 
enzymes. For this, the substrate of the second enzyme is added to the system. The oxidation 
of this substrate leads to the reduction of the cofactors. For this method, most often, the 
formate dehydrogenase (FDH) from Candida boidinii is used (Slusarczyk et al., 2000), which 
under the reduction of NAD+ produces CO2 from formate. 
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ADH
NADH+H+ NAD+
R2R1
OH
R1 R2
O
FDH
HCOOH CO2 
 
Figure 3: Enzyme-coupled cofactor regeneration of alcohol dehydrogenase. 
 
The biochemical characteristics of CPCR and CpSADH allow both the enzyme- and 
substrate-coupled approaches for coenzyme regeneration (Peters et al., 1993c; Zelinski et al., 
1999; Endo and Koizumi, 2001; Matsuyama et al., 2002). Due to the alcohol dehydrogenase 
activity of the CPCR and CpSADH, NADH regeneration may be carried out in a substrate 
coupled reaction using 2-propanol as hydrogen donor (Figure 2).The enzyme coupled mode 
can be carried out with FDH as a second enzyme and formate as the ultimate hydrogen donor 
(Figure 3). 
1.7 Alcohol dehydrogenases in organic solvents 
The application of enzymes in organic or aqueous-organic solvents (liquid-liquid two-phase 
system) rather than conventional media (purely aqueous system) is increasingly used. The 
presence of a substantial amount of organic solvent in the biocatalytic reaction medium may 
offer certain important advantages in comparison to the aqueous reaction medium. High 
concentrations of poorly water-soluble substrates and/or products are possible in organic 
solvent-containing media. The chance of microbial contamination is reduced because 
microorganisms cannot grow in organic solvents. Furthermore, reaction equilibrium may be 
shifted favorably, and substrate and/or product hydrolysis can be largely prevented (Brink and 
Tramper, 1985). In case of two-liquid-phase systems extra advantageous phenomena could 
occur. Substrate or product inhibition may be reduced as a consequence of a lower inhibitor 
concentration in the aqueous environment of the enzyme, and recovery of product and 
biocatalyst is facilitated (Brink and Tramper, 1985) because in such a two-phase system, the 
product is extracted in the organic phase while the biocatalyst remains in the aqueous phase. 
Stabilization of the biocatalyst, particularly thermo-stability is another advantage of organic 
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solvent containing media (Zaks and Klibanov, 1984) because many denaturing mechanisms 
are based on hydrolytic reactions. The reaction in organic solvents can be influenced by the 
choice of the organic solvents. Many organic solvents lead to a variation of the substrate and 
cause a change in the chemo-, regio- and stereo-selectivity of the biocatalyst. Contrary to the 
advantages, the main drawbacks of introducing an organic solvent is smaller catalytic 
activities, which therefore require larger quantities of biocatalyst, as well as possible 
denaturation of sensitive biocatalysts responsible for the desired bioconversion by the organic 
solvents (Faber, 2004). The influence of this denaturation could be due to the withdrawal of 
water from the biocatalyst in presence of organic solvents, which is required for its activity 
and/or catalytic active conformation. Therefore, just a hydrate covering can be sufficient for 
conformational flexibility needed for the catalytic activity (Zaks and Klibanov, 1988). A 
direct contact with the organic solvents can lead to inhibition or change in conformation of 
the enzyme. In case of aqueous-organic two-phase systems, the organic solvent can lead to 
deactivation of the enzyme due to the occurrence of liquid-liquid interface between the 
solvents and presence of residual amounts of organic solvent in aqueous medium (Ghatorae et 
al., 1994; Halling et al., 1998). To overcome this deactivation, methods to guide the choice of 
the proper solvent have been proposed, such as that reported by Brink and Tramper (1985). 
Laane et al. (1985; 1987) suggested using the polarity of solvents, expressed by the log P 
value (Logarithm of the partition coefficient of a given compound in the standard n-
octanol/water two-phase system) as the main criterion for optimizing organic solvents in multi 
liquid-phase biocatalysis. But, Filho et al. (2003) reported that the log P concept is not 
satisfactory to guide the choice of an organic solvent serving as the second phase in ADH-
catalyzed reactions and therefore recommended that instead of the hydrophobicity of the 
solvent (log P) its functionality should be considered when screening for a solvent.   
 
Increasingly aqueous-organic two-phase systems are used for enzymatic synthesis with 
alcohol dehydrogenases (Wandrey et al., 2003; Gröger and Hummel, 2004) without 
intermixing the phases. Several cofactor-dependent alcohol dehydrogenases had been 
extensively used in such a liquid-liquid aqueous-organic two-phase system for synthetic 
applications and were found to have a catalytic active conformation in the presence of organic 
solvents. These include, YADH (Yeast alcohol dehydrogenase), HLADH (Horse liver alcohol 
dehydrogenase), TBADH (Thermoanaerobium brockii alcohol dehydrogenase), LBADH 
(Lactobacillus brevis alcohol dehydrogenase), LmADH (Lactobacillus minor alcohol 
dehydrogenase), ReADH (Rhodococcus erythropolis alcohol dehydrogenase) (Deetz and 
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Rozzell, 1988; Guinn et al., 1991; Snijder-Lambers et al., 1991; Jönnsson et al., 1999; Filho et 
al., 2003; Gröger et al., 2003; Gupta et al., 2004). Of the examined ADHs, the stability and 
activity of the HLADH both as native and as immobilisate bound to different carriers was 
found to be the best in organic media with different water contents and using substrate-
coupled regeneration mode (Grunwald et al., 1986; Zaks and Klibanov, 1988; Deetz and 
Rozzell, 1988; Snijder-Lambers et al., 1991; Larsson et al., 1991; Guinn et al., 1991; Filho et 
al., 2003). However, a limiting factor for employing alcohol dehydrogenases in organic 
solvents is the necessary use of the nicotinamide adenine dinucleotide cofactors which are 
strictly polar molecules and thus insoluble in organic solvents. They remain therefore bound 
to the biocatalysts and cannot diffuse through the solvents. Thus only substrate-coupled 
cofactor regeneration method can be employed. The enzyme-coupled regeneration with 
formate dehydrogenase is also possible in aqueous-organic systems, but the FDH from 
C.biodinii is reported to be very unstable in the presence of organic solvents (Gröger et al., 
2003). But a mutant of the FDH from C.biodinii showed higher stability in hexane 
(Slusarczyk et al., 2000; Gröger et al., 2003) and was thus employed in the enzyme-coupled 
cofactor regeneration in organic solvents. 
1.8 Immobilization 
Immobilized enzymes are defined as “enzymes which are physically confined or localized in a 
certain region of space with retention of their catalytic activities, and which can be used 
repeatedly and continuously” (Katchalski-Katzir, 1971). Like any other methods, the 
immobilization of enzymes has its own advantages and disadvantages. The main advantages 
include low downstream processing cost, possibility of enzyme recycling, separation of the 
enzyme catalyst easily from the reaction mixture, better stability especially true for ADH 
enzymes towards heat (Liao and Chen 2001; Julliard et al., 1986), cofactor binding to enzyme 
(less waste) and easy realization of continuous production. The main disadvantages of 
enzyme immobilization are loss of absolute enzyme activity due to the immobilization 
process, additional costs of carriers or other reagents used for immobilization process and 
potential for mass transfer limitations. However, immobilization of enzymes has become an 
indispensable part of the industrial biotransformations especially useful for expensive 
enzymes (Liese et al., 2000). The choice of the immobilization method therefore depends on 
the enzyme stability (Keinan et al., 1986b; Kelly et al., 1977) and the process of application. 
Organic solvents are frequently used as reaction medium in order to facilitate reactions with 
hydrophobic, non-water-soluble substrates. However, the disadvantages of employing alcohol 
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dehydrogenases are low enzyme stability and activity in organic solvents, since the natural 
environment of many enzymes including the alcohol dehydrogenases is aqueous. This leads to 
very fast denaturation of the enzyme by the organic solvent (Keinan et al., 1986b; Orlich, 
2000; Gröger et al., 2003). On the other hand, the poor solubility of many substrates and/or 
products does not allow their employment in pure aqueous medium. The influence of this 
denaturation by the organic solvent might be reduced and on the same time the solubility of 
many hydrophobic substrates can be increased, and consequently the biocatalyst stability 
enhanced, by immobilizing the biocatalysts at or in a protective support. In that case one also 
benefits from the intrinsic advantages provided by immobilization itself.  
 
There are several possibilities of immobilization of biocatalysts for the employment in 
organic solvents. In general, the most commonly used immobilization methods are adsorption 
or covalent linkage to the carrier. Adsorption is the simplest and the oldest method of 
immobilizing an enzyme onto a water-insoluble carrier. In this method, the biocatalysts are 
held to the surface of the carriers by physical forces (van der Waals forces). A disadvantage, 
however, of such a method is the relative weakness of adsorptive binding forces. Adsorbed 
biocatalysts are easily desorbed by temperature fluctuations, and even more readily by 
changes in substrate and ionic concentrations (Hartmeier, 1988). In covalent binding, the 
atoms are linked by means of shared electron pairs. This produces a tight association between 
a biocatalyst and a carrier and hence the biocatalyst is not desorbed from the carrier and 
therefore is more suited for application in non-conventional media. The covalent binding of 
enzymes to solid supports can effectively extend the lifetime of the biocatalysts by protecting 
the native three-dimensional (3D) structure of enzyme molecules and may result in enhanced 
enzyme activity and stability in organic solvents as compared with that of native enzyme in 
the same reaction media (Wang et al., 2001). There are many protocols to covalently 
immobilize proteins (Royer, 1980; Klibanov, 1983; Rosevear, 1984; Hartmeier, 1985; Chibata 
et al., 1986; Katchalski-Katzir, 1993; Bickerstaff, 1997). However, most of these protocols for 
covalent protein immobilization have some drawbacks when trying to quantitatively 
immobilize, under mild experimental conditions, large amounts of proteins per milliliter of 
support with a long-term handling of the activated supports, e.g., when immobilization is 
carried out at an industrial level. Thus, there are not so many easy-to-perform methodologies 
that may be applied to immobilize large amounts of any protein in any solid under mild 
experimental conditions.  
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Epoxy-activated supports seem to be almost ideal systems to develop very easy protocols for 
enzyme immobilization (Hartmeier, 1985; Katchalski-Katzir, 1993; Bickerstaff, 1997; 
Wheatley and Schmidt, 1999; Katchalski-Katsir and Kraemer, 2000). Epoxy groups are very 
stable at neutral pH values even in wet conditions, and hence commercial supports can be 
stored for long periods of time and can be prepared quite far from the place where the enzyme 
has to be immobilized. Moreover, these epoxy supports may be utilized to stabilize enzymes 
through multipoint covalent attachment by controlling the enzyme-support interactions 
(Mateo et al., 2000a; Mateo et al., 2002). Furthermore, epoxy supports are able to react with 
different nucleophilic groups on the protein surface (e.g. amino, hydroxy, or thiol moieties) to 
form extremely strong linkages (secondary amino bonds, ether bonds, thioether bonds) with 
minimal chemical modification of the protein. But, epoxy groups are hardly reactive for 
enzyme immobilization under mild experimental conditions (neutral pH, low ionic strength) 
(Hannibal-Friederich et al., 1980; Melander et al., 1984; Smalla et al., 1988; Wheatley and 
Schmidt, 1999). Thus, immobilization on epoxy supports proceeds via a two-step 
immobilization mechanism: a rapid preliminary physical adsorption, and then the covalent 
attachment between nucleophilic groups of the enzyme (amino, thiol, or hydroxy groups) and 
a high density of nearby epoxy groups in the support is strongly favored (Melander et al., 
1984; Smalla et al., 1988; Wheatley and Schmidt, 1999; Mateo et al., 2000b; Mateo et al., 
2002). For this reason, most of the commercial supports designed for protein immobilization 
have a fairly hydrophobic nature, and the recommended immobilization conditions include 
the use of a high ionic strength (to force the hydrophobic adsorption of the proteins). The 
commercially available SEPABEADS® EC-EP (Resindion S.r.l., Italy) is a conventional 
epoxy-activated support which has been used for performing very easy industrial 
immobilization of biocatalysts. By just immobilizing the enzymes inside porous supports, it 
may be possible to increase the enzyme operational stability by preventing any intermolecular 
process (proteolysis, aggregation) and by preserving the enzyme from interactions with 
external interfaces (air, oxygen, immiscible organic solvents, etc.) (Gupta, 1991; Bes et al., 
1995; Fernandez-Lafuente et al., 1998). However, random immobilization might not promote 
any conformational stabilization of immobilized enzymes. In fact, there are reports of 
immobilization procedures with no effect or even negative effects on the stability of some 
enzymes (Klibanov, 1982; Rody et al., 1983; Gianfreda et al., 1991; Nanalov et al., 1993; 
Desmukh et al., 1993). However, it is generally accepted that such stabilization should be 
achieved if the immobilization of each enzyme molecule occurs through several residues, 
mainly if the reactive groups in the support are secluded from its surface through very short 
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spacer arms. In this way, all the residues of the enzyme molecule involved in immobilization 
have to preserve their relative positions almost completely unaffected during any 
conformational change promoted by heat, organic solvents, or any other distorting agents 
(Guisan, 1988; Mozhaev et al., 1990; Guisan et al., 1991). Thus, such multipoint covalently 
immobilized enzymes should become much more stable than their soluble counterparts or 
than randomly immobilized derivatives. The Sepabeads EC-EP is not only capable of 
immobilizing enzymes but also of achieving multipoint covalent attachment between the 
immobilized enzyme and the support. However, the hydrophobicity of the support may create 
some stability problems on the immobilized enzyme (Mateo et al., 2002). Having in mind this 
two-step mechanism for the covalent immobilization of proteins on epoxy supports, 
multifunctional supports have been recently proposed as a second generation of activated 
supports that are able to covalently immobilize enzymes, antibodies, and other proteins under 
very mild experimental conditions (Mateo et al., 2000b; Mateo et al., 2001; Abad et al., 2002; 
Mateo et al., 2003).  In general, these multifunctional supports should contain two types of 
functional groups: (1) groups that are able to promote the physical adsorption of proteins 
(e.g., by ionic exchange, by adsorption on immobilized metal chelates); and (2) groups that 
are able to covalently immobilize the enzyme (e.g., epoxy groups). In this way, enzymes are 
physically adsorbed on the support first via different phenomena and then some covalent 
linking could take place between nucleophilic groups of the protein (amino, thiol, and 
hydroxyl ones) and the epoxy groups on the support surface. The commercially available 
SEPABEADS® EC-HFA (support activated with epoxy-amino groups) (Resindion S.r.l., 
Italy) is an example of such a hetero (multi) functional support which is implied by the 
introduction of a modification of the epoxy groups on the support surface (e.g., through 
introduction of amino groups) and therefore is an alternative to conventional epoxy supports 
in the immobilization of industrial enzymes. In this case, the epoxy moieties have been 
introduced by modification of a layer of ethylenediamine covalently bound to the support 
surface. Therefore, using these supports, there is a 1:1 ratio between the number of amino 
groups and the reactive epoxy groups (that determine the physical adsorption and covalent 
immobilization rate, respectively). Thus, this support has a great anionic exchanger power and 
a high number of epoxy groups. Immobilization proceeds at low ionic strength using amino-
epoxy Sepabeads while requiring high ionic strength using conventional monofunctional 
epoxy supports (Mateo et al., 2003; Torres et al., 2003).  
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Another well-known method of immobilization of enzymes for their application in 
hydrophobic solvents is via entrapment in hydrogels. An increase in the stability and also the 
activity of the alcohol dehydrogenase can be achieved in hydrophobic media by such an 
immobilization. In a hydrogel, the enzyme remains in its natural aqueous environment. The 
hydrogels protects the enzyme against the influence of organic solvents, but at the same time, 
reactions with poorly water-soluble substrates to produce single enantiomer are made possible 
(Ansorge-Schumacher et al., 2000). Hydrogels are characterized by a high water-content and 
result mostly from the cross-linking of hydrophilic monomers or also polymers that form a 
lattice structure/network into which biocatalyst molecules can be entrapped. They can be used 
in organic solvents as the so-called gel-stabilized two-phase system. The surrounding solvent 
serves thereby as reservoir for hydrophobic substrates, which can diffuse into the matrix, 
while the product is extracted directly from the gel. For the entrapment of enzymes both 
artificial and natural matrices is suitable. Natural materials are non-toxic and the gelation 
process is usually very gentle. The simplest methods for gel formation are ionotropic and 
cooling gelation. The most common method for the production of immobilisate by ionotropic 
gelation is introducing the solution in drops, which can be gelled into an aqueous ionic-bath. 
However, this method has a disadvantage with cofactor-dependent enzymes in that it leads to 
very quick washing away of the cofactor (König, 1996). Polyvinyl alcohol is an example of a 
more modern synthetic polymer, which forms a hydrogel by cooling gelation. It is non-toxic 
and therefore also suitable for sensitive enzymes. Gelation of the aqueous polyvinyl alcohol 
solutions takes place by “freezing and thawing” mechanism, in which the solution is first 
frozen and then slowly thawed. Hardening of the gels is based on the formation of hydrogen 
bonds between the polymer chains (Lozinsky and Plieva, 1998; Prüsse, 2000), between which 
biocatalyst and cofactor can be entrapped. This method is particularly very suitable for 
sensitive enzymes, since no higher temperatures than ambient temperature are needed and the 
biocatalyst does not come in contact with toxic monomers, as it is for example with the 
production of polyacrylamide gels. 
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1.9 Aim and motivation of the research work 
Chiral compounds are valuable building blocks for the synthesis of pharmaceuticals, 
agrochemicals and natural materials. For the synthesis of these products, oxidoreductases are 
of special interest, because of high enantioselectivity and a wide substrate spectrum.   
 
The chiral hydroxyacids and/or esters of today always resulted mainly through microbial 
reductions with Baker’s yeast. The ADH1 reacts mainly with aldehydes to produce the S-
alcohols and its substrate spectrum is also limited.  In addition, instability to heat and organic 
solvents are also exhibited. Other well-known carbonyl reductases need NADPH as cofactor 
and are therefore cost-intensive for industrial use.   
 
The CPCR (Peters et al., 1992, 1993a, Kula et al., 1996) is a very versatile biocatalyst and the 
industrial use of this enzyme is of large interest. But the fermentation of the wild type of 
C.parapsilosis resulted only in small quantities of the enzyme (< 0.03% of the total cell 
proteins). So for industrial application of this enzyme, sufficient and economic availability of 
the biocatalyst must be guaranteed. 
 
Another well-known industrially important secondary alcohol dehydrogenase is the CpSADH 
(Kojima et al., 1995). Both the CPCR and the CpSADH are two oxidoreductases from two 
different types of C.parapsilosis strains. Both these enzymes are NADH-cofactor dependent, 
exhibit a wide substrate spectrum and are S-specific. However, it was not clear which of the 
two oxidoreductases is the real CPCR with its broad versatility and substrate spectrum as has 
been described in literature data. Furthermore, old literature data available for the CPCR 
showed that the enzyme had totally different biochemical characteristic features than that of 
CpSADH. But, recent characterization of the commercially available purified wtCPCR 
(Juelich Fine Chemicals, Juelich, Germany) by Steinsiek (2006) showed that certain specific 
biochemical characteristics like the pH- and temperature-optimum data of the CPCR indeed 
agreed much more with the data of the CpSADH though the range and percentual conversion 
of significant substrates matched with the results described by Peters et al. (1993a).   
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The present work would be to identify which of the two oxidoreductases that are found in the 
C.parapsilosis is the real CPCR. With this view, both the genes coding for CPCR and 
CpSADH would be amplified by PCR from the gDNA of the “CPCR” type strain of 
C.parapsilosis, after which conditions would be created for the employment of both these 
enzymes within the technical range by cloning and expression of the CPCR and the CpSADH 
in a suitable expression system, preferably E.coli. For amplification of the CPCR gene, the 
method of reverse genetics was selected. From the partial N- and C-terminal protein 
sequences (Bönitz, 2001) of the enzyme, the DNA sequence would be derived by the method 
of PCR based genome walking (Siebert et al., 1995). For the amplification of the CpSADH 
gene, primers would be deduced from the published sequences and via conventional PCR, the 
DNA sequence would be derived. Both the recombinant enzymes would then be characterized 
with respect to biochemical properties, molecular features and substrate spectrum and 
compared with the wild type of CPCR. In addition, the recombinant protein would be made 
available for easy purification using different optimized chromatographic methods. 
Furthermore, attempts would be made for downstream application of the recombinant enzyme 
in conventional and non-conventional media (organic solvents) using both soluble and 
immobilized enzyme. The enzymatic synthesis in organic solvents is particularly of interest 
due to the possibility of stereospecific reductions of industrially important hydrophobic 
substrates like acetophenone and its derivatives. Immobilization of the recombinant enzyme 
would be carried out via entrapment in hydrogels and covalent binding and the immobilisate 
would be employed for synthesis in organic solvents which serves as the substrate reservoir. 
The stability and activity of the soluble enzyme (in pure aqueous and in aqueous-organic 
system) would then be compared with the immobilisate in an aqueous-organic two-phase 
system. 
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2 Materials and Methods 
2.1  Materials 
2.1.1 Chemicals  
 
Agar  Beco (Nuernberg, Germany)   
Acrylamide-Bisacrylamide-Solution                          MP Biomedicals (Aurora, USA) 
BIO-RAD Protein Assay                                            Bio-Rad Laboratories GmbH (Munich,  
  Germany) 
DAB-substrate Roche Applied Science (Mannheim, 
   Germany) 
Glucose-Monohydrate   Roquette GmbH (Frankfurt, Germany) 
Glycogen    Serva (Heidelberg, Germany) 
Isopropyl-β-D-thiogalactopyranoside        Qbiogene (Heidelberg, Germany)    
Siliconoil                                                                     Drawin (Wacker-Chemie, Munich  
  Germany) 
SeaKem LE Agarose                                                   FMC BioProducts (Rockland, USA) 
    
All other chemicals not mentioned here were of high technical grade and obtained from 
Sigma (Steinheim, Germany), Aldrich (Taufkirchen, Germany), Fluka (Neu-Ulm, Germany), 
Merck (Darmstadt, Germany) or Roth (Karlsruhe, Germany). Growth media components 
were bought from Difco (Detroit, USA), Ohly (Hamburg, Germany) or Roth (Karlsruhe, 
Germany). All substrates for the carbonyl reductase were obtained from Aldrich (Taufkirchen, 
Germany), Fluka (Neu-Ulm, Germany), Lancaster (Frankfurt a. M., Germany) or Merck 
(Darmstadt, Germany) and were of the highest quality. 
 
Cofactors 
 
NAD + (ß- nicotinamide adenine dinucleotide; oxidized form) was purchased from Fluka (Neu 
Ulm, Germany).  The reduced form of the cofactor NADH + H+ (ß-nicotinamide adenine 
dinucleotide; Reduced di-sodium salt; > 99.5%), was obtained from Juelich Fine Chemicals 
(Juelich, Germany).  
 
 
 
  
2 Materials and Methods 18
2.1.2 Devices 
 
Agarose gel electrophoresis chamber Bio-Rad (Munich, Germany) 
Centrifuge (Sorvale® RC5B-Refrigerated DuPont Instruments (Bad Hamburg, Germany) 
Superspeed Centrifuges) 
Chamber for Western blot-Analysis  Invitrogen (Karlsruhe) 
(Xcell SureLockTM Mini-Cell with   
XCell IITM Blot Module) 
FPLC (LKB-Controller, LCC-501 Plus) Pharmacia (Uppsala, Sweden) 
Gas chromatograph (HP 5890 Series II) Hewlett Packard (Walbronn, Germany) 
HPLC  Beckmann Coulter System Gold (Munich, 
                                                                        Germany) 
Incubation shaker (Multitron II)  Infors AG ( Bottmingen, Schwitzerland) 
Lab shaker    IKA®-Werke GmbH & CO. KG (Staufen) 
Lyophilizer  Schrader (Friedland, Germany) 
Microplate Reader Spectramax Plus 340 Molecular Devices (Munich, Germany) 
Microscope DM RB  Leitz (Wetzlar, Germany) 
Over-head-shaker (RK 10-VS)  Heto Lab Equibment (Allerod, Denmark) 
Protein gel chamber (Mini Protean II) Bio-Rad Laboratories (Munich, Germany) 
Spectrophotometer DU®Series  Beckmann (Fullerton, CA) 
Table centrifuge (GS-15R-Zentrifuge) Beckmann (Munich, Germany) 
Table centrifuge  (Minispin Plus) Eppendorf (Hamburg, Germany) 
Thermoblock (Thermomixer 5436) Eppendorf (Hamburg, Germany) 
Thermo-PCR-Cycler GeneAmp® PCR Applied Biosystems (Foster City, USA) 
System 9700 
Ultrasonication device (Sonopuls  Bandelin Electronic (Berlin, Germany) 
HD200 with Micro tip MS73) 
UV- Transilluminator Gel Doc 2000TM Bio-Rad Laboratories (Munich, Germany)  
Vivaspin-Concentrator 20 ml  Vivascience, Sartorius group (Goettingen, 
                                                                        Germany) 
Vortex (REAX 2000)  Heidolph Instruments (Schwabach, Germany) 
 
Chromatography matrices 
 
Anion Exchange: Macro Prep High Q                               Bio-Rad (Munich, Germany)  
IMAC: Ni-NTA Superflow and Ni-NTA Agarose        Qiagen GmbH (Hilden, Germany) 
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2.1.3 Cultivation media 
 
All media for cell cultivation namely LB-medium and TB-medium were based on the 
standard protocols (Sambrook et al., 1989). The protocol for yeast medium was as described 
by DSMZ, Germany. If a percentage is given for a component in media or buffer recipes 
(e.g.10% NaCl), it describes a weight per volume ratio. Solidified agar plates were made with 
2% agar. 
 
LB medium 
Tryptone            1% 
NaCl                  1%              
Yeast extract      0.5% 
 
Deionized water as required. The pH was adjusted to 7.2 with NaOH. The solution was 
autoclaved for 20 minutes at 121 °C.   
 
TB medium 
Deionized water, to 900 ml 
Glycerol              4 ml 
Tryptone             12 g 
Yeast extract       24 g  
 
The components were shaken until the solutes had dissolved and then sterilized by 
autoclaving for 20 minutes at 121 °C. The solution was allowed to cool to 60 °C or less, and 
then 100 ml of a sterile solution of 0.17 M KH2PO4, 0.72 M K2HPO4 was added. (This 
solution was made by dissolving 2.31 g of KH2PO4 and 12.54 g of K2HPO4 in 90 ml of 
deionized H2O. After the salts had dissolved, the volume of the solution was adjusted to 100 
ml with deionized H2O and sterilized by autoclaving for 20 minutes at 121 °C.) 
 
Yeast medium 
Yeast extract       0.3% 
Malt extract        0.3% 
Peptone               0.5% 
Glucose               1% 
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Deionized water as required. The solution was autoclaved for 20 minutes at 121 °C.   
 
SOC medium (100 ml) 
Tryptone                   2 g 
Yeast extract        0.5 g 
1 M NaCl             1 ml 
1 M KCl                   0.25 ml 
2 M Mg2+ stock,       1 ml 
(filter-sterilized) 
2 M glucose,     1 ml 
(filter-sterilized) 
 
Tryptone, yeast extract, NaCl and KCl were added to 97 ml deionized water and stirred to 
dissolve. This was then autoclaved for 20 min at 121 °C and cooled down to room 
temperature. 2 M Mg2+ stock and 2 M glucose were then added, each to a final concentration 
of 20 mM. The final volume of the solution was then brought to 100 ml with sterile, deionized 
water.  
 
2 M Mg2+ stock 
MgCl2.6H2O            20.33 g   
MgSO4.7H2O    24.65 g 
 
Deionized water was added to 100 ml and the solution was filter sterilized. 
 
Stock solutions for antibiotics 
Ampicillin            100 mg/ml in deionized water. Filter sterilized through 0.2 µm filter  
                             membranes. Stored at –20 °C. Used at 100 µg/ml. 
Kanamycin 30 mg/ml in deionized water. Filter sterilized through 0.2 µm filter 
                             membranes. Stored at –20 °C. Used at 30 µg/ml. 
 
2.1.4 Microorganisms 
 
Candida parapsilosis DSMZ 70125  
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E. coli DH5α   [(supE44 ∆lacU169 Φ80 lacZ∆M15) hsdR17 recA1 
gyrA96 thi-1 relA1] (Pharmacia) 
 
E. coli JM109               [recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi ∆ (lac-proAB) 
F’(traD36 proAB+ lacIq lacZ∆M15)] (Stratagene) 
 
EZ competent cells [F'::Tn10(Tcr) proA+B+ laclqZ∆M15] recA1 end A1  
                                         recA1 end A1 hsdR17 (rK12– mK12+) lac glnV44 thi-1 gyrA96 
                                         relA1 (Qiagen) 
 
E.coli BL21(DE3)  [B F- ompT hsdSB (rB- mB-) gal dcm (DE3)] (Novagen) 
 
 
2.1.5 Vectors 
 
pKK223-3 4584 bp, ColE1-Replicon, Ptac, AmpR  (Pharmacia)  
 
pDrive 3851 bp, ColE1-Replicon, LacZ ∝-peptide,PT7,PSP6 
                                                     AmpR, KanR (Qiagen) 
 
pET-26b(+) 5360 bp, ColE1-Replicon, PT7lac, KanR (Novagen) 
    
2.1.6 Materials for Molecular biology work 
 
Antibody- conjugate Anti-His6-Peroxidase  Roche Applied Science (Mannheim,   
                                                                                    Germany) 
Advantage2 Polymerase Mix    BD Biosciences (Heidelberg, Germany) 
Calf Intestine Alkaline Phosphatase   MBI Fermentas (St. Leon-Rot, Germany) 
Eppendorf® HotmasterMix    Eppendorf (Hamburg, Germany) 
GeneRuler 1 kb DNA Ladder    MBI Fermentas (St. Leon-Rot, Germany) 
Isis-& GoTM Mastermix    Qbiogene (Heidelberg, Germany) 
PageRulerTM Prestained Protein Ladder  MBI Fermentas (St. Leon-Rot, Germany) 
PageBlueTM Protein Staining Solution  MBI Fermentas (St. Leon-Rot, Germany) 
PVDF Membrane     Invitrogen (Karlsruhe, Germany) 
Restriction Enzymes     MBI Fermentas (St. Leon-Rot, Germany)                  
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T4 DNA Ligase     MBI Fermentas (St. Leon-Rot, Germany) 
TripleMaster® PCR System    Eppendorf (Hamburg, Germany) 
Kits 
 
BD Universal GenomeWalker Kit   BD Biosciences, Clontech (Heidelberg, 
                                                                                    Germany) 
E.Z.N.A. Gel Extraction Kit    PEQLAB (Erlangen, Germany) 
E.Z.N.A. Plasmid Miniprep Kit I   PEQLAB (Erlangen, Germany) 
PCR Cloning Plus Kit     Qiagen (Hilden, Germany) 
PCR Purification Kit     Qiagen (Hilden, Germany) 
  
The above-mentioned materials were used according to the manufacture’s instructions. 
2.2 Microbiological methods 
2.2.1 Conservation and storage of microbiological strains 
 
For long-term storage of E.coli cells, cryo-cultures were made either with DMSO or with 
glycerol. 
 
DMSO  
 A single colony was picked up from LB-agar plate and inoculated into a 5 ml liquid LB 
medium containing appropriate antibiotic if required, incubated at 37 °C on a shaker until the 
OD660 reached 0.8. This culture was transferred to cryo-vials and then 5% (v/v) of sterile 
DMSO was added. The cells were shock-frozen in liquid nitrogen and stored at –80 °C. 
 
Glycerol 
 This method was used for preparing stock cultures of E.coli cells harboring either pET 
vectors or pET recombinants. For this, a single colony was picked up from LB-agar plate and 
inoculated into a 5 ml liquid LB medium containing appropriate antibiotic if required, 
incubated at 37 °C on a shaker with vigorous shaking until the OD600 reached 0.6-0.8. Then 
0.9 ml of the culture was removed and transferred to a cryo-vial, and 0.1 ml of 87% glycerol 
was added. The culture was mixed well and stored at –80 °C. 
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2.2.2 Cell cultivation 
 
Cell cultivation was carried out either in shake-flasks with baffles or in solidified agar plates 
with the media composition as described in section (2.1.3). 
 
Candida parapsilosis  
The cells were grown overnight either in liquid yeast medium at 37 °C in a shaker incubator 
at 200-250 rpm, or on agar-solidified (2%) yeast-medium plates. 
 
Escherichia coli 
E.coli strains were grown in LB or TB medium at 37 °C, 140-200 rpm, in a volume ranging 
from 10-1000 ml in shake flasks with baffles by inoculating one colony from agar plate or 
with preculture in a ratio of 1:25 or 1:50 (4-2% v/v). The ratio between the volume of the 
media and the volume of the shake flask was 1:5 (e.g. 100 ml media was used for cultivation 
in a shake flask having a volume of 500 ml). For isolation of vector material or for screening 
of clones, E.coli strains harboring plasmids were grown overnight at 37 °C in a shaker 
incubator at 140-160 rpm containing necessary antibiotic in the media composition. 
 
Expression of recombinant CpSADH and recombinant CPCR in E.coli  
The expression of carbonyl reductase was carried out in two different types of E.coli strains 
namely, JM109 and BL21(DE3). The recombinant constructs JM109pKK223-3CpSADH18 
(containing the gene for CpSADH) and JM109pKK223-3CPCR9 (containing the gene for 
CPCR) was constructed without His6-tag on the gene of interest. The other set of recombinant 
constructs BL21(DE3)pET26b+CpSADH28his (containing the gene for CpSADH) and 
BL21(DE3)pET26b+CPCR9his (containing the gene for CPCR) was constructed with His6-
tag on the N-terminal of the gene of interest. 
 
Without His6-tag: 
 The E.coli strain JM109, containing the recombinant CpSADH and CPCR gene was grown 
overnight in 10-200 ml TBamp or LBamp medium at 37 °C, 140 rpm. This overnight preculture 
was then added to 100-4000 ml of the main culture in a ratio of 1:25 or 1:50 (preculture: main 
culture) and grown at 30 °C, 100-120 rpm, until the OD550 reached 1.2-1.6 (between early and 
mid-log phase). At this point the induction for protein expression was carried out by the 
addition of 1 mM IPTG and the production strains were cultivated for an additional 6 hours 
also at 30 °C and 100-120 rpm. After the induction phase, the cells were harvested by 
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centrifugation at 20000 rpm for 10 min at 4 °C. The supernatant was discarded and the pellets 
were washed with ice-cold 20 mM TEA-HCl (pH 8) and re-centrifuged with the same 
conditions as stated above. The supernatant was again discarded and the pellets were stored at 
–20 °C till use. 
 
With His6-tag:  
 The E.coli strain BL21(DE3), containing the recombinant CpSADH and CPCR gene with an 
N-terminal His6-tags was grown overnight in 10-200 ml TBkan medium at 37 °C, 140 rpm. 
This overnight preculture was then added to 100-4000 ml of the main culture (TBkan medium) 
in a ratio of 1:50 (preculture: main culture) and grown at 30 °C, 100-120 rpm, until the OD600 
reached 0.6-0.8. At this point the induction for protein expression was carried out by the 
addition of 1 mM IPTG and the production strains were cultivated for an additional 6 hours at 
28 °C and 100-120 rpm. After the induction phase, the cells were harvested by centrifugation 
at 20000 rpm for 10 min at 4 °C. The supernatant was discarded and the pellets were washed 
with ice-cold 20 mM Tris-HCl (pH 8) and re-centrifuged with the same conditions as stated 
above. The supernatant was again discarded and the pellets were stored at –20 °C till use. 
 
2.2.3 Cell disruption and preparation of cleared E.coli lysates under native    
conditions 
 
E.coli cells were disrupted by ultra-sonication on ice using a sonicator equipped with a 
microtip (Sonopuls HD200). 
 
Lysis of recombinant constructs JM109pKK223-3CpSADH18 and JM109pKK223-
3CPCR9 
The frozen pellets were thawed on ice for 15 min and resuspended with Lysis Buffer I at 4 ml 
per gram wet weight of cells. Lysozyme was added to a final concentration of 1 mg/ml and 
the cell suspension was thereby incubated on ice for 30-40 min. Sonication was carried out 
with sonicator using four 1 min bursts with 70% intensity and with a 1 min cooling period 
between each burst. The lysate was centrifuged at 20000 rpm for 20-30 min at 4 °C to pellet 
the cellular debris. The supernatant was stored and used as cell free cleared lysate (crude 
extract) for further experiments e.g. protein purification (2.4.3) or activity tests (2.4.2). 
Lysis Buffer I:   50 mM as well as 100 mM TEA-HCl (pH: 8.3 as well as 7.5). 
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Lysis of recombinant constructs BL21(DE3)pET26b+CpSADH28his and 
BL21(DE3)pET26b+CPCR9his 
The frozen pellets were thawed on ice for 15 min and resuspended with Lysis Buffer II at 4 
ml per gram wet weight of cells. Lysozyme was added to a final concentration of 1 mg/ml and 
the cell suspension was thereby incubated on ice for 30-40 min. Sonication was carried out 
with sonicator using six 30 sec bursts with 70% intensity and with a 1 min cooling period 
between each burst. The lysate was centrifuged at 20000 rpm for 20-30 min at 4 °C to pellet 
the cellular debris. The supernatant was stored and used as cell free cleared lysate (crude 
extract) for further experiments e.g. protein purification (2.4.3) or activity tests (2.4.2). 
Lysis Buffer II (1 liter):  
50 mM NaH2PO4  6.90 g NaH2PO4.H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
10 mM imidazole  0.68 g imidazole (MW 68.08 g/mol) 
 
The pH was adjusted to 8.0 using NaOH. 
 
2.2.4 Preparation of competent cells of E.coli 
 
Competent cells of the E.coli strains (2.1.4) were made by the methods of RbCl (Hanahan, 
1983) and CaCl2 (Cohen et al., 1972). 
 
Preparation according to Hanahan (1983):   
One single colony of E.coli strain was removed and inoculated in 10 ml of LB-medium. The 
E.coli cells were grown overnight at 37 °C in a shaker incubator at 140 rpm. 1 ml of the 
overnight culture was added to 100 ml of prewarmed LB-broth and the culture was shaken at 
37 °C and 200 rpm until an OD600 of 0.5 was reached (approximately 90-120 min).  The 
culture was then cooled on ice for 5 min and transferred to a sterile centrifuge tube. The cells 
were collected by centrifugation at low speed (5 min, 4000 x g, 4 °C). The supernatant was 
removed carefully and the cells were always kept on ice. The cells were resuspended gently in 
cold (4 °C) TfBI solution (30 ml for a 100 ml culture) and the suspension was kept on ice for 
an additional 15 min. The cells were thereby collected by centrifugation (5 min, 4000 x g, 4 
°C). The supernatant was carefully removed always keeping the cells on ice. The cells were 
then gently resuspended in 4 ml of ice-cold TfBII solution. Aliquots of 200 µl of the cell 
suspension were prepared in sterile microcentrifuge tubes and shock-frozen in liquid nitrogen. 
The competent cells were stored at –80 °C. 
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TfBI solution (200 ml)    TfBII solution (100 ml) 
100 mM RbCl  2.42 g   10 mM RbCl  0.12 g 
50 mM MnCl2.4H2O   2.98 g   10 mM MOPS  0.21 g 
30 mM K-acetate 0.59 g   75 mM CaCl2.2H2O 1.10 g 
10 mM CaCl2.2H2O 0.29 g   15% glycerol  18.50 g 
15% glycerol  36.9 g   H2O   added up to 100 ml 
H2O added up to 200 ml 
 
For TfBI, the pH was adjusted to 5.8 with acetic acid whereas for TfBII the pH was adjusted 
to 6.8 with 1 M NaOH. Each of the solutions was filter-sterilized with 0.2 µm diameter filters 
and stored at 4 °C till use. 
 
Preparation according to Cohen (1972):   
One single colony of E.coli strain was removed and inoculated in 5 ml of LB-medium. The 
E.coli cells were grown overnight at 37 °C in a shaker incubator at 250 rpm. 700 µl of the 
overnight culture was added to 100 ml of prewarmed LB-broth in a sterile 1-L shake-flask 
with baffles, and the culture was shaken at 37 °C and 250 rpm until an OD590 of 0.4-0.5 was 
reached. Aliquots of the culture were then prepared in two 50-ml pre-chilled, sterile 
polypropylene tubes and incubated on ice for 5-10 min. The cells were kept cold for all the 
steps. Cells were collected by centrifugation for 7 min at 1600 x g and 4 °C. The supernatant 
was carefully removed and each of the pellets was resuspended very gently in 10 ml of ice-
cold CaCl2 solution. The cells were collected by centrifugation for 5 min at 1100 x g and 4 
°C. The supernatant was carefully removed and each of the pellets was resuspended very 
gently again in 10 ml of ice-cold CaCl2 solution. The resuspended cells were then kept on ice 
for 30 min. The cells were collected by centrifugation for 5 min at 1100 x g and 4 °C. The 
supernatant was carefully removed and each of the pellets was finally resuspended gently but 
very well in 2 ml of ice-cold CaCl2 solution. The cells were dispensed in 200 µl volume into 
prechilled, sterile microcentrifuge tubes and immediately frozen at –80 °C. 
CaCl2 solution 
CaCl2  100 mM 
Glycerol 15% 
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2.3 Molecular biology methods 
2.3.1 Preparation of C.parapsilosis genomic DNA (gDNA) 
 
The total genomic DNA from C.parapsilosis was isolated by lysis of the cells. The yeast cells 
were grown overnight in liquid yeast medium (100-150 ml). The overnight culture was 
harvested at 4000-5000 rpm for 5-10 min and then washed with sterile deionized water. The 
cells were resuspended in 3 ml of 0.9 M sorbitol + 0.1 M EDTA (pH 7.0). This was followed 
by the addition of 0.1 ml of 2.5 mg/ml zymolase100T + 0.05% 2-mercaptoethanol and 
incubated at 37 °C for 1 h. Then the spheroplasts were harvested. At this point if lysis of the 
cells occurs, there is no need to resuspend the cells in 5 ml of 50 mM Tris + 20 mM EDTA 
(pH 7.0). 0.5 ml of 10% SDS and 5 mg of protease K were added and then incubated at 60 °C 
for 30 minutes. To this, 0.5 ml of 5 M potassium acetate was added and stored on ice for 1 h. 
This was centrifuged at 10000 rpm for 10 min. The supernatant was transferred to a fresh tube 
and 2 volumes of 100% ethanol was added at room temperature, and then stored at –20 °C for 
4-5 h (it is also possible to store at –20 °C for 1-2 days). This was centrifuged at 5000-6000 
rpm for 15 min and the supernatant was discarded. The pellets were dried and resuspended in 
3 ml of TE (this may take few hours), centrifuged at 10000 rpm for 15 minutes to remove any 
remaining debris and the supernatant was transferred to another tube. 0.15 ml of DNAse free 
RNAse was added and incubated for 30 min at 37 °C. Then one volume of 100% 2-propanol 
was added and gently shaken to mix. At this point the DNA precipitated looking like a 
cocoon. If no cocoon is observed, then a further centrifugation at 5000 rpm for 10 min is 
needed. Then the DNA was washed twice with 70% ethanol, each time discarding the 
supernatant. The DNA was then resuspended in TE (about 1.5 ml) or sterilized deionized 
water. The purified gDNA was stored at –20 °C. 
TE 10 mM Tris-HCl, pH 7.5 
 1 mM EDTA, pH 8  
 
2.3.2 Construction of genomic DNA libraries 
 
The genomic DNA libraries of C.parapsilosis were prepared as described in the user’s manual 
of the Universal Genome Walker kit (BD Biosciences, Clontech). Four libraries were 
constructed with the genomic DNA of C.parapsilosis by digesting with four different 
restriction enzymes (Blunt-end cutters) included in the kit namely, EcoRV, DraI, StuI and 
PvuII. The kit also provides human genomic DNA as positive control library that has to be 
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digested with PvuII, and a pre-constructed human genome-walker library. Each of the 
digested DNA libraries was ligated to the genome walker adaptor. The digested and ligated 
libraries were stored at –20 °C till use. For long-term storage the libraries can also be stored at 
–80 °C. 
 
2.3.3 Synthetic DNA-oligonucleotides  
 
 As a guideline for oligonucleotide primers, the Tm-value, that is the temperature in which 
50% of the strands are denatured, was determined as described below. As a starting point, an 
annealing temperature at least 5 °C below Tm was chosen. All the primers were always 
constructed in the 5’-3’ direction and were synthesized from Metabion (Martinsried, 
Germany) or from Biomers (Ulm, Germany) at the highest purity (HPLC grade) having a 
concentration of 100 pmol/µl. 
Tm = 2 °C x (A+T) + 4 °C x (G+C) 
 
For genome walking: 
Two gene-specific primers - one for primary PCR (GSP1) and one for nested PCR (GSP2) 
were designed taking a few aspects in consideration: The nested PCR primer should anneal to 
sequences beyond the 3’end of the primary PCR primer (i.e. upstream of the primary PCR 
primer when walking upstream and downstream of the primary PCR primer when walking 
downstream). The primers were constructed with at least 30 nucleotides in length and with a 
G/C-content of 40-60% taking into account the partial amino acids sequences of the wtCPCR.  
 
SET A:               (3´- TCG-TTA-TCG-CAT-AAC-TTA-TCG-GTT-ACT-TGG-5´) 
Primer CPCR-R1b: 5´- AGC-AAT-AGC-GTA-TTG-AAT-AGC-CAA-TGA-ACC-3´ 
  (For primary PCR)   (3´- GTT-TGG-TGG-TGG-TCG-TGG-ACT-TTA-TGT-TTG-5´) 
Primer CPCR-R2b: 5´- CAA-ACC-ACC-ACC-AGC-ACC-TGA-AAT-ACA-AAC-3´ 
  (For nested PCR) 
 
SET B: 
Primer CPCR-V1: 5’- ATA-ACA-ATA-TAA-ATA-GAC-CAC-GAG-GGA-ATG-3’ 
(For primary PCR) 
 
Primer CPCR-V2: 5’- ATG-CCA-ATT-GGC-TCA-ACA-CAT-TTC-TTT-CAT- 3’ 
(For nested PCR) 
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The primers of SET B were designed based on the amplified PCR product with the primers of 
SET A. 
 
For gene specific amplifications: 
The forward and the reverse primers for the amplification of the CpSADH gene from 
C.parapsilosis DSMZ 70125 strain were derived from the nucleotide sequence coding for the 
same gene from C.parapsilosis IFO 1396 (Kojima et al., 1995). The forward and the reverse 
primers for the amplification of the CPCR gene were based on the nucleotide sequence of the 
PCR product that was generated with the primer combinations of SET B and adaptor primers. 
The list of primers is as follows: 
 
ADH-J1 5’-CCG AAT TCC ATG TCA ATT CCA TCA AGC CAG-3’ 
ADH-J2 5’-CCC AAG CTT CTA TGG ATT AAA AAC AAC TCT-3’ 
CPCR-F1A 5’-CCG AAT TCC ATG CCA ATT GGC TCA ACA CAT-3’ 
CPCR-F2 5’-CCC CTG CAG TTA CTT GCT GGT GTC AAG TAC-3’ 
JADH-NHis 5’-CCC CAT ATG CAC CAT CAT CAT CAC CAC ATG TCA ATT CCA   
  TCA AGC CAG-3’   
JADH-CXho 5’-CCC CTC GAG CTA TGG ATT AAA AAC AAC TCT-3’ 
CPCR-Nhis 5’-CCC CAT ATG CAC CAT CAT CAT CAC CAC ATG CCA ATT GGC 
 TCA ACA CAT-3’  
CPCR-CXho 5’-CCC CTC GAG TTA CTT GCT GGT GTC AAG TAC- 3’ 
 
2.3.4 Polymerase chain reaction (PCR) 
 
Specific DNA fragments can be amplified in vitro with the help of PCR (Mullis and Faloona, 
1987). Through the different cycles of PCR namely denaturation, annealing of the primers 
and elongation (extension) of DNA, it is possible to have an exponential amplification of the 
DNA template as because every newly built DNA fragment serves as a starting material for 
the following reaction.  In the reactions, gDNA (2.3.1) or constructed libraries (2.3.2) were 
used as templates for the specific primers. The DNA fragments were amplified with 
thermostable polymerases. For preparative methods such as cloning of DNA fragments, all 
the PCR products were purified with the PCR Purification kit (Qiagen). 
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PCR set-up for the amplification of the constructed libraries with the Genome Walker 
kit using adaptor primers: 
PCR technique was used for walking the gene and amplification of the adaptor ligated gDNA 
libraries of C.parapsilosis. Two PCR reactions followed: Primary PCR and secondary or 
nested PCR. Two primers were used in each PCR reaction: Adaptor primer 1(AP1) and gene-
specific primer (GSP1) for the primary PCR, while adaptor primer 2 (AP2) and gene-specific 
primer (GSP2) for the nested PCR.  
 
The polymerase used was Advantage 2 Polymerase Mix (BD Biosciences). This mix contains 
a mixture of two different polymerases. The simultaneous use of two different DNA 
polymerases (primary and proofreading) in a PCR reaction allows amplification of 
significantly longer fragments in a process known as long and accurate PCR or long-distance 
PCR (LD PCR) (Barnes, 1994; Cheng et al., 1994). However, the usefulness of two-enzyme 
systems is not limited to LD PCR. In fact, the efficiency of most PCR reactions can be 
significantly improved by using the two-enzyme combination. Advantage 2 Polymerase Mix 
contains the Taq polymerase and a minor amount of proofreading polymerase. The inclusion 
of a minor amount of a proofreading polymerase results in an error rate that is 3-fold lower 
than that of conventional PCR with Taq alone (Barnes, 1994; Frey et al., 1995; Nelson et al., 
1995). This Mix also contains TaqStart antibody, which has been shown to significantly 
improve the efficiency and specificity of PCR amplifications by reducing background DNA 
synthesis (Kellogg et al., 1994). This polymerase leaves a single 3’A-overhang on the 
amplified PCR product and therefore the product can be cloned into any vector having a T- or 
U-overhang.  
 
The gene-specific primers used were either from SET A or from SET B (see 2.3.3). Both the 
adaptor primer 1 (AP1) and adaptor primer 2 (AP2) were supplied with the kit. The PCR 
reactions were set up as described in the user’s manual of the Genome Walker kit. A 
“Touchdown (TD)” PCR was followed in order to get a more precise amplified PCR product 
without any background and to get rid of unspecific products (Hecker and Roux, 1996; Roux, 
1995; Don et al., 1991).  
 
The cyclic parameters for the primary and nested touchdown PCR were as follows: 
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Primary TD PCR Nested TD PCR 
94 °C 2 sec  
72 °C 3 min 
7 cycles 
94 °C   2 sec 
72 °C   3 min 
5 cycles 
94 °C 2 sec 
70 °C   3 min 5 cycles 
94 °C 2 sec 
70 °C 3 min 5 cycles 
94 °C 2 sec 
67 °C 3 min 32 cycles 
94 °C 2 sec 
67 °C 3 min 19 cycles 
67 °C for an additional 4 min 67 °C  for an additional 4 min 
4 °C cooling              ∝ 4 °C cooling              ∝ 
 
 
PCR set-up for the amplification of CpSADH and CPCR without His6-tag: 
For amplification of both the genes, the DraI digested library of C.parapsilosis was used as a 
template. Isis & GoTM Mastermix was used as the source of DNA polymerase. ISIS DNA 
polymerase is a highly accurate, thermostable DNA polymerase. It is a recombinant enzyme, 
originally isolated from Pyrococcus abyssi Orsay strain (Dietrich et al., 2002; Gueguen et al., 
2001). For the amplification of the CpSADH gene, the primer combination of ADH-J1 
(forward) and ADH-J2 (reverse) were used (see 2.3.3). For the amplification of CPCR gene, 
the primer combination of CPCR-F1A (forward) and CPCR-F2 (reverse) were used (see 
2.3.3). The PCR reaction set-up for both the genes was the same, which is as follows: 
PCR reaction set-up: 
Components     Volume   Concentration 
Isis & GoTM Mastermix (5 x)   10 µl    1 x 
Dra I digested library    2 µl    0.6 ng   
Forward primer    12 µl    24 pmole 
(2 pmole/µl) 
Reverse primer    12 µl    24 pmole 
(2 pmole/µl) 
Sterile deionized H2O    14 µl    -- 
Total volume     50 µl     
 
The PCR cyclic parameters for amplification of CpSADH and CPCR were: 
 
Steps   CpSADH  CPCR   Time  Cycles 
Denaturation  93 °C   93 °C   5 min  1  
Denaturation  93 °C   93 °C   30 sec 
Annealing  50 °C   55 °C   30 sec  30 
Elongation  72 °C   72 °C   2 min   
Cooling  4 °C   4 °C   ∝  -- 
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PCR set-up for the amplification of CpSADH and CPCR with His6-tag: 
For amplification of both the genes, the DraI digested library of C.parapsilosis was used as a 
template. For the amplification of the CpSADH gene with His6-tag on the N-terminal, the 
primer combination of JADH-NHis (forward) and JADH-CXho (reverse) were used (see 
2.3.3). For the amplification of CPCR gene with His6-tag on the N-terminal, the primer 
combination of CPCR-Nhis (forward) and CPCR-CXho (reverse) were used (see 2.3.3). The 
PCR reaction set-up for both the genes was the same, which is as follows: 
PCR reaction set-up: 
Components   Volume  Concentration   
TripleMaster Polymerase Mix (5 U/µl) 0.5 µl   0.05 U/µl 
Dra I digested library   5 µl   1.5 ng    
Forward primer    2 µl   10 pmole 
(5 pmole/µl) 
Reverse primer    2 µl   10 pmole 
(5 pmole/µl) 
Sterile deionized H2O    up to 50 µl  -- 
Total volume     50 µl 
 
The PCR cyclic parameters for amplification of CpSADH and CPCR with His-tags were: 
 
Steps   CpSADH-his  CPCR-his  Time  Cycles 
Denaturation  94 °C   94 °C   2 min  1 
Denaturation  94 °C   94 °C   20 sec 
Annealing  50 °C   55 °C   20 sec  32 
Elongation  72 °C   72 °C   1 min   
Final elongation 72 °C   72 °C   1 min  1 
Cooling  4 °C   4 °C   ∝  -- 
 
 
2.3.5 Agarose gel electrophoresis 
 
Analytical as well as preparative gel electrophoresis of double-stranded DNA fragments were 
performed in 0.5-1.5% agarose gels (Aaij and Borst, 1972; Helling et al., 1974; Sambrook et 
al., 1989) supplemented with ethidium bromide (final concentration 0.5 µg/ml). The agarose 
was dissolved in 1x TAE buffer. Before loading on the gel, the DNA samples were mixed 
with 1 x DNA-loading buffer (end concentration). For determination of fragment size and 
concentration estimation, a defined amount of DNA size marker (GeneRulerTM 1 kb DNA 
Ladder) was included. Bands were visualized using a UV transilluminator at 312 nm. In 
preparative electrophoresis, the desired DNA fragment was excised using a scalpel under the 
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UV. The excised fragment isolated from the gel was then purified with the “E.N.Z.A. Gel-
extraction kit” (PEQLAB). 
50 x TAE buffer, pH 8 (1 liter)    6 x DNA-loading buffer   
Tris base 242 g  Tris-HCl (pH 7.6) 10 mM 
Glacial acetic acid 57.1 ml  Glycerol  60% (v/v)  
EDTA 18.6 g  EDTA   60 mM 
Deionized water up to 1 l    Bromophenol blue 0.03% (w/v) 
 
2.3.6 Plasmid DNA isolation from E.coli 
 
Alkaline lysis:   
For screening of positive transformants, alkaline lysis (Birnboim and Doly, 1979) was done 
for plasmid isolation. The method involves 3 steps: first washing with RNAse solution, 
second lysis of the cells with lysis buffer and third precipitation with Na-acetate. A single 
colony was inoculated in 5 ml of LB(antibiotic) medium and grown overnight at 37 °C. The 
overnight culture was harvested by centrifugation for 10 min at 5000 rpm. The supernatant 
was discarded and the pellets were suspended by vortexing in 400 µl of ice-cold Solution A. 
To the suspension, 800 µl of Solution B was added and mixed by inverting the tube several 
times. Care should be taken not to vortex the suspension.  The mixture was incubated on ice 
for 5 min and then, 600 µl of ice-cold Solution C was added and mixed by inverting the tube 
several times. A second incubation was done on ice for 15 min followed by centrifugation (4 
°C, 13000 rpm, 10 min). 400 µl of the supernatant was taken in a fresh microcentrifuge and 
260 µl of 2-propanol was added and incubated at –20 °C for 2 h. The DNA was collected by 
centrifugation (4 °C, 13000 rpm, 15 min). The supernatant was discarded carefully and the 
DNA was washed with 100 µl of 70% ethanol and centrifuged in vacuum till all of the ethanol 
was removed. The isolated plasmid DNA was then suspended in 50-100 µl of 10 mM Tris-
HCl (pH 8). With the help of restriction analysis (2.3.7) and agarose gel electrophoresis 
(2.3.5), the plasmid-DNA was checked for insertion of the vector/insert constructs. 
Solution A:    Solution B:  Solution C: 
Glucose  50 mM  NaOH  0.2 N  Sodium acetate (pH 4.8)     3 M 
EDTA   10 mM  SDS  1% (w/v) 
Tris-HCl (pH  8) 25 mM 
RNAse A/ml  100 µg 
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Plasmid MiniPrep Kit: 
Different amounts of plasmid DNA after the alkaline lysis could be isolated through the 
membrane columns (Ish-Horowitz and Burke, 1981) of E.N.Z.A. Plasmid Miniprep Kit I 
(PEQLAB). 5 ml of the overnight culture of E.coli was centrifuged (10 min, 5000 rpm, 4 °C) 
and the plasmid-DNA was isolated following the manufacturer’s instructions. The eluted 
DNA was quite concentrated and clean for further cloning, restriction analysis, transformation 
or sequencing. 
 
2.3.7 DNA restriction digestion 
 
Digestion of the DNA with restriction endonucleases was performed in the buffer supplied 
with the restriction enzyme and in accordance with the suppliers’ recommendations for 
temperatures and duration of digestion. All the restriction endonucleases were bought from 
MBI Fermentas. Mostly digestion was done for 4-5 h (in case of EcoRI, PstI and HindIII) or 
up to 16 h (in case of NdeI and XhoI) using 10-20 U (EcoRI, PstI and HindIII) or 5-6 U (NdeI 
and XhoI) of the enzyme and 0.5-1.5 µg DNA. The digestion reaction was incubated at 37 °C 
and after completion of the restriction digestion, the reaction mix was analyzed by agarose gel 
electrophoresis (2.3.5). For preparative restriction digestion e.g., cloning of DNA fragments, 
reaction mix was purified with the PCR Purification kit (Qiagen) and quantified by agarose 
gel electrophoresis.  
 
2.3.8 5’ Dephosphorylation of DNA fragments 
 
The digested and linearized plasmids were dephosphorylated at its 5’-termini directly after 
restriction digestion with Calf Intestine Alkaline Phosphatase (CIAP, MBI Fermentas) for 60-
90 min at 37 °C with 1 U of CIAP in accordance with the suppliers’ recommendations. All the 
dephosphorylated linearized plasmid DNA was purified with the PCR Purification kit 
(Qiagen) directly after the dephosphorylation was completed. 
 
2.3.9 Ligation of DNA fragments 
 
PCR Cloning Plus Kit (Qiagen):  
This kit was used for UA cloning. For that, the DNA fragment (PCR product) was ligated into 
the pDrive cloning vector supplied with the kit. The DNA ligation reaction was carried out in 
a total volume of 10 µl. The protocol was followed as mentioned in the user’s manual. The 
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insert to vector molar ratio was adjusted to 8:1.The formula applied for estimating the 
concentration  (in ng) of the insert/PCR product to be used for the ligation is as follows: 
ng of the vector/PCR product required  =
Conc. of  the vector (ng) x PCR product size  (bp) x molar ratio
Size of the vector (bp)
 
 
Ligation of DNA fragments (“sticky-ends”):  
For other successive ligation reactions of the insert to vectors (e.g. pKK223-3 or pET26b+), a 
20 µl reaction volume was used with 5:1 molar ratio of insert to vector, 2-3 U of T4 DNA 
Ligase and 1x Ligation buffer (MBI Fermentas). The ligation mixture was incubated at 16-22 
°C overnight (16-18 h). Thermal inactivation was done at 65 °C for 20 min. A control ligation 
was always done with the vector alone without any insert to check for self-ligation of the 
vector. After ligation reaction was completed, the mix was used for transformation (2.3.10). 
 
2.3.10 Transformation and selection 
 
Blue-white selection:  
The blue-white selection is a method of differentiating transformants that carry the vector-
insert construct to those that do not carry any insert by using X-Gal (5-bromo-4-chloro-3-
indolyl-[beta]-D-galactopyranoside) and IPTG (Isopropyl-[beta]-D-thiogalactopyranoside) as 
selection markers (Ullmann et al., 1967). The pDrive cloning vector (Qiagen) is capable of 
blue-white selection and was used for selection of positive clones. Transformation of the 
plasmid was done using QIAGEN EZ competent cells (ready-to-use) according to the 
manufacturer’s instructions. As blue white selection was used, therefore X-Gal (80 µg/ml LB 
agar) and IPTG (0.05 mM final concentration) were included in the LB agar plates along with 
ampicillin (100 µg/ml LB agar). The plates were incubated at room temperature until the 
transformation mixture had absorbed into the agar. After that, the plates were inverted and 
incubated at 37 °C overnight (16-18 h). For blue-white selection, a second incubation at 4 °C 
was done for a few hours. This cold incubation enhances blue color development and thereby 
facilitates differentiation between blue colonies and white colonies. 
 
Transformation with heat-shock: 
Method 1: About 10 µl of the ligation mix or 10-20 ng of the circular vector DNA was added 
to 190 µl of thawed competent cells on ice and mixed by gentle tapping of the 
microcentrifuge tubes. This mix was incubated on ice for 30 min and then a heat shock was 
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given at 42 °C for 90 sec, after which a second incubation was done on ice for 5 min. To this, 
800 µl of LB medium (containing 20 mM MgSO4 and 10 mM KCl) was added and 
regeneration was done at 37 °C, 1200 rpm for 2 h on a thermo-mixer (Eppendorf). The 
transformation mixture was plated onto LB agar plates containing appropriate antibiotic for 
selection and incubated at 37 °C overnight (Hanahan, 1983). 
 
Method 2:  Alternatively, about 2-6 µl of the ligation mix was added to a prechilled 15-ml 
polypropylene tube and placed on ice. The competent cells were thawed on ice and mixed 
gently by mild tapping of the tubes. 100-200 µl of the cells were then transferred to the 
prepared tubes containing 2-6 µl of the ligation mix. This was gently mixed and incubated on 
ice for 20 min. A heat shock was given to the cells thereafter for 65 sec on a prewarmed water 
bath set exactly at 42 °C (without shaking), after which the tube was immediately placed back 
on ice for 2 min. To this, 900 µl room temperature SOC medium (2.1.3) was added and 
regeneration was done on a shaker incubator at 37 °C and 200-250 rpm for 1.5-2 h. 
 
2.3.11 Preparation of DNAse free RNAse 
 
The commercially available RNAse was made DNAse free by incubating the RNAse stock 
solution at 95 °C for 15 min.   
 
2.3.12 Sequencing 
 
For determination of the nucleotide sequences of DNA fragments of vector/insert constructs, 
sequencing was done by Sequiserve (Vaterstetten, Germany). Before sequencing, the 
recombinant plasmid DNA was purified with E.N.Z.A. Plasmid Miniprep kit (PEQLAB).  
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2.3.13 Description of cloning set-up of recombinant CPCR and CpSADH 
 
 
Table 1: Cloning set-up of recombinant CPCR (excluding genome walking). 
 
Expression vectors Cloning/Expression 
Strains (E.coli) 
Primers 
(Forward, Reverse) 
Restriction sites, 
His6-tag position 
pKK223-3 JM109 CPCR-F1A 
CPCR-F2 
EcoRI 
PstI 
pET-26b(+) DH5α, BL21(DE3) CPCR-Nhis 
CPCR-CXho 
NdeI, N-terminal 
XhoI 
Expression vectors Cloning/Expression 
Strains (E.coli) 
Primers 
(Forward, Reverse) 
Restriction sites, 
His6-tag position 
pKK223-3 JM109 ADH-J1 
ADH-J2 
EcoRI 
HindIII 
pET-26b(+) DH5α, BL21(DE3) JADH-NHis 
JADH-CXho 
NdeI, N-terminal 
XhoI 
 
Table 2: Cloning set-up of recombinant CpSADH. 
 
2.4 Biochemical and analytical methods 
2.4.1 Determination of protein  
 
Bradford method (Bradford, 1976) was used to measure the protein concentration of solutions 
with the help of spectrophotometer or microplate reader. This is based on the coomassie blue 
dye-binding assay in which a differential color change of the dye occurs in response to 
various concentrations of protein .The maximum absorbance of the dye shifts from 465 nm to 
595 nm when binding of protein occurs. The complex between the coloring dye and protein is 
formed after about 2 minutes and is stable for one hour in solution. The increase of the 
extinction is measured at 595 nm.  
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For determination of protein, 200 µl of Bio-Rad reagent was mixed with 800 µl of protein 
solution. Since the absorption is proportional to the protein quantity, the concentration of the 
protein solution can be determined over a linear calibration curve. The calibration curve was 
obtained with known protein concentrations of standard protein namely, bovine serum 
albumin (BSA, albumin fraction V) by reading the absorbance of the diluted BSA at 595 nm. 
The absorbance versus protein concentration curve was linear in the restricted protein 
concentration range (between 1 mg and 20 mg protein/ml sample solution). 
 
Alternatively for the determination of smaller protein concentrations, a microtiterplate assay 
was accomplished. For this, the Bio-Rad coloring dye was diluted in the ratio of 1:5 with 
deionized water. For determination of the calibration curve, standard protein solutions (BSA) 
was used within a concentration range between 0.05 and 0.5 mg/ml. 200 µl of the diluted dye 
was mixed with 10 µl of protein solutions and after 10 min to 20 min, the extinction was 
determined at 595 nm. Using the calibration curve, the protein concentration of the unknown 
protein solution was determined. All the measurements were done in triplicate and the 
average value was calculated and used. 
 
2.4.2 Determination of enzyme activity 
 
Activity test for reduction:  
 The reducing activity of enzymes (CPCR/CpSADH) in aqueous medium was determined 
spectrophotometrically by measuring the rate of consumption of the cofactor NADH + H+ at 
340 nm. Acetyl-butyric-acid-ethyl ester (ABEE) was used as a standard substrate, which is 
reduced through the oxidation of the cofactor. The measurement was carried out for 1 min at 
37 °C and pH 7. 1 Unit (U) of enzyme is defined as the amount of enzyme required to 
transform 1 µmol of ABEE per minute under the experimental conditions. The substrate 
spectrum of the enzyme was determined with this method. 
Standard enzyme test:  880 µl buffer (100 mM TEA-HCl, pH 7) 
    100 µl ABEE solution (80 mM in 100 mM TEA-HCl, pH 7) 
    10 µl NADH + H+ (20 mM in 100 mM TEA-HCl, pH 7) 
    10 µl CPCR/CpSADH solution 
 
The volumetric activity of the enzyme was determined by equation (1) 
         
Volumetric activity  =    Vtotal. dA/dt . df          (U/ml)  (1)         
            Vpip . ε . d  
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Vtotal  Total volume of reaction (µl) 
dA/dt  Difference in the extinction per min (min-1) 
Vpip  Volume of enzyme solution (µl) 
ε  Extinction coefficient of NADH at 340 nm (6.22 l mmol-1 cm-1) 
d  Path length of cuvette (1cm) 
In case of microtiterplate the path length is 0.26 cm for 100 µl volume and 
0.67 cm for 200 µl reaction volume 
df  Dilution factor 
 
The specific activity of enzyme was determined by equation (2) 
Specific activity =   Volumetric activity  (U/mg) (2) 
 Protein concentration    
 
In order to determine the activity of large number of samples, e.g. during measurement of 
enzyme characteristics, activity tests in microtiterplate was carried out. The method was 
optimized for the specific enzymes.  
Reaction for microtiterplate:   80 µl ABEE solution (100 mM in 100 mM TEA-HCl, pH 7) 
    10 µl NADH + H+ (12.5 mM in 100 mM TEA-HCl, pH 7) 
    10 µl CPCR/CpSADH solution 
 
Activity test for oxidation: 
 For determination of oxidizing activity of the enzyme, the method was used as described by 
Kojima (Kojima et al., 1995).  
Standard reaction mixture:  50 mM Tris-HCl (pH 9) 
     50 mM (S)-1,3-butanediol 
     2.5 mM NAD+  
     10 µl enzyme solution 
 
The reaction was carried out in a total volume of 1 ml in cuvette at 30 °C for 1 min. The rate 
of NAD+ reduction was followed at 340 nm. 
 
Colorimetric activity test for CpSADH: 
 The method for the colorimetric activity test was used as developed by Steinsiek (Steinsiek, 
2006). The test was accomplished with native protein gels. The activity for NAD+ reduction 
was made visible in the protein bands. With the oxidation of (S)-1-phenylethanol, reduced 
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NADH transfers the electrons to phenazinmethosulphate, which converts the coloring dye 
iodonitrotetrazoliumviolet to insoluble, red formazane (Blaich, 1987; Peters, 1993). The band, 
in which the protein with the appropriate activity is located, colors itself dark red. 
Assay for coloring activity:    100 mM TEA-HCl, pH 7  
30 mM (S)-1-phenylethanol  
0.1 mM NAD+  
0.2 mg/ml phenazinmethosulphate 
0.5 mg/ml iodonitrotetrazoliumviolet 
 
After the native gel electrophoresis, the gels were incubated in the above reaction solution in 
darkness for 5-10 min.  
 
2.4.3 Protein purification 
 
Anion exchange chromatography: 
 In ionic exchange chromatography, the protein is bound to the matrix through electrostatic 
interaction (Rossomando, 1990). The material used here for the chromatographic purification 
(MacroPrep High Q) is a strong anion exchanger made of copolymer beads of methacrylate 
with quaternary ammonium ions as functional group. The adsorbed molecules could be eluted 
with the change in the column conditions, by mixing two buffers with different salt 
concentrations over step-gradient through continuous (linear) gradient with a FPLC system. 
The recombinant CpSADH (JM109pKK223-3CpSADH18 construct) was purified by this 
method. The first eluted fraction of protein with weak ions was achieved at 100 mM NaCl 
concentration. Thereby the NaCl concentration was increased in steps of 200 mM, 300 mM 
and 400 mM. The rest of the cell proteins were washed and eluted out of the matrix by 
increasing the NaCl concentration to 1 M. Fractions were collected at the rate of 12 ml with 
the help of auto-sampler and analyzed with SDS-PAGE (2.4.4) and also with the standard 
activity assays (2.4.2) and protein assays (2.4.1). The eluted fractions between 200-300 mM 
of NaCl concentrations showed activity for CpSADH. The flow rate of all the different steps 
was kept at 2 ml/min except for the loading step. The different steps for the purification were: 
Equilibration:  Before loading the protein, the column with the matrix was always  
   equilibrated with the Loading/Binding buffer A for 5 column volumes   
Loading:  1 ml/min for 2 loop-volumes  
Binding/washing: 2 ml/min for 3 column volumes with Buffer A 
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Elution:  2 ml/min for 1.5 column volumes for every gradient step with different  
  concentrations of NaCl in the Elution buffer B (100-400 mM)   
Final washing: 2 ml/min for 5 column volumes with the Elution buffer B (up to 1 M  
  NaCl concentration) 
Equilibration:  2 ml/min for 3 column volumes with Buffer A 
 
Loading/Binding buffer A  50 mM TEA-HCl (pH 8.3)  
 
Elution buffer B   50 mM TEA-HCl (pH 8.3) 
    1 M NaCl    
 
The buffer compositions were optimized for binding of the specific protein (recombinant 
CpSADH). 
 
Immobilized metal affinity chromatography (IMAC) with Ni-NTA: 
Immobilized-metal affinity chromatography (IMAC) was first used to purify proteins in 1975 
(Porath et al., 1975) using the chelating ligand iminodiacetic acid (IDA). IDA was charged 
with metal ions such as Zn2+, Cu2+, or Ni2+, and then used to purify a variety of different 
proteins and peptides (Sulkowski, 1985). Compared to the 3 metal-chelating sites of IDA that 
cannot tightly bind metal ions, Nitrilotriacetic acid (NTA, Qiagen) which is a tetradentate 
chelating adsorbent occupies four of the six ligand binding sites in the coordination sphere of 
the nickel ion, leaving two sites free to interact with the His6-tags. NTA binds metal ions far 
more stable than other available chelating resins (Hochuli, 1989) and retains the ions under a 
wide variety of conditions, especially under stringent wash conditions. NTA matrices can 
therefore bind His6-tagged proteins very tightly and allow purification of proteins very easily 
through elution with an increasing concentration of imidazole. Ni-NTA superflow and Ni-
NTA agarose (Qiagen) were used for the purification of the N-terminal His6-tagged 
recombinant CpSADH [BL21(DE3)pET26b+CpSADH28his construct] under native 
conditions. Ni-NTA agarose was used for batch-purification of the protein in small scales. For 
preparative purification, Ni-NTA superflow was used and the protein was purified with the 
FPLC system in one step. The background proteins that were non-specific and bound to the 
matrix with a low-affinity were first eluted at 10 mM imidazole concentration. CpSADH was 
eluted in a very pure form by increasing the imidazole concentration to 250 mM. The flow 
rate and the different steps of purification were: 
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Equilibration:  2 ml/min for 5 column volumes with  Buffer A (100%) 
Loading:  1 ml/min for 2 loop volumes 
Binding/Washing: 1 ml/min for 5 column volumes with Buffer A (100%) until A280 is 
stable 
Elution: 2 ml/min for 5 column volumes with Buffer B (100%). Protein is eluted 
within the first 1-3 column volumes. The next 2 column volumes is for 
final washing 
Equilibration: 2 ml/min for 2-3 column volumes with Buffer A (100%) 
 
Buffer A (Lysis/Binding/Washing) 1 liter: 
50 mM NaH2PO4  6.90 g NaH2PO4.H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
10 mM imidazole  0.68 g imidazole (MW 68.08 g/mol) 
 
The pH was adjusted to 8.0 using NaOH. 
 
Buffer B (Elution buffer) 1 liter: 
50 mM NaH2PO4  6.90 g NaH2PO4.H2O (MW 137.99 g/mol) 
300 mM NaCl   17.54 g NaCl (MW 58.44 g/mol) 
250 mM imidazole  17.00 g imidazole (MW 68.08 g/mol) 
 
The pH was adjusted to 8.0 using NaOH. 
 
Ultrafiltration:  
 For buffer exchange, desalting and concentration of the eluted protein fractions containing 
enzymatic activity from anion exchange and IMAC, the protein fractions were pooled and 
concentrated by centrifugation (5000 rpm, 4 °C) with the Vivaspin 20 ml concentrators 
(Vivascience) having a molecular weight cut-off (MWCO) of 10000 Daltons. The protein was 
concentrated to the desired level, the filtrate was removed and the concentrator was refilled 
with the desired buffer (100 mM TEA-HCl, pH 7.5). The sample was then again concentrated 
and the process was repeated until the salt concentration was sufficiently removed. Typically, 
3 wash cycles were carried out. The final concentrated and desalted recombinant CpSADH 
dissolved in 100 mM TEA-HCl, pH 7.5, was either stored at –20 °C in 50% glycerol (v/v) or 
lyophilized by freeze-drying and the enzyme powder was then stored at –20 °C. 
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2.4.4 Gel electrophoresis  
 
SDS-PAGE: 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out for the separation of 
proteins by discontinued polyacrylamide gel  (Laemmli, 1970). For this, 12% polyacrylamide 
gels were made. The 12% resolving gel was over-laid with 2-propanol to ensure a flat surface 
and to exclude air. After polymerization 2-propanol was removed, the sample combs were 
attached and 5% stacking (loading) gel was poured. The protein samples for analysis were 
mixed in 1:1 ratio with the reduced sample buffer Roti®Load1 (4x) (Roth) and subjected to 
heat denaturation at 95 °C for 5-7 min. The samples were then cooled and centrifuged shortly. 
10-20 µl of each of the prepared samples were pipetted in every comb. As a molecular weight 
standard, 5 µl of the protein marker PageRulerTM Prestained Protein Ladder (MBI Fermentas) 
was also loaded. The separation of the protein was carried out at a constant voltage supply of 
either 150 or 180 V for 60-90 min. For visualization of the protein bands, the gels were first 
washed with deionized water and then stained with PageBlueTM Protein Staining Solution 
(MBI Fermentas) for 60 min to overnight. Since polymerization takes place immediately after 
the addition of APS and TEMED, these components were directly added just before pouring 
the gels after a quick mixing.   
Composition of the resolving and stacking gels for SDS/Native-PAGE were as follows: 
 
Components     Resolving gel [ml]   Stacking gel (5%) [ml]  
(12%)  (7.5%)            
40% Acrylamide mix  3.0  1.9    0.5 
1.5 M Tris-HCl, pH 8.8 2.5  2.5    _ 
1 M Tris-HCl, pH 6.8  _  _    0.5 
10% (w/v) SDS  0.1  _    0.04 
10% (w/v) APS  0.1  0.1    0.04  
TEMED   0.004  0.004    0.004 
Deionized H2O  4.3  5.5    2.9 
Total volume   10  10    4  
SDS running buffer:   
Tris  3 g/l 
Glycine 14.4 g/l 
SDS  1 g/l 
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Native-PAGE:  
 In native PAGE, the protein is not denatured and remains in its active form (Schägger and 
Jagow, 1991).  Therefore the gel contains no SDS and the charge of the proteins in the gel 
depends on their isoelectric point and the pH of the used buffer. Corresponding to SDS-gels, 
5% stacking gel and 7.5% resolving gel was made as described earlier. SDS was substituted 
with deionized water both in the gels and in the running buffer. The protein samples were 
mixed in the ratio of 1:1 with the native sample buffer and directly loaded on the gel slots. 
The separation was done for 4-5 h at a constant voltage of 100 V. In order to prevent activity 
loss through over-heating, the gel chamber was placed on an ice-bath. The gels were then 
directly used for activity staining (2.4.2; colorimetric activity test for CpSADH). 
 
2.4.5 Transfer of protein (Western Blot) 
 
The principle of immunoblotting method (Kyhse-Andersen, 1984) lies in the discontinued 
transfer of protein on membranes. The protein bands of the SDS-polyacrylamide gel were 
transferred by western blot to a PVDF membrane (Invitrogen) by running for 80 min with a 
constant voltage of 30 V. The protein-free areas of the transfer membrane were saturated by 
incubation for 1 hour in a blocking solution composed of 3% BSA in TBS buffer. The 
membrane was thereafter treated with a solution containing antibody-conjugate from anti-
His6-peroxidase for 1 hour. The membrane was then washed three times for 5 min in TBS-
Tween and finally soaked in 1 x DAB solution. After 1-10 min (depending on the intensity of 
the staining), the enzymatic reaction was stopped by repeated washing with deionized water.  
 
Transfer buffer:     DAB solution: 
5 x SDS running buffer 20% (v/v)  DAB substrate (10 x)  10%  
Methanol   10% (v/v)  Peroxide buffer  90% 
TBS buffer:      Antibody solution: 
Tris-HCl, pH 7.2  10 mM   Anti-His6-antibody conjugate    40 µl 
NaCl    150 mM  BSA       1% 
TBS-Tween: 
Tris-HCl, pH 7.2  10 mM 
NaCl    150 mM 
Tween 20   0.1% (v/v) 
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2.4.6 Chromatographic analysis of substrate and product 
 
HPLC: 
 The conversion of acetophenone into phenylethanol by CpSADH in aqueous system was 
analyzed with HPLC using a Nucleosil 100/5C18 column (250 x 4 mm) and a UV detector 
166 (Beckmann Coulter). The running solvents used were 60% H2SO4 at pH 3 and 40% 
acetonitrile with a flow rate of 0.6 ml/min and a column temperature of 40 °C. The injection 
volume and wavelength used were 20 µl and 220 nm respectively. 
  
GC:   
The conversion of substrate to product in organic solvent (hexane) was analyzed with GC 
using decane as internal standard. For this, the FS-FFAP-CB-0.25 column was used which has 
a length of 25 m and an internal diameter of 0.25 mm. The detector used was FID (Flame 
ionization detector. The injector and detector temperatures were set at 220 °C. A split of 1:50 
and a pressure of 60 kPa with nitrogen as carrier gas were used. The temperature program was 
used as developed and used by Steinsiek (2006).   
Original oven temperature:  40 °C for 4 minutes 
Temperature increase:  20 °C per minute till 100 °C 
     30 °C per minute till 180 °C 
End temperature:   180 °C for 7 minutes 
Total time duration:   16.7 minutes 
 
The retention times of hexane was 1.2-1.5 min, acetone was 1.6 min, 2-propanol was 2.2 min, 
decane was 2.95 min, acetophenone was 10.1 min and phenylethanol was 11.0 min. 
 
Stereoselective synthesis by CpSADH was analyzed by a chiral GC column to determine the 
enantiomeric purity of the product. For this, FS-Cyclodex-beta-I/P capillary column was used 
with a split of 1:30 and a pressure of 100 kPa with nitrogen as carrier gas. The temperature 
program was: 100 °C for 3 min; 30 °C per minute till 150 °C; 150 °C for 4 min. Under these 
conditions, retention of acetophenone was 7 min and (S)-1-phenylethanol was 8.1 min. 
  
2.4.7 Inhibition study 
 
The inhibition of CpSADH when exposed to different reagents was studied by the method as 
described by Kojima (Kojima et al., 1995). For this, a definite amount of the enzyme was 
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incubated at 30 °C for 30 min with different reagents and the residual activity was measured 
using the activity assay for microtiterplate (2.4.2) in a volume of 100 µl. As a control, the 
same amount of enzyme (untreated) was incubated without any reagent for the same time and 
temperature. The untreated enzyme was then compared to the treated ones. 
 
2.4.8 Temperature optimum and activation energy 
 
In order to determine the temperature optimum of recombinant CpSADH with and without 
His6-tag, the activity of the enzyme was measured spectrophotometrically for 1 min by 
following the oxidation of NADH at 340 nm in different temperatures ranging from 25-58 °C; 
using the standard activity assay conditions for microtiterplate (2.4.2). All the solutions were 
heated to the above temperatures before adding the enzyme. The activation energy was 
calculated based on the Arrhenius equation (equation 3) that is, 
=k A . e-EA/RT  (3)   k   =    Rate constant 
     A   =  Pre-exponential factor 
     EA =  Activation Energy (J mol -1) 
     R   =  Gas constant (8.314 J mol-1 K-1) 
     T   =  Absolute temperature (K-1) 
 
From the temperature-dependent rate constants of the linear range of the optimum curve, the 
activation energy can be calculated by plotting ln k against the reciprocal value of the absolute 
temperature. The gradient of the straight line determined from the diagram equals to -EA · R-1. 
 
2.4.9 Temperature stability and half-life  
 
The temperature stability of recombinant CpSADH was determined by incubating the enzyme 
solution (2 U/ml) in 100 mM TEA-HCl (pH 7.5) for a period of 24 h at a temperature ranging 
from 25-45 °C and measuring the residual activity at regular time intervals 
spectrophotometrically at 340 nm for 2 min and 37 °C by following the oxidation of NADH 
using the standard activity assay for microtiterplate (2.4.2). The half-life of the enzyme was 
calculated over the inactivation constant that is given in equation (4). By plotting the natural 
logarithm of the activity against the time the inactivation constant can be determined as the 
slope. 
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A = A0 . e-kt  (4) A = Activity at time t 
    A0 = Activity at the beginning of measurement at t0 
    k = Inactivation constant 
    t = Time 
 
The half-life τ can be calculate by the following equation (5) 
 
τ = ln 2  (5) 
        k   
 
 
2.4.10  pH optimum and pH stability 
 
The optimum pH of the recombinant CpSADH was determined spectrophotometrically. 
Substrate, cofactor (NADH) and enzyme were dissolved in 100 mM TEA-buffer with 
different pH ranging from 5.5-10 and the activity was measured for 2 min at 37 °C using the 
standard activity test for microtiterplate (2.4.2) by following the oxidation of NADH at 340 
nm. 
 
The pH stability was determined by incubating the enzyme (2 U/ml) in 100 mM TEA-buffer 
with different pH ranging from 5.5-8.5 for a period of 24 h at 25 °C. The residual activity was 
measured at regular time intervals at 37 °C for 2 min and 340 nm spectrophotometrically 
using the standard activity test for microtiterplate. 
 
2.4.11 Stability in hexane 
 
The half-life of the recombinant CpSADH with His6-tag in direct contact with the organic 
solvent was analyzed in an aqueous-organic two-phase system. The aqueous phase consisted 
of a definite amount of lyophilized CpSADH powder (2 U) after IMAC purification in 100 
mM TEA-HCl, pH 7.5 and the organic phase consisted of hexane. The hexane phase 
consisted of a volume of 25, 50 and 75% in a total volume of 1 ml. The aqueous phase was 
mixed with a magnetic stirrer and the hexane phase was lain over it. The reaction vials were 
stirred at 25 °C without inter-mixing the two phases. In regular time intervals, each of the 
reaction vials was withdrawn, the lower (aqueous) phase was taken off and the residual 
activity was determined photometrically. 
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The stability of the enzyme was also determined in hexane alone. For this, lyophilized 
CpSADH powder (2 U) was incubated in this organic solvent in reaction vials and after 
regular time intervals each of the reaction vials was withdrawn, the enzyme was extracted 
with 100 mM TEA-HCl, pH 7.5 and the residual activity was measured photometrically and 
compared to the untreated enzyme powder. 
 
2.4.12 Synthesis in aqueous system 
 
In order to determine the conversion of acetophenone in purely aqueous system, enzymatic 
synthesis was carried out at 30 °C in a reaction volume of 1 ml consisting of 0.5 U of 
recombinant CpSADH, 10% (v/v) 2-propanol for cofactor regeneration and 1 mM NADH as 
cofactor. Furthermore, to determine the influence of 2-propanol on the activity of the enzyme, 
2-propanol was used in a concentration of 5 to 20% (v/v). As the solubility of acetophenone 
in buffer is only about 45 mM, therefore this concentration was used in the synthetic 
reactions. After the reaction was completed, the enzyme was inactivated by heating at 95 °C 
for 5 min, and the concentration of substrate and product was measured via HPLC (2.4.6).  
 
2.4.13 Synthesis in liquid two-phase system 
 
The activity of the CpSADH in a purely organic reaction medium was examined with the 
enzyme lyophilized together with NADH based on the method described by Steinsiek (2006). 
For that 1 U of IMAC purified CpSADH together with 10 µmole of NADH were lyophilized 
directly in the reaction vials and the reaction was started by adding 1 ml of the organic 
solvent, consisting of hexane with 200 mM acetophenone and 10 mM decane. Two sets were 
examined without additional water, two with 0.1% (v/v) water, two with 0.5% (v/v) water and 
another two with 1% (v/v) water. To one set in each case, 1% (v/v) of 2-propanol was added. 
The reaction vials were mixed on an overhead shaker and after 48 h the product formation 
was determined by GC. 
 
Biocatalytic synthesis in aqueous-organic two-phase system using the recombinant CpSADH 
with His6-tag was carried out according to the procedure described by Steinsiek (Steinsiek, 
2006). For this, different percentages of hexane as organic phase were used (2.4.11) in a total 
reaction volume of 1 ml. The aqueous phase consisted of enzyme, 1 mM NADH dissolved in 
100 mM TEA-HCl (pH 7.5). The enzyme concentration used was 0.5 U per ml and was based 
on the total reaction volume. 
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The organic phase consisted of 10 mM decane (calculated over the organic phase) as internal 
standard, acetophenone as substrate. The concentration of the substrate was calculated over 
the aqueous and organic phases. For cofactor regeneration, 2-propanol was used in a 
concentration of 10% (v/v) of the aqueous phase. The concentrations of substrate and product 
in aqueous phase were measured by HPLC, and in organic phase by GC (2.4.6). 
 
2.4.14 Substrate spectrum of recombinant CpSADH 
 
The conversion of different substrates was determined photometrically at 340 nm over the 
oxidation of the cofactor NADH + H+. The substrates were dissolved in a concentration of 10 
mM in 100 mM TEA-HCl, pH 7 and the relative activity in comparison to the standard 
substrate ABEE was analyzed. The activity assay consisted of 8 mM of each substrate (from 
10 mM stock solution), 0.2 mM NADH and 10 µl of enzyme solution in a total volume of 1 
ml and the activity was measured at 37 °C for 1 min. 
2.5 Immobilization of recombinant CpSADH 
2.5.1 Immobilization in polyvinyl alcohol (PVA) 
  
The immobilization of the enzyme together with the cofactor in the PVA matrix was carried 
out by the method as described by Steinsiek (Steinsiek, 2006). For this, first a 12% (w/v) 
polyvinyl alcohol (PVA) solution was prepared and afterwards diluted with the enzyme 
solution to 9%. 3 g PVA MW 10-98 together with 3 g polyethylene glycol (PEG 1000) and 21 
ml of 100 mM TEA-buffer pH 7.5 were heated up to 90 °C and the solution was dissolved 
with continuous stirring. After the cooling of the solution to room temperature, 2 ml of 1.5 M 
NaOH were dropped carefully into the solution under vigorous stirring. This was done to 
ensure complete saponification of the polyvinyl alcohol (Prüsse, 2000). After about 30 
minutes of stirring, the pH value was adjusted to pH 7.5 with concentrated hydrochloric acid 
solution. For the production of beads, the polyvinyl alcohol solution (after saponification and 
pH adjustment) was mixed with the enzyme solution in a ratio of 3:1. For the standard 
reaction, 2 units of enzyme solution in 100 mM TEA-HCl pH 7.5 with 1 mM NADH + H+ per 
ml of beads were used. Beads of PVA-enzyme solution were produced via introduction of the 
solution in drops into prechilled (-70 °C) silicone oil and following a slow thawing process 
(overnight at 4 °C). Before using the beads for synthesis, they were slowly warmed up to 
room temperature and washed with hexane. 
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The activity of immobilized enzymes cannot be determined directly, since the substrate and/or 
product concentrations in the hydrogel cannot be detected. By determining the balanced 
distribution, the final concentrations of substrate and product that are distributed in the 
organic phase and hydrogel phase, can be calculated. This equilibrium position was quantified 
with enzyme-free immobilisates over the reduction of the concentrations in the organic phase, 
after the equilibrium was reached. For this, 1 gram immobilisate in the ratio of 1:3 in hexane 
with varying substrate and/or product concentrations were used. The size of the beads was 
about 10 µl regulated over the dropping volume.  
 
Standard reaction conditions for PVA beads: Unless otherwise stated all syntheses with 
immobilized enzyme in PVA beads were carried out according to the following assay 
conditions: 1 gram immobilisate, 10 mM decane, 3.3% 2-propanol (v/v), 200 mM 
acetophenone as substrate. 
 
Hexane was used as the organic phase. Decane was used as an internal standard in a 
concentration of 10 mM added to the organic phase. The immobilisate was used in a ratio of 
1:3 to the organic phase. The concentration of 2-propanol that was added into the organic 
phase is related to the volume of the aqueous phase (hydrogel phase), such that its 
concentration in the aqueous phase amounts to 10%. Enzymatic synthesis was carried out at 
25 °C by stirring in an over-head shaker for proper mixing of the two phases. 
 
2.5.2 Immobilization in Sepabeads 
 
SEPABEADS® EC-SERIES (Resindion S.r.l., Italy) are ready-to-use enzyme carriers. Two 
types of the Sepabeads series namely, EC-HFA and EC-EP were used to immobilize the 
enzyme. SEPABEADS® EC-HFA are crosslinked copolymer of methacrylate containing 
amino and epoxy groups whereas SEPABEADS® EC-EP are crosslinked copolymer of 
methacrylate containing oxirane (epoxy) groups. 
 
Immobilization procedure: 
For SEPABEADS® EC-EP, 10 units of the enzyme (IMAC purified) dissolved in 4 ml of 200 
mM potassium phosphate buffer (pH 8) were added to 1 gram of sepabeads. In case of 
SEPABEADS® EC-HFA, the same units of enzyme were dissolved in 4 ml of 20 mM 
potassium phosphate buffer (pH 7.6). The buffer compositions were optimized for each of the 
two types of beads. The ratio of enzyme solution to beads was always kept at 4:1.The enzyme 
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solution was stirred in an overhead shaker at 25 °C for about 2 hours (till the adsorption was 
completed). During this time, the remaining activity was checked in the solution every 1 hour. 
After the adsorption was completed, the immobilization (for covalent binding) was proceeded 
at 5 °C for 48 h. The supernatant was eliminated after checking the residual activity and the 
immobilized enzyme was washed thoroughly five times with deionized water and five times 
with 50 mM potassium phosphate buffer (pH 7.6). 
 
Standard reaction conditions for Sepabeads: A ratio of 0.0625 wet biocatalyst to the total 
reaction volume was used. This ratio was calculated by dividing the amount of wet biocatalyst 
(in gram) with the total reaction volume (in ml). Unless otherwise stated all synthetic 
reactions with the enzyme immobilized Sepabeads were carried out as follows: 
 
1. Reaction set-up for aqueous system  
250 mg beads 
1 mM NADH  
10% 2-propanol (v/v) 
45 mM acetophenone in 50 mM potassium phosphate buffer, pH 7.6 
The reaction was carried out in a total volume of 4 ml at 25 °C with proper mixing in an end-
to-end shaker. 
 
2. Reaction set-up for aqueous-organic system 
In the immobilization method with Sepabeads, it was not possible to co-immobilize NADH 
like in the PVA beads. The NADH should be freely available to reach the active center of the 
enzyme and was therefore supplied in a small aqueous phase. Two types of reaction 
conditions were set up as described:  
SET A:     SET B: 
250 mg beads     250 mg beads 
Aqueous phase (1 ml) consisting of,  Aqueous phase (0.5 ml) consisting of, 
1 mM NADH dissolved in 50 mM   1 mM NADH dissolved in 50 mM  
potassium phosphate buffer, pH 7.6  potassium phosphate buffer, pH 7.6 
Organic phase (3 ml) consisting of,  Organic phase (3.5 ml) consisting of, 
3.33% 2-propanol (v/v)   1.42% 2-propanol (v/v) 
10 mM decane    10 mM decane 
200 mM acetophenone as substrate  200 mM acetophenone as substrate 
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The reactions were carried out in a total volume of 4 ml at 25 °C. 
 
Hexane was used as the organic phase. Decane was used as an internal standard in a 
concentration of 10 mM (calculated over the organic phase) added to the organic phase. The 
concentration of 2-propanol that was added into the organic phase is related to the volume of 
the aqueous phase, such that its concentration in the aqueous phase amounts to 10%. The 
substrate concentration was calculated over the aqueous and organic phases and a final 
concentration of 200 mM was used. To ensure proper mixing of the two phases, the reaction 
vials were stirred in an end-to-end shaker. 
 
It was found that the substrate and/or product when used showed some affinity towards the 
Sepabeads. Some amounts of the substrate and/or product were always bound to the carriers. 
In order to quantify the material balance, the same amount (250 mg) of enzyme-free beads 
were used in a reaction volume of 4 ml containing varying concentrations of substrate and 
product. After the equilibrium was reached, the final concentrations of substrate/product 
present in the reaction volume were measured with HPLC (aqueous phase) and with GC 
(organic phase). 
 
2.5.3 Stability of the immobilized CpSADH in Sepabeads 
 
The stability of the CpSADH immobilized in the Sepabeads was determined over the half-life 
of the immobilized enzyme in an aqueous-organic two-phase system. For this, 250 mg of the 
immobilisate were stored in an aqueous-organic phase in a ratio of 1:3 (1 ml buffer: 3 ml 
hexane). The reaction vials were stirred in an end-to-end shaker and were incubated at 25 °C, 
30 °C and 37 °C. In regular time intervals (after every 24 h), each of the reaction vials (from 
each temperature) was taken out and the aqueous-hexane phases were carefully thrown away. 
The remaining amounts of the aqueous-organic phases were sucked away with filter papers. 
The reaction was thereafter started by freshly adding another 1 ml buffer consisting of 1 mM 
NADH, and 3 ml hexane consisting of 266 mM acetophenone as substrate and 10 mM decane 
as internal standard. The final NADH concentration was therefore 1 mM (calculate over the 
aqueous phase), that of decane was 10 mM (calculated over the organic phase) and that of 
acetophenone was 200 mM (calculated over the aqueous-organic phase). The reaction was 
accomplished at 25 °C with stirring and after 24 hours the substrate and product 
concentrations were determined. 
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3 Results and Discussion 
3.1 Cloning of CPCR and CpSADH  
3.1.1 Isolation of genomic DNA from C.parapsilosis 
 
Based on the method as described in section (2.3.1) the genomic DNA (gDNA) from 
C.parapsilosis DSMZ 70125 strain was isolated with a very high purity. The isolated gDNA 
had a size of about 23 kb (23000 bp) and a concentration of 400 ng/µl and was also intact 
without any smears. The isolated gDNA was used as the template for the construction of 
libraries with the GenomeWalker kit. The following figure shows the gel document of the 
isolated gDNA.  The genomic DNA of C.parapsilosis isolated by Bönitz (Bönitz, 2001) was 
7500 bp only, which is about 15.5 kb less as compared to the DNA that has been isolated in 
this work. The reason could be shearing of DNA during the isolation process. 
 
Figure 4: Genomic DNA of C.parapsilosis. Lane 1= C.parapsilosis gDNA; Lane 2 = λ DNA Hind III marker; 
Lane 3 = GeneRulerTM 1 kb DNA ladder. 1 µl of the isolated genomic DNA was loaded in 0.5% agarose/EtBr 
gel.  
 
3.1.2 Construction of libraries 
 
Four different libraries were constructed from the total genomic DNA of C.parapsilosis by 
digesting the gDNA with EcoRV, DraI, StuI and PvuII (Blunt-end cutters). Of the four 
libraries, the one digested with StuI was only partially digested, whereas all the other three 
were fully digested. It seemed that there may be no or only few restriction sites for StuI in the 
gDNA of C.parapsilosis. The positive control library (consisting of human gDNA) was 
constructed by digesting with PvuII. 
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The following Figure 5 illustrates the different libraries produced. 
 
Figure 5: Gel documention of the digested genomic DNA from C.parapsilosis. Lane 1 = library digested with 
EcoRV; Lane 2 = library digested with DraI; Lane 3 = library digested with StuI; Lane 4 = GeneRulerTM 1 kb 
DNA ladder; Lane 5 = library digested with PvuII; Lane 6 = control human genomic DNA library digested with 
PvuII. 5 µl of the digested genomic DNA libraries were loaded in 0.5% agarose/EtBr gel. 
 
The above figure shows that the library digested with StuI (Lane 3) is only partially digested 
as compared to other libraries. The digestion time with StuI was prolonged in order to see if 
the enzyme digests the DNA fully, but it also resulted in partial digestion.   
 
The libraries were purified with phenol: chloroform extraction and were then ligated to the 
GenomeWalker adaptors according to the supplier’s instructions. These adaptor-ligated 
libraries were used for genome walking with PCR. 
 
3.1.3 Analysis of the partial amino acids sequences of wtCPCR 
 
For genome walking of the C.parapsilosis gDNA to amplify the CPCR gene, the partial 
protein sequences of the wtCPCR (Bönitz, 2001) were analyzed in order to determine the 
homologies with other ADHs and also to predict probable primer regions for genome 
walking. The partial amino acids sequences and the derived nucleotide sequences of the 
wtCPCR from the N-terminal towards the C-terminal are described in the next page. The 
source of information of the gene sequences was created by considering the codon usage of 
C.parapsilosis and degeneration of the genetic code.  
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CPCR-Sequence 1(N-terminal) 
PEIPKTQKAVVFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAW 
Gene sequence 1(N-terminal) 
5’-CCA-GAA-ATT-CCA-AAA-ACT-CAA-AAA-GCT-GTT-GTT-TTT-GAA-ACT-TCA-
GGT-GGT-AAA-TTG-GAA-TAC-AAA-GAT-ATT-CCA-GTT-CCA-AAA-CCA-AAA-
TCA-AAT-CAA-TTG-TTG-ATT-AAT-GTT-AAA-TAC-TCA-GGT-GTT-TGT-CAC-ACT-
GAT-TTG-CAC-GCT-TGG-3’ 
 
CPCR-Sequence 2  
AAPILCAGVTVYK 
Gene sequence 2 
5’-GCT-GCT-CCA-ATT-TTG-TGT-GCT-GGT-GTT-ACT-GTT-TAC-AAA-3’ 
 
CPCR-Sequence 3  
AGEWVCISGAGGGLGSLAIQYAIA 
Gene sequence 3 
5’-GCT-GGT-GAA-TGG-GTT-TGT-ATT-TCA-GGT-GCT-GGT-GGT-GGT-TTG-GGT-
TCA-TTG-GCT-ATT-CAA-TAC-GCT-ATT-GCT-3’ 
 
CPCR-Sequence 4 
SLGAEAYIDFTKEKDIVEAV 
Gene sequence 4 
5’-TCA-TTG-GGT-GCT-GAA-GCT-TAC-ATT-GAT-TTT-ACT-AAA-GAA-AAA-GAT-
ATT-GTT-GAA-GCT-GTT-3’ 
 
CPCR-Sequence 5 
VVAPVFDVVKSVEIKGSYVGNRKDTQEALDFFARGKVK 
Gene sequence 5 
5’-GTT-GTT-GCT-CCA-GTT-TTT-GAT-GTT-GTT-AAA-TCA-GTT-GAA-ATT-AAA-
GGT-TCA-TAC-GTT-GGT-AAT-AGA-AAA-GAT-ACT-CAA-GAA-GCT-TTG-GAT-
TTT-TTT-GCT-AGA-GGT-AAA-GTT-AAA-3’  
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CPCR-Sequence 6 (C-terminal) 
IVGLSELPEVFKLMEEGKILGRYVLDTSK 
Gene sequence 6(C-terminal) 
5’-ATT-GTT-GGT-TTG-TCA-GAA-TTG-CCA-GAA-GTT-TTT-AAA-TTG-ATG-GAA-
GGT-AAA-ATT-TTG-GGT-AGA-TAC-GTT-TTG-GAT-ACT-TCA-AAA-3’ 
 
Each of the above 6 sequences were aligned using the databases (ExPASy, NCBI). It was 
found that all of them had homologies in different percentage with other alcohol 
dehydrogenases of Candida albicans, Saccharomyces cerevisiae, Pichia stipitis (yeast), the 
highest being with the ADH1 of C.albicans (85.5%).  
 
The individual gene sequences were then compared with a patented ADH of C.parapsilosis 
(Kojima et al., 1995). It was found that in Gene sequence 1, 20 bases in between the 
fragments 59-78 has 77% homology with the said enzyme in between 531-510. In Gene 
sequence 2, 28 bases in between the fragments 12-39 has 74% homology with the said 
enzyme in between 577-606. In Gene sequence 3, 28 bases in between the fragments 18-45 
has 75% homology with the said enzyme in between 528-549. In Gene sequence 4, 20 bases 
in between the fragments 8-27 has 70% homology with the said enzyme in between 718-735. 
In Gene sequence 5, 23 bases in between the fragments 13-35 has 76% homology with the 
said enzyme in between 701-719. In Gene sequence 6, 21 bases in between the fragments 66-
86 has 77% homology with the said enzyme in between 750-730. This homology study 
showed that the partial amino acids sequences of the wtCPCR had some homologies in some 
parts of the sequences with this patented ADH, though in general both the sequences were 
quite different from each other.  
 
The probable primer regions for genome walking were determined taking the gene sequences 
(derived from the partial amino acids sequences) of the wtCPCR into consideration. Gene 
sequence 3 was selected for designing the primers. This sequence was chosen because of low 
homologies to other ADHs to rule out unspecific binding. Moreover the N-terminal sequence 
derived by Bönitz (2001) was not intended to be used in this work, because this had already 
been done by Bönitz with doubtful success. Furthermore, it was not really expected that the 
same sequence would be found but rather with an extension at the N-terminal. As this 
sequence was somewhere in the middle of the wtCPCR gene (since it was neither in the N- 
nor towards the C-terminal), the primers were designed as such that the walking of the gene 
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with the Genome Walker kit would take place upstream i.e. towards the N-terminal in order to 
amplify the start (5’-end) of the CPCR gene. 
 
3.1.4 PCR amplification of CPCR from the libraries and subcloning in 
pDrive vector 
 
In her work Bönitz (2001) cloned a DNA sequence coding for 349 amino acids, which was 
believed to be the complete CPCR gene. But, from the substrate spectrum analysis it was 
found that the enzyme considered as CPCR was not so. The probable reason could be that the 
sequence cloned by Bönitz was not the complete sequence. It was also not clear if it was the 
right gene though the DNA sequence had high homologies with other ADHs. In this work, a 
method was needed so as to get the whole CPCR gene sequence. As such the genome walking 
technique was applied primarily because the N-terminal sequence derived by Bönitz was not 
intended to be used. 
 
The four different libraries constructed were amplified using the primer combinations of SET 
A and of SET B (2.3.3) as gene specific primers and the adaptor primers that were supplied 
with the GenomeWalker kit. In the first instance, the PCR amplification of the libraries were 
carried out with the SET A primers such that, the genome walking would take place upstream 
in order to identify the start and open reading frame of the CPCR gene (5’-end) and followed 
by walking downstream to amplify the end (3’-end) with the SET B primers. Using the primer 
combination of SET A as gene specific primers and the PCR cycles as described earlier (see 
2.3.4; PCR set-up for the amplification of the constructed libraries with the Genome Walker 
kit using adaptor primers), the libraries were walked upstream. The primary PCR consisted of 
the primer CPCR-R1b and adaptor primer 1 (AP1) [outer primers] while the nested PCR 
consisted of the primer CPCR-R2b and adaptor primer 2 (AP2) [inner primers]. In order to 
increase the specificity of the PCR products and to minimize unwanted amplifications, the 
products of the primary PCR were used as the template for the nested PCR. Figure 6 depicts 
the amplified PCR products of the nested PCR. 
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Figure 6:  Gel documentation of the products of nested TD-PCR. Lane 1 = library digested with EcoRV; Lane 2 
= library digested with DraI; Lane 3 = library digested with StuI; Lane 4 = library digested with PvuII; Lane 5  = 
GeneRulerTM 1 kb DNA Ladder; Lane 6 = negative control without template DNA; Lane 7 = positive control 
(control human genomic DNA library digested with PvuII). 5µl of the digested genomic DNA libraries were 
loaded in 1.5% agarose/EtBr gel.  
 
As can be seen from Figure 6, of the four libraries, a major amplification of a DNA fragment 
of about 1300 bp was found to be amplified in the DraI digested library. A very small 
amplification of the same range (about 1300 bp) was also found to be amplified by the PvuII 
library. The rest of the libraries showed little or no amplification at all.  The possible reason 
could be that the nucleotide sequence coding for CPCR must have restriction sites for EcoRV, 
StuI and PvuII within it. Therefore, digesting the gDNA with these enzymes resulted in the 
cleavage within the CPCR gene and thus fragmentation. The PCR product of 1300 bp 
amplified by the DraI library was subcloned into the pDrive vector (Qiagen) via UA-cloning 
in which the A-overhang of the PCR product hybridize to the U-overhang of the vector. The 
cloned product was sequenced at Sequiserve (Vaterstetten, Germany). The sequenced DNA 
fragment is shown in Figure 7. 
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  1 GAATTGTGCG GCCATTTAGG TGACACTATA GAATACAGCG GCCGCGAGCT CGGGCCCCCA 
       61 CACGTGTGGT CTAGAGCTAG CCTAGGCTCG AGAAGCTTGT CGACGAATTC AGATTACTAT 
      121 AGGGCACGCG TGGTCGACGG CCCGGGCTGG TAAATCATGC GATAAAACTC GGAGTAACAA 
      181 AGTCCGCAAT CTGGTTTTTT TTATAATCAC ACACAAAAAA CACTGAGGTA GAACAAAATC 
      241 CACAAACCCA CAAACACACA AACCCACAAA AGAACAAAAG AACAATGTAA CCCACCCAGA 
      301 TCCAGTCACC CACTCACACA CCTACAACTT TCATCAGATC ATTTCCGAAT TGGRAAAAAA 
      361 AGTCATCCTA TACAAAAATG TACACGCTCA CACAAAACTC ACTTCTTTAT TACTATTCCA 
      421 TATAGTATTA GAAACGGAGT GGGTGAATGT ATTCCTTGCA GATAAGCGCT TCAACATTAT 
      481 GCATGAACCA AAAACACCAA CATGTATCAG AATAACATTC ACCCGCAAAA AAAAGCATAA 
      541 AATCATGCAT ATCCGATGGT TGAATAATTT TTATTTTCAA AAAGCYAAAT GTAACAATAT 
      601 AAATAGACCA CGAGGGAATG CCAATTGGCT CAACACATTT CTTTCATTTC AAAAGCTTTA 
      661 TTAGATCAAT TGCAGTTAAC AAAGTAACTA CTATTCCAAT TAAAGCGTTC ACTACTACTA 
      721 CAACTAAAAC TAAAACTAAA ATTACAACTA CAACTACAAC AAACAGTTTT ATATCTACAA 
      781 TGCCAGAAAT TCCAAAGACC CAAAAAGCTG TTGTGTTTGA AACAAGCGGA GGTAAATTAG 
      841 AATACAAGGA TATTCCAGTC CCCAAACCAA AATCAAATGA ATTGTTGATT AATGTCAAGT 
      901 ACTCTGGTGT GTGCCATACT GATTTACACG CTTGGAAAGG TGATTGGCCA TTGGACACCA 
      961 AATTACCCCT TGTTGGTGGT CATGAGGGTG CTGGTGTTGT TGTTGGCATG GGTGATAATG 
     1021 TCAAAGGATG GGAAATTGGT GATTATGCTG GTATCAAATG GTTGAATGGC TCTTGTTTGA 
     1081 ATTGTGAATT TTGTGAACAA GGAGCTGAAC CAAATTGCCC TCAAGCTGAC TTGTCTGGTT 
     1141 ACACCCATGA TGGYTCATTC GAACAATATG CTACTGCTGA TGCTGTCCAA GCTGCTAGAA 
     1201 TCCCCAAGAA TGCTGATTTG GCTAAAGCTG CTCCAATTTT GTGTGCTGGT GTTACTGTAT 
     1261 ACAAGGCTTT GAAGACTGCT CAATTGAAGG CTGGTGAATG GGTTTGTATT TCWGGTGCTG 
     1321 GTGGTGGTTT GAATCACGAA TTCTGGATCC GATACGTAAC GCGTCTGCAG CATGCGTGGT 
     1381 ACCGAGCTT 
 
Figure 7: Nucleotide sequence of the first DNA fragment. The highlighted grey region represents the ORF 
starting with an ATG. 
 
The ORF (Open reading frame) of the sequence began with an ATG that codes for 
methionine. The ORF was read from 5’-3’ Frame 3 (start-618; end-1388). The translated 
amino acid sequence beginning from position 618 is as follows: 
 
CPCR- HALF: 
 
MPIGSTHFFHFKSFIRSIAVNKVTTIPIKAFTTTTTKTKTKITTTTTTNSFISTMPEIPKTQKAV
VFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAWKGDWPLDTKLPLVGGHEGA
GVVVGMGDNVKGWEIGDYAGIKWLNGSCLNCEFCEQGAEPNCPQADLSGYTHDXSFEQ
YATADAVQAARIPKNADLAKAAPILCAGVTVYKALKTAQLKAGEWVCIXGAGGGLNHEFWI
RYVTRLQHAWYRA (257 amino acids) 
 
Global alignment of this amino acid sequence resulted in close matches of approximately 
40% with ADH2 (Taylor et al., 1998 in GenBank; Jones et al., 2004) and ADH1 (Bertram et 
al., 1996; Shen et al., 1991) of C.albicans and the ADH of P.stipitis (Passoth et al., 1998). 
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Since the walking of CPCR was done upstream to get the start of the gene, it was presumed 
that the above amino acid sequence (CPCR-HALF) is nearly the half of the whole CPCR 
gene. 
 
Another genome walking (downstream) was done to amplify the 3’-end of the CPCR gene, 
using the primer combinations of CPCR-V1 and adaptor primer 1 (AP1) for primary PCR; 
and CPCR-V2 and adaptor primer 2 (AP2) for nested PCR. The PCR cycles used are 
described in the section (2.3.4; PCR set-up for the amplification of the constructed libraries 
with the Genome Walker kit using adaptor primers). The first gene specific primer, CPCR-V1 
was constructed slightly upstream of the start codon, ATG, in between the base region 591-
620 (Figure 7). The nested gene specific primer, CPCR-V2 was constructed starting with the 
start codon, ATG, in between the base region 618-647 (Figure 7). The DraI digested library 
was used as the template because the previous amplified product was obtained from it as well. 
A 2000 bp DNA fragment was amplified which was subcloned again into the pDrive vector. 
The gel documentation of the amplified PCR product and also the sequenced DNA fragment 
thereof are described in the following figures (Figure 8 and Figure 9). 
 
 
 
 
Figure 8: Gel documentation of the nested TD-PCR product. Lane 1 = amplified product from the DraI digested 
library; Lane 2 = negative control; Lane 3 = GeneRulerTM 1 kb DNA Ladder; Lane 4 = positive control. 
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The DNA sequence of the amplified product is as follows: 
 
        1 GAATTGTGCG GCCATTTAGG TGACACTATA GAATACAGCG GCCGCGAGCT CGGGCCCCCA 
       61 CACGTGTGGT CTAGAGCTAG CCTAGGCTCG AGAAGCTTGT CGACGAATTC AGATTATGCC 
      121 AATTGGCTCA ACACATTTCT TTCATTTCAA AAGCTTTATT AGATCAATTG CAGTTAACAA 
      181 AGTAACTACT ATTCCAATTA AAGCGTTCAC TACTACTACA ACTAAAACTA AAACTAAAAT 
      241 TACAACTACA ACTACAACAA ACAGTTTTAT ATCTACAATG CCAGAAATTC CAAAGACCCA 
      301 AAAAGCTGTT GTGTTTGAAA CAAGCGGAGG TAAATTAGAA TACAAGGATA TTCCAGTCCC 
      361 CAAACCAAAA TCAAATGAAT TGTTGATTAA TGTCAAGTAC TCTGGTGTGT GCCATACTGA 
      421 TTTACACGCT TGGAAAGGTG ATTGGCCATT GGACACCAAA TTACCCCTTG TTGGTGGTCA 
      481 TGAGGGTGCT GGTGTTGTTG TTGGCATGGG TGATAATGTC AAAGGATGGG AAATTGGTGA 
      541 TTATGCTGGT ATCAAATGGT TGAATGGCTC TTGTTTGAAT TGTGAATTTT GTGAACAAGG 
      601 AGCTGAACCA AATTGCCCTC AAGCTGACTT GTCTGGTTAC ACCCATGATG GTTCATTCGA 
      661 ACAATATGCT ACTGCTGATG CTGTCCAAGC TGCTAGAATC CCCAAGAATG CTGATTTGGC 
      721 TAAAGCTGCT CCAATTTTGT GTGCTGGTGT TACTGTATAC AAGGCTTTGA AGACTGCTCA 
      781 ATTGAAGGCT GGTGAATGGG TTTGTATTTC TGGTGCTGGT GGTGGATTGG GTTCATTGGC 
      841 TATTCAATAC GCTATTGCCA TGGGTTACAG AGTTATTGGT ATCGATGGAG GTGCTGAAAA 
      901 GGGTGAATAC ATTAAATCTT TAGGAGCTGA AGCTTATATT GACTTTACCA AGGAAAAAGA 
      961 TATTGTCGAA GCTGTTAAAA AGGCAACTAA TGGTGGCCCA CATGGAGTTA TCAATGTGTC 
     1021 TGTTTCCGAA AAGGCCATCA ATCAATCAGT TGAATATGTT AGACCATTGG GTAAAGTTGT 
     1081 TCTTGTTGGT TTACCAGCTG GATCCAAAGT TGTTGCCCCT GTTTTCGATG CTGTTGTTAA 
     1141 ATCAGTTGAA ATTAAAGGTT CTTATGTTGG TAACAGAAAG GATACTCAAG AGGCTTTGGA 
     1201 TTTCTTTGCT AGAGGTAAAG TCAATTGTCA AATCAAGATT GTTGGTCTTA GTGAATTACC 
     1261 AGAAGTTTTC AAATTGATGG AAGAAGGTAA GATTTTGGGA AGATACGTAC TTGACACCAG 
     1321 CAAGTAAAAG AGTTAGAGAG TAGATCAAAT GTTTTGGTTT AATAGTTCTT CTTTTATATT 
     1381 GACGAAATGA GATGGAATTT GGAAATTGTG TAAAAAAGAG AAAAGAAATG TAGATTCAAC 
     1441 TTATACACAC TTTACTTGCA AGCTTTGCAA AGCTGGAGGT TATTTTCCTA ATCAACGCTT 
     1501 ATCTTTTTCA ATTCTATCAC GCAACACATT CAATTGTATC TGATTTGTCA AGTTTTCATC 
     1561 ATTAATCAAT TCAATAGTTT TGTTCTTTTC CTTCATTTCA ATACTCAAGT GTTCAATTTG 
     1621 CTTTTGTAAT TTACTAACCA ATTTTTCCAA TTTGCCAATT CGTACATCCT TATCTTTAAT 
     1681 TATAAACTCT AGTTTCTCAT TTTTCAAAGT AATTGAGTTC AAATTTGTAA TCAAGTCCTC 
     1741 ATTTTCATTT CGTAGTTGAT GATTTTCCTT AATGATTACA ACTGTGGCGG CATCATTATC 
     1801 ACTAATGTTG TCCTTTAGTT TATCTTGTTG AACACTCTTT GACTTTGATT TAGTGCTGGG 
     1861 CGGGACTTTT TCTTTTTCGA TTCCTAAGAT TGTCGATGGA GATGGTGACT TGGAGCTAAA 
     1921 TGGAGTTTCG TCCTCCTCCT CTGTGTTACT TTGGCAATGA TGATGATGAT GTTGCTGTTC 
     1981 TTTCAGAAGT AGCTTTTCCA CTAATTGTTT ACCAGCCCGG GCCGTCGACC ACGCGTGCCC 
     2041 TATAGTAATC ACGAATTCTG GATCCGATAC GTAACGCGTC TGCAGCATGC GTGGTACCGA 
     2101 GCTTT 
 
Figure 9: Nucleotide sequence of the second DNA fragment. The highlighted grey region represents the full 
CPCR gene with the start codon ATG and stop codon TAA. 
 
 
The ORF with an ATG as start codon began from the region 116 and ended with a stop codon 
TAA (ochre) at position 1327 (Figure 9). Therefore the CPCR began with an ATG that codes 
for methionine and ended with the stop codon TAA and constituted of 1212 bp. Further 
analysis of the DNA sequences upstream of the start codon ATG at position 618 (Figure 7), 
showed that some parts of the sequence had close homologies to that of different eukaryotic 
promoter regions (Altschul, et al. 1997), which meant that there were no additional DNA 
sequences upstream of this start codon that could be a part of this gene coding for CPCR, and 
that the sequence that has been derived through genome walking is a complete sequence of 
CPCR with a start and a stop codon. 
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The translated amino acid sequences beginning from the region 116 of Figure 9 is as follows: 
 
CPCR-FULL: 
 
  1  mpigsthffh fksfirsiav nkvttipika ftttttktkt kittttttns fistmpeipk   
 61  tqkavvfets ggkleykdip vpkpksnell invkysgvch tdlhawkgdw pldtklplvg   
121  ghegagvvvg mgdnvkgwei gdyagikwln gsclncefce qgaepncpqa dlsgythdgs   
181  feqyatadav qaaripknad lakaapilca gvtvykalkt aqlkagewvc isgaggglgs   
241  laiqyaiamg yrvigidgga ekgeyikslg aeayidftke kdiveavkka tnggphgvin   
301  vsvsekainq sveyvrplgk vvlvglpags kvvapvfdav vksveikgsy vgnrkdtqea   
361  ldffargkvn cqikivglse lpevfklmee gkilgryvld tsk Stop (403 amino acids)  
 
Figure 10: Translated amino acid sequence of recombinant CPCR. 
 
Global alignment (ExPASy; and other databases) of this amino acid sequence resulted in 
close homologies to ADH2 (Taylor et al., 1998 in GenBank; Jones et al., 2004) with 71% 
identities, and ADH1 with 73% identities of C.albicans (Bertram et al., 1996; Shen et al., 
1991). The alignment of the translated protein sequence to that of ADH1 and ADH2 are 
shown in Figure 11. 
 
CPCR        MPIGSTHFFHFKSFIRSIAVNKVTTIPIKAFTTTTTKTKTKITTTTTTNSFISTMPEIPK 
ADH-2       -------------------------------------------------------MSVPT 
ADH-1       -----------------------------------------------------MSEQIPK 
                                                                      *  
 
 
CPCR        TQKAVVFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAWKGDWPLDTKLPLVG 
ADH-2       TQKAVIFETNGGKLEYKDIPVPKPKANELLINVKYSGVCHTDLHAWKGDWPLATKLPLVG 
ADH-1       TQKAVVFDTNGGQLVYKDYPVPTPKPNELLIHVKYSGVCHTDLHARKGDWPLATKLPLVG 
            ***** * * ** * *** *** ** ***** ************* ****** ******* 
 
 
CPCR        GHEGAGVVVGMGDNVKGWEIGDYAGIKWLNGSCLNCEFCEQGAEPNCPQADLSGYTHDGS 
ADH-2       GHEGAGVVVALGENVKGWKVGDYAGVKWLNGSCLNCEYCQSGAEPNCAEADLSGYTHDGS 
ADH-1       GHEGAGVVVGMGENVKGWKIGDFAGIKWLNGSCMSCEFCQQGAEPNCGEADLSGYTHDGS 
            *********  * *****  ** ** *******  ** *  ******  *********** 
 
 
CPCR        FEQYATADAVQAARIPKNADLAKAAPILCAGVTVYKALKTAQLKAGEWVCISGAGGGLGS 
ADH-2       FQQYATADAVQAARIPAGTDLANVAPILCAGVTVYKALKTAELEAGQWVAISGAAGGLGS 
ADH-1       FEQYATADAVQAAKIPAGTDLANVAPILCAGVTVYKALKTADLAAGQWVAISGAGGGLGS 
            * *********** **   ***  ***************** * ** ** **** ***** 
 
 
CPCR        LAIQYAIAMGYRVIGIDGGAEKGEYIKSLGAEAYIDFTKEKDIVEAVKKATNGGPHGVIN 
ADH-2       LAVQYAKAMGYRVLAIDGGEDKGEFVKSLGAETFIDFTKEKDVVEAVKKATNGGPHGVIN 
ADH-1       LAVQYARAMGLRVVAIDGGDEKGEFVKSLGAEAYVDFTKDKDIVEAVKKATDGGPHGAIN 
            ** *** *** **  ****  ***  ******   **** ** ******** ***** ** 
 
 
CPCR        VSVSEKAINQSVEYVRPLGKVVLVGLPAGSKVVAPVFDAVVKSVEIKGSYVGNRKDTQEA 
ADH-2       VSVSERAIGQSTEYVRTLGKVVLVGLPAGAKISTPVFDAVIKTIQIKGSYVGNRKDTAEA 
ADH-1       VSVSEKAIDQSVEYVRPLGKVVLVGLPAHAKVTAPVFDAVVKSIEIKGSYVGNRKDTAEA 
            ***** ** ** **** ***********  *   ****** *   ************ ** 
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CPCR        LDFFARGKVNCQIKIVGLSELPEVFKLMEEGKILGRYVLDTSK 
ADH-2       VDFFTRGLIKCPIKIVGLSELPEVYKLMEEGKILGRYVLDNDK 
ADH-1       IDFFSRGLIKCPIKIVGLSDLPEVFKLMEEGKILGRYVLDTSK 
             *** **   * ******* **** ***************  * 
 
Figure 11: Global alignment score of the CPCR with ADH1 and ADH2 from Candida albicans. The “*” 
represents close homologies with CPCR. 
 
The CPCR therefore began with a methionine (M) followed by a proline (P) in the N-
terminal. The total number of amino acids is 403. The C-terminal amino acid sequence of 
CPCR ended with a serine, lysine and followed by the stop codon TAA. Contrary to the start 
codon methionine, Bönitz (2001) reported that the N-terminal protein sequence of wtCPCR 
began with a proline instead, and therefore an amino acid triplet codon coding for methionine 
had to be added to the DNA sequence for the expression of the CPCR gene. This could 
signify that the N-terminal protein sequence of the wtCPCR was not complete. 
 
In the work from Bönitz (Bönitz, 2001), the recombinant CPCR was described to have 349 
amino acids which was derived from the same known partial protein sequences of the 
wtCPCR as has been described in section (3.1.3). But, using the same amino acid sequences 
as primers and with genome walking, a protein sequence of 403 amino acids was amplified 
which possessed close identities with the ADH1 and ADH2. The new derived CPCR in this 
work had an additional 54 amino acids 
“MPIGSTHFFHFKSFIRSIAVNKVTTIPIKAFTTTTTKTKTKITTTTTTNSFIST” on its N-
terminal. But the new recombinant CPCR protein also included all the known partial amino 
acids sequences of the wtCPCR and the complete CPCR protein sequence cloned by Bönitz. 
The following alignment (Figure 12) summarizes a comparison of the different known partial 
amino acids sequences (Sequence 1, 2,3,4,5 and 6; from N- towards C-terminal) of the 
wtCPCR, the CPCR cloned by Bönitz and the CPCR that had been derived in this work. 
 
CPCR              MPIGSTHFFHFKSFIRSIAVNKVTTIPIKAFTTTTTKTKTKITTTTTTNSFISTMPEIPK 
CPCR-Bönitz       ------------------------------------------------------MPEIPK 
SEQ1              -------------------------------------------------------PEIPK 
SEQ2              ------------------------------------------------------------ 
SEQ3              ------------------------------------------------------------ 
SEQ4              ------------------------------------------------------------ 
SEQ5              ------------------------------------------------------------ 
SEQ6              ------------------------------------------------------------ 
   
                                                                             
CPCR              TQKAVVFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAWKGDWPLDTKLPLVG 
CPCR-Bonitz       TQKAVVFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAWKGDWPLDTKLPLVG 
SEQ1              TQKAVVFETSGGKLEYKDIPVPKPKSNELLINVKYSGVCHTDLHAW-------------- 
SEQ2              ------------------------------------------------------------ 
SEQ3              ------------------------------------------------------------ 
SEQ4              ------------------------------------------------------------ 
SEQ5              ------------------------------------------------------------ 
SEQ6              ------------------------------------------------------------ 
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CPCR              GHEGAGVVVGMGDNVKGWEIGDYAGIKWLNGSCLNCEFCEQGAEPNCPQADLSGYTHDGS 
CPCR-Bonitz       GHEGAGVVVGMGDNVKGWEIGDYAGIKWLNGSCLNCEFCEQGAEPNCPQADLSGYTHDGS 
SEQ1              ------------------------------------------------------------ 
SEQ2              ------------------------------------------------------------ 
SEQ3              ------------------------------------------------------------ 
SEQ4              ------------------------------------------------------------ 
SEQ5              ------------------------------------------------------------ 
SEQ6              ------------------------------------------------------------ 
                                                                              
 
CPCR              FEQYATADAVQAARIPKNADLAKAAPILCAGVTVYKALKTAQLKAGEWVCISGAGGGLGS 
CPCR-Bonitz       FEQYATADAVQAARIPKNADLAKAAPILCAGVTVYKALKTAQLKAGEWVCISGAGGGLGS 
SEQ1              ------------------------------------------------------------ 
SEQ2              -----------------------AAPILCAGVTVYK------------------------ 
SEQ3              --------------------------------------------AGEWVCISGAGGGLGS 
SEQ4              ------------------------------------------------------------ 
SEQ5              ------------------------------------------------------------ 
SEQ6              ------------------------------------------------------------ 
                                                                               
 
CPCR              LAIQYAIAMGYRVIGIDGGAEKGEYIKSLGAEAYIDFTKEKDIVEAVKKATNGGPHGVIN 
CPCR-Bonitz       LAIQYAIAMGYRVIGIDGGAEKGEYIKSLGAEAYIDFTKEKDIVEAVKKATNGGPHGVIN 
SEQ1              ------------------------------------------------------------ 
SEQ2              ------------------------------------------------------------ 
SEQ3              LAIQYAIA---------------------------------------------------- 
SEQ4              ---------------------------SLGAEAYIDFTKEKDIVEAV------------- 
SEQ5              ------------------------------------------------------------ 
SEQ6              ------------------------------------------------------------ 
 
                                                                               
CPCR              VSVSEKAINQSVEYVRPLGKVVLVGLPAGSKVVAPVFDAVVKSVEIKGSYVGNRKDTQEA 
CPCR-Bonitz       VSVSEKAINQSVEYVRPLGKVVLVGLPAGSKVVAPVFDAVVKSVEIKGSYVGNRKDTQEA 
SEQ1              ------------------------------------------------------------ 
SEQ2              ------------------------------------------------------------ 
SEQ3              ------------------------------------------------------------ 
SEQ4              ------------------------------------------------------------ 
SEQ5              -------------------------------VVAPVFD-VVKSVEIKGSYVGNRKDTQEA 
SEQ6              ------------------------------------------------------------ 
                                                                               
 
CPCR              LDFFARGKVNCQIKIVGLSELPEVFKLMEEGKILGRYVLDTSK 
CPCR-Bonitz       LDFFARGKVNCQIKIVGLSELPEVFKLMEEGKILGRYVLDTQK 
SEQ1              ------------------------------------------- 
SEQ2              ------------------------------------------- 
SEQ3              ------------------------------------------- 
SEQ4              ------------------------------------------- 
SEQ5              LDFFARGKVK--------------------------------- 
SEQ6              --------------IVGLSELPEVFKLMEEGKILGRYVLDTSK 
                                                              
 
Figure 12: Alignment of recombinant CPCR translated protein to that of different known partial protein 
sequences of wtCPCR gene and the CPCR cloned by Bönitz. 
 
A reason behind this lack of 54 amino acids in the cloned CPCR from Bönitz could be that, 
when purifying the wtCPCR for sequencing the protein, this amino acid sequence somehow 
got detached maybe due to instability of the N-terminal amino acids of the wtCPCR itself, and 
therefore the CPCR gene cloned by Bönitz was not a complete one. Based on the homologies 
with other alcohol dehydrogenases as described above, and analysis with the partial protein 
sequences of wtCPCR and the cloned CPCR from Bönitz, makes it however possible to state 
that the gene that has been cloned in this work is an ADH from C.parapsilosis.  
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The derived 403 amino acid sequence of CPCR was further analyzed for possible 
glycosylation motifs to check if the CPCR is a glycoprotein. Glycosylation belongs to the 
post-translational modifications, through which a protein must pass after translation in order 
to fold it in its correct native condition if necessary. Glycosylation occurs widely in 
eukaryotes but very rarely in prokaryotes. When expressing a eukaryotic protein such as the 
CPCR in a prokaryotic host such as E.coli, it must be assured that such a modification is not 
required or important for the eukaryotic protein expression, otherwise it would not have been 
feasible for the expression of recombinant CPCR as an active enzyme in E.coli. Bönitz 
already reported in her work that the test for sugar with the wtCPCR showed no signal for 
glycosylation and confirmed that the carbonyl reductase possessed no sugar residues. In this 
work therefore, the possibilities for glycosylation were based only on sequence analysis. The 
403 amino acids of CPCR were searched for possible N-linked glycosylation sites with the 
help of protein databases such as NetNGlyc 1.0 server that predicts N-glycosylation sites in 
human protein. N-glycosylation motifs of N-G-S at position 150, N-V-S at position 300 and 
N-Q-S at position 309 were found to be present in the amino acid sequence of CPCR (Figure 
10). For N-linked glycosylation, a tripeptide sequence, known as glycosylation sequon 
consisting of Asn-X-Ser or Asn-X-Thr, where X could be any amino acid except proline 
(Gavel and Von Heijne 1990) is necessary but not sufficient for glycosylation (Pless et al., 
1977). Proteins without signal peptides are unlikely to be exposed to the N-glycosylation 
machinery and thus are not glycosylated even though they contain potential motifs. The 54 
additional amino acids sequence that is present in the N-terminal of the recombinant CPCR 
was therefore analyzed for signal peptides using the database SignalP server that predicts for 
signal peptides in eukaryotes. It was found that the 54 amino acids sequences of CPCR was 
not a signal peptide (Nielsen et al., 1997) and were parts of the mature protein. Both the 
experimental analysis done by Bönitz (2001) and the sequence analysis confirmed that the 
CPCR was not a glycoprotein and could be therefore expressed as an active enzyme in an 
E.coli expression system.  
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3.1.5 Cloning of the 1212 bp CPCR gene into expression vectors 
 
For expression of the recombinant CPCR gene in E.coli, the gene was cloned into two 
expression vectors namely pKK223-3 and pET-26b(+) under the control of two promoters: 
TAC ( lac-trp hybrid promoter) and T7lac ( T7-lac hybrid promoter). 
 
The pKK223-3 vector has the following structural elements: 
 
1. A regular TAC-promoter element that is induced with IPTG (Isopropyl-ß-D-
thiogalactoside) for the expression of the target gene. 
2. The LacZ ribosome-binding site followed by an ATG start codon. 
3.  A “Multiple cloning site”, into which the insertion of a foreign DNA can be done.  
4. A strong transcription terminator, for e.g. the rrnB at the end of the “Multiple cloning 
site”. 
5. A “Replication origin” (ori) and the ß-Lactamase gene. This gene enables the selection 
of the recombinant bacterial clone over the ampicillin resistance (Sutcliffe, 1979).  
  
The pET-26b(+) vector has the following structural elements: 
 
1. A T7lac-promoter element (Studier et al., 1990; Dubendorff and Studier, 1991) that is 
induced with IPTG for the expression of the target gene. 
2. The ribosome-binding site is followed by a unique NdeI site for cloning into the     
ATG start codon at the 5’-end of the insert coding sequence. 
3.  A “Multiple cloning site”, into which the insertion of a foreign DNA can be done.  
4. A strong transcription terminator, for e.g. the T7 at the end of the “Multiple cloning 
site”. 
5. A “Replication origin” (ori) and the kanamycin-coding gene. This gene enables the 
selection of the recombinant bacterial clone over the kanamycin resistance.  
            
The recombinant CPCR had been able to be cloned in the correct orientation into the 
expression vectors and corresponding restriction sites for cloning were introduced at both 
ends of the gene. Apart from the desired orientation of the gene, a suitable distance of the start 
codon methionine (ATG) from the promoter could be kept and thus the ribosome also could 
bind on the plasmid.  
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For cloning into the pKK223-3 vector, an EcoRI site was added into the 5’-end of the CPCR 
gene. On the 3’-end of the gene, a PstI restriction site, as well as a stop codon TAA has been 
introduced (primer combinations: CPCR-F1A and CPCR-F2).  
 
In the case of the pET-26b(+) vector, an NdeI site was added into the 5’-end of the CPCR 
gene. This vector was used for expression of the CPCR with His6-tag. Therefore a His6-tag on 
the N-terminal of the CPCR gene was introduced by adding six histidine residues just after 
the NdeI site on the 5’-end. On the 3’-end of the gene, an XhoI restriction site was introduced 
just after the stop codon TAA (primer combinations: CPCR-Nhis and CPCR-CXho). 
 
In  Figure 13, the restriction map of the recombinant CPCR gene derived from genome 
walking (Figure 9) is described. With the help of this map it was evident, which restriction 
enzymes cannot generally be used for cloning of the CPCR, since they would cause 
fragmentation of the gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Map of the recombinant CPCR gene. 
 
For cloning the CPCR gene into the expression vectors, apart from the insertion of the 
restriction sites, an error-free amplification of the PCR product was necessary. The 
occurrence of accidental mutations in the process of amplification, could lead to an inactive 
recombinant protein. The Taq-polymerase possesses no “ proof-reading activity” (Flaman et 
al., 1994) and therefore the appearance of mutations during the process of amplification 
cannot be avoided. Due to this, the amplification of the PCR-products (CPCR as well as 
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CpSADH) for cloning in the expression vectors were carried out only with thermostable and 
proof-reading polymerases such as ISIS & GO TM Mastermix (Qbiogene) or TripleMaster® 
PCR System (Eppendorf). The DraI digested library was used as a template for PCR 
amplification of the CPCR gene. 
 
The amplified CPCR fragment with the primer combinations of CPCR-F1A/CPCR-F2 (PCR 
cycles as described in section 2.3.4; PCR set-up for the amplification of CpSADH and CPCR 
without His6-tag) and the pKK223-3 expression vector were after restriction digestion, ligated 
together and transformed into competent E.coli JM109 expression strain.  
 
 The amplified CPCR fragment with the primer combinations of CPCR-Nhis /CPCR-CXho 
(PCR cycles as described in section 2.3.4; PCR set-up for the amplification of CpSADH and 
CPCR with His6-tag), and the pET-26b(+) expression vector were after restriction digestion, 
ligated together and transformed into competent E.coli  BL21(DE3) expression strain . 
 
 In Figure 14(a), an agarose gel is represented, which shows the self-digested CPCR-PCR-
product and the expression vector pKK223-3 that had been isolated in each case, after 
incubation with EcoRI and PstI. Whereas, in Figure 14(b), the represented agarose gel shows 
the self-digested CPCR-PCR-product and the expression vector pET-26b(+) that had been 
isolated, after incubation with NdeI and XhoI.  
Figure 14  
(a): Restriction digestion of the PCR amplified CPCR gene and the expression vector pKK223-3. Lane 1= 
Digested pKK223-3 with EcoRI and PstI for 4 h at 37 °C; Lane 2= GeneRulerTM 1 kb DNA ladder; Lane 3 = 
Digested CPCR fragment with EcoRI and PstI for 4 h at 37 °C. 
(b): Restriction digestion of the PCR amplified CPCR gene and the expression vector pET-26b(+). Lane 1= 
Digested CPCR fragment with NdeI and XhoI for 16 h at 37 °C; Lane 2= Digested pET-26b(+) with NdeI and 
XhoI for 16 h at 37 °C; Lane 3 = GeneRulerTM 1 kb DNA ladder. 
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The plasmids that were isolated from the transformed bacteria are shown in Figure 15(a) for 
the recombinant vector construct pKK223-3CPCR9 and in Figure 15(b) for the recombinant 
vector construct pET26b+CPCR9his. The plasmids were likewise digested, as in this above 
example, as a check for successful ligation, with the restriction enzymes and isolated 
afterwards in agarose gels. Positive clones could be identified thereby as the plasmids with an 
increase in the size, which was due to the ligation of the CPCR gene into the plasmids (as 
shown in Figure 15 a and b). Before further use, positively tested clones in the restriction 
analysis, were finally confirmed through DNA sequencing for the completeness and 
correctness of the CPCR gene on molecular level and to exclude errors such as point 
mutations, etc. 
 
  
Figure 15 
(a): Restriction digestion of the CPCR/pKK223-3 recombinant vector construct after successful ligation and 
cloning. Lane 1= GeneRulerTM 1 kb DNA ladder; Lane 2 = Digested pKK223-3CPCR9 construct with EcoRI for 
4 h at 37 °C. 
(b): Restriction digestion of the CPCR/pET-26b(+)  recombinant vector construct after successful ligation and 
cloning. Lane 1= Digested pET-26b+ vector with NdeI for 4 h at 37 °C as an example of self-ligation possessing 
no insert within it; Lane 2= GeneRulerTM 1 kb DNA ladder; Lane 3 = Digested pET26b+CPCR9his construct 
with NdeI for 4 h at 37 °C.  
 
3.1.6 Cloning of the 1011 bp CpSADH gene into expression vectors 
 
  
The CpSADH gene coding for an alcohol dehydrogenase from C.parapsilosis IFO 1396 strain 
was first reported by Kojima et al. in the year 1995. The presence of this gene was searched 
for in the C.parapsilosis DSMZ 70125 strain. This was done by PCR amplification of the 
CpSADH gene using the DraI digested library as template and the primer combinations ADH-
J1 and ADH-J2 (PCR cycles as described in section 2.3.4; PCR set-up for the amplification of 
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CpSADH and CPCR without His6-tag). The amplified CpSADH fragment and the pKK223-3 
expression vector were after restriction digestion, ligated together and transformed into 
competent E.coli JM109 expression strain.  
 
Furthermore, the cloning of the said gene was also done by an addition of N-terminal six-
histidine residues in order to facilitate easy purification of the recombinant protein. For this 
the said gene was amplified by PCR using the DraI digested library and the primer 
combinations of JADH-NHis and JADH-CXho (PCR cycles as described in section 2.3.4; 
PCR set-up for the amplification of CpSADH and CPCR with His6-tag). The amplified 
fragment and the pET-26b(+) expression vector were after restriction digestion, ligated 
together and transformed into competent E.coli  BL21(DE3) expression strain . At this point it 
should be stated that a powerful feature of the pET system is the ability to clone target genes 
under conditions of extremely low transcriptional activity, that is, in the absence of a source 
of T7 RNA polymerase. Background expression is minimal in the absence of T7 RNA 
polymerase because the host RNA polymerases do not initiate from T7 promoters and the 
cloning sites in pET plasmids are in regions weakly transcribed by read-through activity of 
bacterial RNA polymerase. Sometimes low levels of basal expression can cause difficulties in 
growth and plasmid instability in some expression hosts due to transcription from the T7 
promoter in the pET plasmids. Therefore for initial cloning of the CpSADH (and also CPCR) 
into the pET-26b(+) and for maintaining the recombinant plasmids, the E.coli strain DH5α 
was used because this bacterial strain is recA– endA– and has high transformation efficiencies 
and good plasmid yields. For expression of protein, the recombinant plasmids were 
transformed into the expression strain BL21(DE3).  
 
For cloning into the pKK223-3 vector, an EcoRI site was added into the 5’-end of the 
CpSADH gene. On the 3’-end of the gene, a HindIII restriction site was added just after the 
stop codon TAG (primer combinations: ADH-J1 and ADH-J2).  
 
In the case of the pET-26b(+) vector, an NdeI site was added into the 5’-end of the CpSADH 
gene. His6-tag on the N-terminal of the CpSADH gene was introduced by adding six histidine 
residues just after the NdeI site on the 5’-end. On the 3’-end of the gene, an XhoI restriction 
site was introduced just after the stop codon TAG (primer combinations: JADH-NHis and 
JADH-CXho). The following restriction map of CpSADH was used to decide which 
restriction sites could be and which ones could not be used. 
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Figure 16: Restriction map of recombinant of CpSADH gene. 
 
The cloning process was the same as described for CPCR. The self-digested CpSADH and the 
expression vector pKK223-3 were isolated in each case after incubation with EcoRI and 
HindIII and ran on agarose gels to check for successful digestion. In case of pET-26b(+) 
expression vector, the CpSADH as well as the vector were digested in each case with NdeI 
and XhoI and later ran on agarose gels. A typical self-digested CpSADH and the individual 
vectors as represented by agarose gels are shown in the following two figures (Figure 17 a 
and b). 
 
In order to check for positive clones and for successful ligation, the recombinant plasmids 
were isolated from the transformed bacteria and likewise digested with the same restriction 
enzymes and later verified by agarose gels. The positive clones were identified as plasmids 
with an increase in the total size due to the ligation of the CpSADH gene into the vectors. An 
alternative way to identify positive clones was to double digest the recombinant plasmids. By 
doing so, the CpSADH gene separated out of the pET-26b(+) vector, which was verified by 
an agarose gel. The recombinant constructs after restriction digestion are shown in Figure 18 
(a) for recombinant vector construct pKK223-3CpSADH18 and in Figure 18(b) for the 
recombinant vector construct pET26b+CpSADH28his. The recombinant plasmids were 
further sequenced to check for the correctness of the CpSADH gene on the molecular level. 
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Figure 17 
(a): Restriction digestion of the PCR amplified CpSADH gene and the expression vector pKK223-3. Lane 1= 
Digested pKK223-3 with EcoRI and HindIII for 4 h at 37 °C; Lane 2= Digested CpSADH fragment with EcoRI 
and HindIII for 4 h at 37 °C; Lane 3 = GeneRulerTM 1 kb DNA ladder. 
(b): Restriction digestion of the PCR amplified CpSADH gene and the expression vector pET-26b(+). Lane 1= 
GeneRulerTM 1 kb DNA ladder; Lane 2= Digested pET-26b(+) with NdeI and XhoI for 16 h at 37 °C; Lane 3 = 
Digested CpSADH fragment with NdeI and XhoI for 16 h at 37 °C. 
 
               (a)         (b)  
 
igure 18 
tion digestion of the CpSADH/pKK223-3 recombinant vector construct after successful ligation and 
TM
pET-26b(+) recombinant vector construct after successful ligation and 
TM
F
(a): Restric
cloning. Lane 1= Digested pKK223-3 vector with EcoRI for 4 h at 37 °C as an example of self-ligation 
possessing no insert within it; Lane 2 = Digested pKK223-3CpSADH18 construct with EcoRI for 4 h at 37 °C; 
Lane 3 = GeneRuler  1 kb DNA ladder. 
(b): Restriction digestion of the CpSADH/
cloning. Lane 1= GeneRuler  1 kb DNA ladder; Lane 2 = Digested pET26b+CpSADH28his construct with 
NdeI and XhoI for 4 h at 37 °C. The double digestion separated the CpSADH gene from the pET-26b(+) vector 
as an evidence of successful ligation.  
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It was observed that with proteins from C.albicans, on translation level, for the triplet codon 
he DNA sequencing of the CpSADH18 (recombinant CpSADH without His6-tag) and 
6
 m
atented CpSADH       ---------------------ATGTCAATTCCATCAAGCCAGTACGGATTCGTATTCAAT 
CTG a serine instead of a leucine could be inserted (Kawaguchi et al., 1989; Suzuki et al., 
1993; Santos et al., 1993). This deviation from the universal genetic code and/or these not 
standardized translation events could lead to the change of the enzyme characteristics and/or 
to the shift of the open reading frame (ORF). Such a triplet was not found in the determined 
sequence of recombinant CPCR in this work and also not in Bönitz’s. 
 
T
CpSADH28his (recombinant CpSADH with His -tag) that had been isolated from the DraI 
gDNA library of C.parapsilosis DSMZ 70125 strain showed that all the amino acids of the 
patented ADH from C.parapsilosis IFO 1396 strain were conserved. But an interesting thing 
that had been noticed through this sequencing was that at position 58 of the DNA sequence of 
the patented ADH (Kojima et al., 1995) a triplet codon CTG (coding for leucine) is present. 
Fortunately, in the CpSADH gene from C.parapsilosis DSMZ 70125, a triplet codon TTG 
(also coding for leucine) was present instead of the CTG. The possibility of “wobble bases” 
due to PCR could be ruled out in this case because both the CpSADH18 that has been 
amplified with the ISIS & GOTM Mastermix and the CpSADH28his that has been amplified 
with TripleMaster® PCR Syste , conserved this triplet codon TTG. The alignment of the 
DNA sequences of all the three types of the CpSADH genes is shown in the following figure.  
 
p
recCpSADH             ---------------------ATGTCAATTCCATCAAGCCAGTACGGATTCGTATTCAAT 
CpSADH-NHis           ATGCACCATCATCATCACCACATGTCAATTCCATCAAGCCAGTACGGATTCGTATTCAAT 
                                           *************************************** 
 
atented CpSADH       AAGCAATCAGGACTTAATCTGAGAAATGATTTGCCTGTCCACAAGCCCAAAGCGGGTCAA p
recCpSADH             AAGCAATCAGGACTTAATTTGAGAAATGATTTGCCTGTCCACAAGCCCAAAGCGGGTCAA 
CpSADH-NHis           AAGCAATCAGGACTTAATTTGAGAAATGATTTGCCTGTCCACAAGCCCAAAGCGGGTCAA 
                      ****************** ***************************************** 
 
atented CpSADH       TTGTTGTTGAAAGTTGATGCTGTTGGATTGTGTCATTCTGATTTACATGTCATTTACGAA p
recCpSADH             TTGTTGTTGAAAGTTGATGCTGTTGGATTGTGTCATTCTGATTTACATGTCATTTACGAA 
CpSADH-NHis           TTGTTGTTGAAAGTTGATGCTGTTGGATTGTGTCATTCTGATTTACATGTCATTTACGAA 
                      ************************************************************ 
 
atented CpSADH       GGGTTGGATTGTGGTGATAATTATGTCATGGGACATGAAATTGCTGGAACTGTTGCTGCT p
recCpSADH             GGGTTGGATTGTGGTGATAATTATGTCATGGGACATGAAATTGCTGGAACTGTTGCTGCT 
CpSADH-NHis           GGGTTGGATTGTGGTGATAATTATGTCATGGGACATGAAATTGCTGGAACTGTTGCTGCT 
                      ************************************************************ 
 
atented CpSADH       GTGGGTGATGATGTCATTAACTACAAGGTTGGTGATCGTGTTGCCTGTGTCGGACCCAAT p
recCpSADH             GTGGGTGATGATGTCATTAACTACAAGGTTGGTGATCGTGTTGCCTGTGTCGGACCCAAT 
CpSADH-NHis           GTGGGTGATGATGTCATTAACTACAAGGTTGGTGATCGTGTTGCCTGTGTCGGACCCAAT 
                      ************************************************************ 
 
atented CpSADH       GGATGTGGTGGGTGCAAGTATTGTCGTGGTGCCATTGACAATGTATGTAAAAACGCATTT p
recCpSADH             GGATGTGGTGGGTGCAAGTATTGTCGTGGTGCCATTGACAATGTATGTAAAAACGCATTT 
CpSADH-NHis           GGATGTGGTGGGTGCAAGTATTGTCGTGGTGCCATTGACAATGTATGTAAAAACGCATTT 
                      ************************************************************ 
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patented CpSADH       GGTGATTGGTTCGGATTGGGGTACGATGGTGGGTATCAACAGTACTTGTTGGTTACTAGA 
recCpSADH             GGTGATTGGTTCGGATTGGGGTACGATGGTGGGTATCAACAGTACTTGTTGGTTACTAGA 
CpSADH-NHis           GGTGATTGGTTCGGATTGGGGTACGATGGTGGGTATCAACAGTACTTGTTGGTTACTAGA 
                      ************************************************************ 
 
patented CpSADH       CCACGTAACTTGTCTCGTATCCCAGATAACGTATCTGCAGACGTGGCTGCGGCTTCAACT 
tented CpSADH       GATGCTGTATTGACACCATATCACGCAATCAAGATGGCTCAAGTGTCACCAACTTCGAAT 
tented CpSADH       ATCTTGCTTATTGGTGCTGGTGGATTGGGTGGAAATGCAATTCAAGTTGCCAAGGCATTT 
tented CpSADH       GGTGCGAAAGTTACTGTTTTGGACAAAAAAAAGGAGGCTCGTGACCAAGCAAAGAAGTTG 
tented CpSADH       GGTGCTGATGCAGTTTATGAAACATTGCCAGAATCCATTTCTCCTGGCTCTTTTTCAGCA 
tented CpSADH       TGTTTTGATTTTGTTTCAGTGCAAGCTACATTTGATGTATGTCAAAAGTATGTTGAACCA 
tented CpSADH       AAGGGTGTAATTATGCCCGTGGGACTCGGTGCTCCTAATTTATCGTTTAATTTGGGAGAT 
tented CpSADH       TTGGCATTGAGAGAAATTCGAATCTTGGGTAGTTTTTGGGGAACTACTAATGATTTGGAT 
tented CpSADH       GATGTTTTGAAATTGGTTAGTGAAGGTAAAGTTAAACCCGTTGTGAGAAGTGCCAAATTG 
tented CpSADH       AAGGAATTGCCAGAGTATATTGAAAAATTGAGAAACAATGCTTATGAAGGTAGAGTTGTT 
tented CpSADH       TTTAATCCATAG 
Figure 19: Global alignment score of the patented CpSADH with that of the CpSADH’s that have been isolated 
recCpSADH             CCACGTAACTTGTCTCGTATCCCAGATAACGTATCTGCAGACGTGGCTGCGGCTTCAACT 
CpSADH-NHis           CCACGTAACTTGTCTCGTATCCCAGATAACGTATCTGCAGACGTGGCTGCGGCTTCAACT 
                      ************************************************************ 
 
pa
recCpSADH             GATGCTGTATTGACACCATATCACGCAATCAAGATGGCTCAAGTGTCACCAACTTCGAAT 
CpSADH-NHis           GATGCTGTATTGACACCATATCACGCAATCAAGATGGCTCAAGTGTCACCAACTTCGAAT 
                      ************************************************************ 
 
pa
recCpSADH             ATCTTGCTTATTGGTGCTGGTGGATTGGGTGGAAATGCAATTCAAGTTGCCAAGGCATTT 
CpSADH-NHis           ATCTTGCTTATTGGTGCTGGTGGATTGGGTGGAAATGCAATTCAAGTTGCCAAGGCATTT 
                      ************************************************************ 
 
pa
recCpSADH             GGTGCGAAAGTTACTGTTTTGGACAAAAAAAAGGAGGCTCGTGACCAAGCAAAGAAGTTG 
CpSADH-NHis           GGTGCGAAAGTTACTGTTTTGGACAAAAAAAAGGAGGCTCGTGACCAAGCAAAGAAGTTG 
                      ************************************************************ 
 
pa
recCpSADH             GGTGCTGATGCAGTTTATGAAACATTGCCAGAATCCATTTCTCCTGGCTCTTTTTCAGCA 
CpSADH-NHis           GGTGCTGATGCAGTTTATGAAACATTGCCAGAATCCATTTCTCCTGGCTCTTTTTCAGCA 
                      ************************************************************ 
 
pa
recCpSADH             TGTTTTGATTTTGTTTCAGTGCAAGCTACATTTGATGTATGTCAAAAGTATGTTGAACCA 
CpSADH-NHis           TGTTTTGATTTTGTTTCAGTGCAAGCTACATTTGATGTATGTCAAAAGTATGTTGAACCA 
                      ************************************************************ 
 
pa
recCpSADH             AAGGGTGTAATTATGCCCGTGGGACTCGGTGCTCCTAATTTATCGTTTAATTTGGGAGAT 
CpSADH-NHis           AAGGGTGTAATTATGCCCGTGGGACTCGGTGCTCCTAATTTATCGTTTAATTTGGGAGAT 
                      ************************************************************ 
 
pa
recCpSADH             TTGGCATTGAGAGAAATTCGAATCTTGGGTAGTTTTTGGGGAACTACTAATGATTTGGAT 
CpSADH-NHis           TTGGCATTGAGAGAAATTCGAATCTTGGGTAGTTTTTGGGGAACTACTAATGATTTGGAT 
                      ************************************************************ 
 
pa
recCpSADH             GATGTTTTGAAATTGGTTAGTGAAGGTAAAGTTAAACCCGTTGTGAGAAGTGCCAAATTG 
CpSADH-NHis           GATGTTTTGAAATTGGTTAGTGAAGGTAAAGTTAAACCCGTTGTGAGAAGTGCCAAATTG 
                      ************************************************************ 
 
pa
recCpSADH             AAGGAATTGCCAGAGTATATTGAAAAATTGAGAAACAATGCTTATGAAGGTAGAGTTGTT 
CpSADH-NHis           AAGGAATTGCCAGAGTATATTGAAAAATTGAGAAACAATGCTTATGAAGGTAGAGTTGTT 
                      ************************************************************ 
 
pa
recCpSADH             TTTAATCCATAG 
CpSADH-NHis           TTTAATCCATAG 
                      ************ 
 
in this work. The “*” designates similarities with the patented CpSADH.  The exchange of “CTG” with “TTG” 
is represented with the grey-marked region. 
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Using the NetNGlyc 1.0 server that predicts N-glycosylation sites in human protein, N-linked 
glycosylation motifs of N-L-S at position 136, N-V-S at position 143 and N-L-S at position 
266 were found to be present in the amino acids sequences of the patented CpSADH by 
Kojima (1995) as well as in the recombinant CpSADH that had been cloned in this work. But 
as stated earlier, such motifs are not sufficient for glycosylation of proteins that do not contain 
signal peptides. Analysis of the amino acids sequence of CpSADH with the SignalP server 
showed that the CpSADH contained no signal peptides within it. Therefore the possibility of 
real glycosylation of CpSADH could be ruled out. Besides Kojima reported also of no such 
probabilities and the enzyme was active when expressed in E.coli. 
 
  1  msipssqygf vfnkqsglnl rndlpvhkpk agqlllkvda vglchsdlhv iyegldcgdn   
 61  yvmgheiagt vaavgddvin ykvgdrvacv gpngcggcky crgaidnvck nafgdwfglg   
121  ydggyqqyll vtrprnlsri pdnvsadvaa astdavltpy haikmaqvsp tsnilligag   
181  glggnaiqva kafgakvtvl dkkkeardqa kklgadavye tlpesispgs fsacfdfvsv   
241  qatfdvcqky vepkgvimpv glgapnlsfn lgdlalreir ilgsfwgttn dlddvlklvs   
301  egkvkpvvrs aklkelpeyi eklrnnayeg rvvfnp Stop (336 amino acids) 
 
Figure 20: Translated amino acids sequence of CpSADH.  
 
3.1.7 Conclusion of the cloning of CPCR and CpSADH 
 
The CPCR and the CpSADH had been successfully cloned. Using the method of genome 
walking and the partial amino acids sequences of the wtCPCR, the CPCR gene was amplified 
from the gDNA library of C.parapsilosis DSMZ 70125. The recombinant CPCR possessed 
403 amino acids, which were 54 amino acids more on the N-terminal when compared to the 
amino acids sequences of the recombinant CPCR that had been cloned by Bönitz (2001). But 
the CPCR (derived in this work) possessed all the known partial amino acids sequences 
within it. A reason behind this lack of 54 amino acids on the N-terminal of the CPCR cloned 
by Bönitz could be that the sequence somehow got detached from the rest of the sequence and 
was not identifiable in the partial amino acids sequences of the wtCPCR and thus this 
sequence began with a proline as a start codon which was quite unusual. These 54 amino 
acids began with a methionine as a start codon and were on the same reading frame with the 
rest of the sequences (as described by Bönitz). This therefore confirmed that the 403 amino 
acids of the CPCR derived in this work had a potential start codon methionine and a stop 
codon TAA and was thus a complete amino acids sequence. Analysis of the 403 amino acids 
of the recombinant CPCR showed that it contained no signal peptides within the first 54 
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amino acids on the N-terminal and that they were parts of the mature protein. Thus with the 
method of genome walking the complete sequence of the CPCR was derived. 
 
The CpSADH gene coding for an alcohol dehydrogenase that had been patented by Kojima in 
1995 were also amplified from the same gDNA library of C.parapsilosis DSMZ 70125. The 
identities of these two enzymes (CpSADH derived in this work and the patented enzyme) 
when compared with the amino acids were 100%. But on the DNA level, the patented ADH 
from C.parapsilosis IFO 1396 strain had a “CTG” triplet at position 58 whereas the 
recombinant CpSADH from C.parapsilosis DSMZ 70125 strain had a “TTG” triplet instead. 
Though both the triplet codons codes for leucine (according to the universal genetic code) but 
it had been reported that a “CTG” in C.albicans coded for serine instead. Such a replacement 
of serine with leucine could alter the enzyme characteristics or activity when expressed in 
E.coli. A similar triplet codon was not found in the DNA sequence of the recombinant CPCR. 
Amplification of both the CPCR and the CpSADH genes from the same strain (DSMZ 70125) 
of C.parapsilosis which is known to be the “CPCR” type strain confirmed that at least two 
alcohol dehydrogenases were present in the same strain though it was not clear which one of 
the two is the “Real CPCR”. 
 
According to Reid (Reid and Fewson, 1994) the NAD- or NADP-dependent alcohol 
dehydrogenases can be classified into three groups depending in their number of amino acids. 
These include the Group I long-chain (also known as medium-chain) (approximately 350 
amino acid residues) zinc-dependent alcohol dehydrogenases, Group II short-chain 
(approximately 250 amino acid residues) zinc-independent alcohol dehydrogenases and the 
Group III (also known as long-chain) “iron-activated” alcohol dehydrogenases that generally 
contain approximately 385 amino acid residues or even up to 900 residues. Accordingly, the 
recombinant CPCR that had been cloned in this work can be classified as a long-chain ADH 
(Group III) since the sequence consisted of 403 amino acids. Both the recombinant CPCR 
from Bönitz’s work that consisted of only 349 amino acids, and the CpSADH that consisted 
of 336 amino acid residues can be categorized therefore as medium-chain ADH (Group I). 
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3.2 Expression of recombinant CPCR and CpSADH 
Conditions for the recombinant expression of genes 
 
The highest goal of a gene cloning for biotechnological applications is the expression of the 
cloned gene in a selected host organism, so that the target protein is produced in sufficiently 
large quantities for commercial employment. Different molecular-biological characteristics 
are used for the regulation of gene expression: 
 
1. The conditions of necessary promoter and terminator sequences for transcription. 
2. The strength of the ribosome-binding site for the initiation of translation. 
3. The copy number of the cloned genes in the host organism and whether a gene is 
placed on a plasmid or is integrated in the host genome. 
4. The final cellular position of the synthesized foreign protein. 
5. The efficiency of translation in the host organism. 
6. The intrinsic stability of the coded protein in the host cell (Glick, 1987; Otha, 1993; 
Glick, 2003). 
 
Other parameters that also are to be considered are the possibilities for the purification of the 
expressed protein from the host organism, and the possibilities for cultivation of huge cell 
mass through fermentation. These conditions are mainly necessary in order to make the 
recombinant protein available for industrial applications, as the primary goals of recombinant 
proteins from the industrial point of view are high product yield, stability and cost 
effectiveness. 
 
The intensity of expression of a foreign protein depends also on the characteristics of the host 
organism. Although many prokaryotic and eukaryotic organisms like Bacillus subtilis, 
different yeasts such as Saccharomyces cerevisae, Hansenula polymorpha or Pichia pastoris, 
or also animal cells, plants cells, and insects (Wilcox and Studnicka, 1988) can be used as 
host systems for the heterologous expression of genes, one uses E.coli for most commercially 
important, genetically modified proteins, at present. The reason behind this is that the 
physiology, molecular biology and genetics of this bacterium are very well known. 
Furthermore, this gram-negative bacterium in contrary to other microorganisms can be 
produced with simple media in large scale and many proteins can be very fast and 
economically experimented.  
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One way for achieving the expression of recombinant proteins is with the plasmid coding 
system because this system allows high product yield. The expression plasmids possess a 
promoter region for initiation of transcription of the gene, a terminator sequence for 
transcription stop at the end of the gene sequence.  The expression plasmids contain at least 
one selection marker. An “Origin of replication” ensures that a plasmid is multiplied 
independently of the bacterial chromosome (Dale, 1994). Numerous systems possess 
additional DNA sequences to reduce problems such as mRNA or plasmid stability, premature 
transcription termination or an ineffective translation initiation (Balbas and Bolivar, 1990).  
 
3.2.1 Expression of recombinant CPCR 
 
The recombinant plasmid constructs carrying the gene coding for CPCR namely pKK223-
3CPCR9 and pET26b+CPCR9his that had been created by successful cloning as described in 
section (3.1.5) were used for the expression of CPCR. For carrying out expression of the 
recombinant CPCR in E.coli, the plasmid pKK223-3CPCR9 was transformed into the E.coli 
JM109 strain and the plasmid pET26b+CPCR9his was transformed into BL21(DE3) strain. 
The expression systems were therefore termed as JM109pKK223-3CPCR9 and 
BL21(DE3)pET26b+CPCR9his, respectively. The vector maps of the expression plasmids are 
shown in Figure 21 that had been created using the computer program CloneManager 6.0 
(Scientific & Educational Software, USA).  
 
 
  
Figure 21: Construction of expression plasmids pKK223-3CPCR9 and pET26b+CPCR9his. 
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The recombinant CPCR was expressed with the methods as described earlier (see section 
2.2.2) in 100-200 ml scales. Cell free crude extracts of these recombinant strains were used to 
determine the specific activity of the expressed recombinant CPCR with the standard assay 
conditions. As a negative control, the same E.coli strains JM109 and BL21(DE3) were 
transformed with the parent vector alone (i.e. pKK223-3 and pET-26b+ respectively) and 
were expressed in parallel with the same conditions and afterwards cell free crude extracts 
were prepared in the same way like that with the enzymes. It was found that when 
determining the activities of the crude extracts by measuring the oxidation of NADH+H+ with 
the spectrophotometer, there were always some background activities of the negative controls. 
Therefore the specific activities of the negative controls were used as reference. These values 
were always subtracted from the values obtained with the enzymes. In her work, Bönitz 
reported to have a specific activity of recombinant CPCR of only 0.3 U/mg with the pKK223-
3/E.coli HB101 construct, no activity with the pKK223-3/E.coli JM109 construct, and a 
maximum of 1.5 U/mg with the pBTac/E.coli JM105 construct when fermentation was carried 
out in 100 ml scales. In comparison, the specific activities of the crude extracts of the 
recombinant constructs JM109pKK223-3CPCR9 was 0.4 U/mg and that of the 
BL21(DE3)pET26b+CPCR9 was 0.5 U/mg when fermentation was done in 100 ml scales in 
shake flasks with LB medium at 30 °C. Induction was done with 1 mM IPTG and after 
induction, cells were grown at 30 °C for the pKK223-3/E.coli JM109 construct and at 28 °C 
for the pET26b+/E.coli BL21(DE3) construct for 6 h. 
 
An interesting observation found with the recombinant CPCR both with and without His6-tag, 
that had been obtained in this work was that the recombinant protein was expressed in the 
host strains only for about 2-3 times. Typically, after the 2nd expression, the enzyme was not 
active anymore. This was noticed for both the expression systems. Alteration in the 
expression parameters like temperature (from 30 °C to as low as 18 °C), IPTG concentrations 
(from 1 mM to 0.1 mM), media compositions, and period of induction all resulted in no 
expression. Analysis of the DNA sequences showed no point mutations or alterations of 
amino acids within the sequences when compared with the DNA sequence of the CPCR 
derived by genome walking. One reason could be instability of the plasmids within the host 
organisms due to storage. The expression plasmids were therefore transformed freshly and 
were then used for expression with induction of IPTG. But, the enzyme was not expressed at 
all. Toxicity of the CPCR to the host strains could be ruled out because the recombinant E.coli 
cells grew normally under the expression conditions and was not inhibited upon induction. To 
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avoid proteolytic degradation, protease inhibitor such as PMSF were also added but gave no 
positive results. Many recombinant proteins form insoluble aggregates known as inclusion 
bodies when over-expressed in E.coli (Rudolf and Lilie, 1996; Clark 1998; Lilie et al., 1998). 
The recombinant CPCR was checked for such inclusion bodies by making SDS-PAGE 
analysis of the expressed bacterial cell pellets and that as well gave no positive signals.  
 
3.2.2 Expression of recombinant CpSADH 
 
The expression of the recombinant CpSADH was carried out using the expression plasmids 
pKK223-3CpSADH18 and pET26b+CpSADH28his that had been successfully cloned as 
described in section (3.1.6). The recombinant CpSADH was expressed in E.coli strains. For 
that, the plasmid pKK223-3CpSADH18 was transformed in competent E.coli JM109 and the 
plasmid pET26b+CpSADH28his was transformed in competent E.coli BL21(DE3) strains 
respectively. The recombinant expression strains thereby created namely, JM109 pKK223-
3CpSADH18 contained the CpSADH without any His6-tag whereas BL21(DE3) 
pET26b+CpSADH28his contained the CpSADH with an N-terminal His6-tag. The vector 
maps of the expression plasmids are shown in the following figure: 
 
 
Figure 22: Construction of expression plasmids pKK223-3CpSADH18 and pET26b+CpSADH28his. 
 
Expression of the recombinant CpSADH was carried out in a volume ranging from 100 ml to 
4 liters scales with the standard method for expression as described previously (see section 
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2.2.2). Cell free cleared lysates of these recombinant strains were used to determine the 
activity, specific activity of the expressed recombinant CpSADH using the standard assay 
conditions. As a negative control, results of similar activity assay of the host E.coli cells 
JM109 and BL21(DE3) that were transformed with the vectors pKK223-3 and pET-26b(+) 
respectively were used for reference. For the expression of CpSADH, batch fermentation was 
carried out in 1 liter scale in TB medium in shake flasks. Cells were induced with 1 mM IPTG 
and were grown for an additional 6 h at 30 °C (JM109pKK223-3CpSADH18) and at 28 °C 
[BL21(DE3)pET26b+CpSADH28his]. Under these conditions, the specific activities of the 
recombinant CpSADH in these two expression systems thereby measured were 14.97 U/mg 
with the construct JM109pKK223-3CpSADH18 whereas 15.3 U/mg with the construct 
BL21(DE3)pET26b+CpSADH28his. 
 
The values of the specific activities of the crude extracts of the two expression systems of 
CpSADH were obtained under the optimized conditions for expression. It was found that for 
the recombinant expression strain JM109pKK223-3CpSADH18 that contained the CpSADH 
gene without any His6-tag, induction with 1 mM IPTG in the mid-log phase (OD550 of ~1.6) 
resulted in comparatively higher activities/specific activities than when induced at early mid-
log phase (OD550 of ~1.2). The recombinant strain BL21(DE3)pET26b+CpSADH28his was 
always induced at an OD600 of 0.8. For the pET expression systems, this OD was described 
the best for the expression of recombinant proteins. These results showed that addition of an 
N-terminal His6-tag on the CpSADH did not alter the activities of the protein. Besides it was 
found that the specific activity of the His-tagged CpSADH was slightly higher than that of the 
CpSADH without tag. 
 
Fermentation of recombinant CpSADH 
 
Fermentation of the recombinant expression strains was carried out in 100 ml to 4 liters 
scales. For preparative scales, batch-fermentation of the expression strains JM109pKK223-
3CpSADH18 and BL21(DE3)pET26b+CpSADH28his were carried out in 5-liter shake flasks 
with baffles with culture media of 1 liter in each flask.  
 
 The level of expression of the recombinant proteins depends on the composition of the 
growth media (Broedel et al., 2001). It was found that the expression of recombinant 
CpSADH was also influenced by the components of the media. Therefore, LB and TB 
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mediums were used to find out the best-optimized media composition. It was found that under 
the same expression conditions (here: 100 ml growth media, growth temperature at 30 °C and 
induction with 1 mM IPTG), the recombinant CpSADH showed specific activities of 4.5 
U/mg when grown in LB medium and 5.5 U/mg when grown in TB medium. 
 
TB medium like other rich nutrient medium has a higher amount of yeast extract and also 
glycerol, which serves as a carbon source. Fermentation with TB medium resulted in higher 
amount of biomass of the expressed E.coli strain as well as showed the highest level of 
protein expression. TB medium was therefore used for preparative fermentation of both 
JM109pKK223-3CpSADH18 and BL21(DE3)pET26b+CpSADH28his expression strains for 
further enzyme production. 
 
Fermentation of the expression strain JM109pKK223-3CpSADH18 was carried out in 5-liter 
shake flasks with baffles with the optimized fermentation conditions as described earlier in 
this section, like growth at 30 °C, induction with 1 mM IPTG at mid-log phase and using TB 
medium. Under these conditions, it was found that from 4 liters of fermentation as much as 40 
gram of biomass was achieved. In case of the expression strain 
BL21(DE3)pET26b+CpSADH28his, under the optimized conditions of fermentation like 
growth at 30 °C using TB medium, induction with 1 mM IPTG at OD600 of 0.8, followed by 
temperature decrease of 28 °C, also carried out in 5-liter shake flasks with baffles, resulted in 
a biomass of 28 gram from 4 liters of fermentation. The amount of biomass achieved in this 
instance was much less when compared to JM109pKK223-3CpSADH18. One reason could 
be the decrease of temperature from 30 °C to 28 °C (after induction), which in turn decreased 
the overall metabolism of the bacteria and increased the overall expression level of the 
recombinant protein (Vasina and Baneyx, 1996; Schirano and Shibata, 1990; Schein and 
Noteborn, 1988). This was clear from the total units of enzyme that was recovered from each 
of the fermentations. The total biomass yield and the total enzyme produced from each of the 
fermentations are summarized in Table 3.  
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      JM109pKK223-3CpSADH18 BL21(DE3)pET26b+CpSADH28his 
Total 
Biomass yield 
          40 gram from 4 liters             28 gram from 4 liters 
Total 
Enzyme yield 
       20632 units from 4 liters         20845 units from 4 liters 
 
Table 3: Total biomass and enzyme yields obtained from 4 liters of cultivation medium through batch-
fermentation in shake flasks with baffles. 
 
As can be seen from Table 3, as much as 10 g biomass/l with a corresponding CpSADH total 
activity of 5158 U/l was obtained from the expression strain JM109pKK223-3CpSADH18. In 
the case of the expression strain BL21(DE3)pET26b+CpSADH28his, 7 g biomass/l with a 
total enzymatic activity of 5211 U/l was obtained. The total activities per liter fermentation 
media that are stated here for both the expression strains, are much higher than that described 
by Bönitz (2001), where she stated that a maximum total activity of only 343 U/l fermentation 
media was achieved by the expression of recombinant CPCR. The specific activity of the 
crude extracts of the recombinant CpSADH (without His6-tag) was 15 U/mg and that of 
CpSADH (with His6-tag) was 15.3 U/mg. Comparatively, Bönitz reported that the maximum 
specific activity of the crude extract of recombinant CPCR obtained was 2.5 U/mg (from 20 
liters batch-fermentation). The specific activity of the crude extract of the recombinant 
CpSADH (Kojima et al., 1995) was described to be as low as 0.6 U/mg.  
 
Purification of recombinant CpSADH (JM109pKK223-3CpSADH18 construct) 
 
Cell free cleared lysate of the recombinant CpSADH (without His6-tag) was used for the 
purification of the recombinant protein through anion-exchange chromatography (Macro Prep 
High Q). The elution of the bound proteins was made by step gradients. The first fractions 
were the cations that were not bound to the matrix at all. The relatively weak ionic bound 
proteins were eluted with 100 mM sodium chloride. CpSADH was eluted with a salt 
concentration from 200 mM onwards. The active fractions showing the activity for CpSADH 
were analyzed with an SDS-PAGE to determine the quality of the purified protein. The 
elution profile of the purification steps as well as the SDS-PAGE of the active fractions is 
shown in Figure 23(a) and (b) respectively.  
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Figure 23 
(a): Elution profile of the purification steps of recombinant CpSADH (without His6-tag) through anion-exchange 
chromatography with step-gradient.  
(b): SDS-PAGE analysis of the active fractions of purified CpSADH. Lane 1= PageRulerTM Prestained Protein 
Ladder. Lanes 2,3 and 4 = Eluted active fractions of CpSADH after anion-exchange chromatography. 
 
The CpSADH was eluted together with other proteins, which was clear from the pattern of 
peak that was achieved. Further the SDS-PAGE also showed the presence of other proteins 
together with the purified CpSADH. The size of the CpSADH determined by the SDS-PAGE 
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analysis was approximately 40 kDa, the same as stated by Kojima (1995). A disadvantage of 
such a matrix is that all proteins that were anions were also bound and with an increase in salt 
concentration were eluted together with CpSADH. A continuous linear gradient instead of 
step gradient was also tried in order to purify the CpSADH through the anion-exchange 
support. Most of the weakly bound proteins were eluted at 100 mM sodium chloride 
concentration. A continuous gradient was followed thereafter from 100-500 mM NaCl. 
Fractions showing the activity of CpSADH were eluted from about 200 mM onwards and 
went up to about 270 mM of NaCl. The elution profile is shown in the following figure: 
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Figure 24: Elution profile of the purification steps of recombinant CpSADH (without His6-tag) through anion-
exchange chromatography with continuous linear-gradient. 
 
The analysis of the eluted active fractions on SDS-gel showed the presence of other proteins 
as well, and the pattern was more or less the same as had been shown in Figure 23 (b). The 
active fractions of CpSADH were concentrated and also desalted through ultrafiltration 
(MWCO 10000 Da). The concentrated and desalted partially purified CpSADH was then 
lyophilized and the enzyme powder was stored at –20 °C till use.  An SDS-gel picture of the 
CpSADH after ultrafiltration is shown in Figure 25. The purification data of the CpSADH are 
described in Table 4. 
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Purification Steps Enzyme 
(Units) Protein (mg) Volume of 
fraction 
(ml) 
Yield 
(%) Specific Activity 
(U/mg)
Purification 
Factor 
(Enrichment)
Crude Extract 1800 200 16 100 9 1 
Anion-Exchange 
Chromatography 
(Macro Prep High Q) 
996 10.5 60 55.3 94.9 10.5 
Ultrafiltration 
10000 Daltons 
Cut-off 
 
897 9.2 6 49.8 97.5 10.8 
Table 4: Purification data of CpSADH with Macro Prep High Q matrix. 
 
 
Figure 25: SDS-PAGE analysis of the purified CpSADH after ultrafiltration. Lane 1= Concentrated and purified 
CpSADH after anion-exchange chromatography; Lane 2 = PageRulerTM Prestained Protein Ladder.  
 
 
The specific activity of the recombinant CpSADH purified through anion-exchange 
chromatography increased from 9 U/mg to 94.9 U/mg and after ultrafiltration reached to 97.5 
U/mg. A yield of only 49.8% was finally achieved. The enrichment factor reached about 10.8 
fold. Using Q-Sepharose FF matrix, Bönitz reported that the recombinant CPCR reached a 
specific activity of 32.1 U/mg and a purification factor of 13.9. Thus the specific activity of 
CpSADH after anion-exchange chromatography was much higher than that of Bönitz’s (after 
Q-Sepharose).  
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Purification of recombinant CpSADH with His6-tag [BL21(DE3)pET26b+CpSADH28 
construct] 
 
For industrial applications, recombinant proteins with higher specific activities, higher yield 
and with fast & easy purification conditions are favored. Enzymes with His6-tags are widely 
known for their easy one-step purification conditions and usually with high yields and very 
high specificities and very low or no background proteins. This is usually done by introducing 
six histidine residues either on the N- or on the C-terminal of the protein. Such a modification 
of the N- or C-terminal with addition of only six amino acids is tolerable to many 
recombinant proteins and the likelihood that such a fusion would adversely affect gene 
function is reduced (Lesley, 2001). But many recombinant proteins are not active anymore or 
show changes in their conformation, specificities with the slightest change in their amino 
acids sequence.  For such proteins, the histidine residues could be cleaved off from the main 
protein after purification by using several commercially available selective proteases. For the 
His-tagged CpSADH it was presumed that such histidine residues would not affect the folding 
of the protein and was used for purification under native conditions.  
 
The cell free cleared lysate of the N-terminal His-tagged recombinant CpSADH was purified 
by Immobilized-Metal Affinity Chromatography (IMAC) using a Ni-Nitrotriacetic Acid (Ni-
NTA) superflow matrix (Qiagen). Cell free cleared lysate of the recombinant CpSADH (with 
His6-tag) was used for the purification of the recombinant protein through Ni-NTA matrix. 
The elution of the bound proteins was made by an increase in the imidazole concentration. 
The first fractions eluted were the bacterial proteins that were not bound to the matrix at all 
and also some weakly bound proteins that were eluted with an imidazole concentration of 10 
mM. His-tagged CpSADH was eluted with an increased imidazole concentration of 250 mM. 
The elution profile of the purification steps of CpSADH (His6-tagged) is shown in Figure 26. 
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Figure 26: Elution profile of the purification steps of recombinant CpSADH (with His6-tag) by IMAC using a 
Ni-NTA superflow matrix. 
 
 Increasing the concentration of imidazole, the recombinant His-tagged CpSADH was eluted 
very easily. The His-tagged CpSADH was not stable in imidazole (250 mM) and it was 
therefore necessary to desalt the active fractions after IMAC purification. This was done by 
ultrafiltration by an exchange of buffer (TEA-HCl, pH 7.5) in at least three cycles. After 
desalting, the final volume of the purified His-tagged CpSADH was reduced/concentrated to 
at least half of the initial volume of the active IMAC fractions. The concentrated and desalted 
purified CpSADH was then lyophilized and the enzyme powder was stored at –20 °C. 
Alternatively, the enzyme could also be stored as liquid in 50% (v/v) glycerol at –20 °C 
without any loss of activity for several months. The purification data of the His-tagged 
CpSADH is summarized in Table 5. To determine the quality of the purified recombinant 
protein, each of the fractions was analyzed with SDS-PAGE and also with Western blot, the 
results of which are shown in Figure 27 (a) and (b) respectively.  
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Purification Steps Enzyme 
(Units) Protein (mg) Volume of 
fraction
(ml) 
Yield 
(%) Specific Activity 
(U/mg)
Purification 
Factor 
(Enrichment) 
Crude Extract 5955.6 264.9 28 100 22.5 1 
IMAC (Ni- NTA) 
Fraction 5000 8 20 84 625 27.8 
Ultrafiltration 
10000 Daltons 
Cut-off 
 
4902.7 7.5 10 82.3 653.7 29 
Table 5: Purification data of His-tagged CpSADH with Ni-NTA superflow matrix. 
 
                          (a)               (b) 
 
Figure 27:  
(a): SDS-PAGE analysis of different fractions of His-tagged CpSADH purified through IMAC using Ni-NTA 
superflow matrix. Lane 1= Crude extract of CpSADH; Lane 2 = IMAC fraction of His-tagged CpSADH (4 µl 
loaded on gel); Lane 3 = Concentrated and desalted purified his-tagged CpSADH after ultrafiltration (4 µl loaded 
on gel); Lane 4 = PageRulerTM Prestained Protein Ladder; Lane 5 = IMAC fraction of His-tagged CpSADH (10 
µl loaded on gel); Lane 6 = Concentrated and desalted purified his-tagged CpSADH after ultrafiltration (10 µl 
loaded on gel). 
(b): Western-blot analysis of the His-tagged CpSADH. Lane 1 = Protein Ladder (Invitrogen); Lane 2 = 
Concentrated IMAC fraction of CpSADH after ultrafiltration; Lane 3 = Flow-through of the IMAC purification 
steps; Lane 4 = IMAC purified fraction of CpSADH.   
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The specific activity of the recombinant His-tagged CpSADH purified by IMAC using Ni-
NTA superflow matrix increased from 22.5 U/mg to 625 U/mg and a further up to 653.7 
U/mg followed by ultrafiltration. This increase in the specific activity after ultrafiltration and 
desalting could be due to the removal of imidazole which was de-stabilizing the enzyme 
(which in turn was showing less activity). A final yield of as much as 82.3% was achieved. 
The enrichment factor reached 29 fold. All these values are much better than those obtained 
by purifying CpSADH with anion-exchange chromatography. Using Q-Sepharose FF matrix, 
Bönitz (2001) reported that the recombinant CPCR reached a specific activity of 32.1 U/mg 
and a purification factor of 13.9. But the specific activity of the recombinant CPCR as stated 
by Bönitz reached finally up to 1199 U/mg after purification with 5’ AMP-Sepharose 4b. But, 
the advantage of IMAC purification is that proteins can be purified in one-step, thus saving 
time, and with high purity enough for industrial applications.  
 
3.2.3 Conclusion of the expression of recombinant CPCR and CpSADH 
 
The expression of recombinant CPCR that had been cloned in this work showed that the 
protein was expressed in both the E.coli hosts JM109 and BL21(DE3) and the specific 
activities of the expressed protein was 0.4 U/mg and 0.5 U/mg respectively. But the problem 
in the expression of this recombinant CPCR was that after about 2 rounds of expression, the 
protein was not expressed anymore and the specific activities were also decreased after every 
successive expression. Alteration of the expression parameters such as media, growth 
temperature, IPTG concentration, induction time, did not express the protein. Inclusion bodies 
were not formed either. Possible reasons could be that the protein was subjected to 
degradation by proteolytic activities of the bacteria or instability of the N-terminal amino 
acids. To prevent degradation, protease inhibitor PMSF was added but without success. The 
functions of many E.coli proteases are not known (Makrides, 1996) and it could be that 
inhibitors like PMSF are not sufficient to prevent such degradation as several E.coli proteases 
are involved in the degradation of a given protein substrate. An alternative is to target the 
protein to the insoluble fraction of the cell, as inclusion-body proteins are generally protected 
from degradation. Another possibility that could be used for the expression of the 
recombinant CPCR was to express it with a fusion protein that stabilizes the N-terminal 
amino acids. Due to the problems in the expression of the recombinant CPCR that had been 
cloned in this work, for necessary comparisons, a recombinant CPCR (also based on the 
known partial amino acids sequences of the wtCPCR) that had been prepared by X-Zyme 
(Dusseldorf, Germany) was used instead. 
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The recombinant CpSADH both with and without His6-tag were successfully expressed and 
were able to be purified. The CpSADH (without His6-tag) was purified by anion-exchange 
chromatography using the Macro Prep High Q matrix. The purified protein had a specific 
activity of 97.5 U/mg, 10.8 fold enrichment and a yield of 49.8%. But a problem in such 
purification was that the contaminations with other cell proteins were comparatively higher. 
Therefore further purification steps would be required. 
 
The recombinant His-tagged CpSADH was purified by IMAC using a Ni-NTA superflow 
matrix. The purified protein had a specific activity of 653.7 U/mg, an enrichment factor of 29 
fold and a final yield of 82.3%. The results showed that the level of purification of the 
recombinant protein was enough for any industrial applications. Thus the His-tagged 
CpSADH was purified very easily in just one step with a high purity.  
 
3.3 Characterization of recombinant CpSADH 
In order to determine if the His-tagged recombinant CpSADH had undergone any 
conformational change or modification due the addition of the histidine residues on its N-
terminal, the temperature and pH optimum of the IMAC purified protein was compared to 
that of the CpSADH (without His6-tag) that had been purified though anion-exchange 
support. It was found that the temperature and pH optima of both the recombinant CpSADH 
(with and without His6-tag) were within the same range. The results shown therefore are for 
the His-tagged CpSADH as all further experiments were carried out with it due to its higher 
purity form. For necessary comparisons though, the purified recombinant CpSADH (without 
His6-tag) was also used as reference. 
 
3.3.1 Temperature optimum and temperature stability 
 
The activity of the recombinant His-tagged CpSADH was measured at different temperatures 
ranging from 25 °C to 58 °C for a period of 1 minute using the standard photometric assay for 
microtiterplates. The temperature optimum is shown in Figure 28. 
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Figure 28: Temperature optimum of the recombinant His-tagged CpSADH photometrically determined for 1 
minute. 
 
The maximum activity was found at 50 °C. At 53 °C about 97% and at 55 °C about 92% of 
the relative activity was measured. The results are in good agreement with those that had been 
described by Kojima (1995) where the temperature optimum measured for the wtCpSADH 
was 50 °C. At 55 °C, 88% of the relative activity was measured for the wtCpSADH. The 
temperature optimum described by Liese (1998) for the wtCPCR was between 50-55 °C. For 
the wtCPCR, Peters (1993, 1993a) and Bönitz (2001) described the temperature optimum for 
reduction to be 37 °C and Peters (1993, 1993a) described the temperature optimum for 
oxidation to be between 50-56 °C. In the work from Steinsiek (2006), the optimum 
temperature for the wtCPCR was described to be 48 °C which is in good agreement with the 
temperature optimum of the recombinant CpSADH. 
 
Plotting the natural logarithm of the activities against the reciprocal of the absolute 
temperatures within the linear range (here between 25 °C and 50 °C), the activation energy of 
41 kJ/mol of the recombinant His-tagged CpSADH was determined. This result is in good 
agreement with Peters (1993, 1993a) where the activation energy of 41.6 kJ/mol was 
determined for the wtCPCR for the reduction of ketones. Steinsiek (2006) described the 
activation energy of the wtCPCR to be 43 kJ/mol. The activation energy of the CpSADH was 
not reported by Kojima (1995). 
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Temperature dependent half-life of the recombinant His-tagged CpSADH was further 
determined by measuring the residual activities at regular time intervals, after incubating the 
enzyme in a solution containing 100 mM TEA-HCl (pH 7.5) at different temperatures ranging 
from 4 °C to 45 °C for a period of 24 hours. An increase in the reaction temperature not only 
increased the activity but also decreased the stability of the enzyme. Therefore, temperatures 
higher than 45 °C were not used. Table 6 shows the half-life and the stability of the enzyme at 
different temperatures. 
 
Temperature (°C) Half-life, τ (h) 
4 990 
21 347 
25 289 
28 105 
30 69 
33 39 
37 34 
40 23 
45 18 
 
                                       Table 6: Half-life of the recombinant His-tagged CpSADH. 
 
The highest stability of the enzyme was found at 4 °C with a half-life of approximately 41 
days. The enzyme showed very high stability at lower temperatures, but with an increase in 
temperature, the decrease in the stability was higher/faster. The half-life of the enzyme was 
reduced with an increase in temperature from 21 to 28 °C about three times. Again from 28 
°C to 37 °C the half-life decreased to about three times. From 40 °C onwards, the half-life of 
the enzyme was below 24 hours. Kojima (1995) described that even after incubation at 40 °C 
for 10 min, more than 90% of the original activity of wtCpSADH was retained. The period of 
incubation was too short to determine the half-life. Moreover the half-life of the recombinant 
CpSADH that had been cloned by the same group was not mentioned. His-tagged 
recombinant CpSADH had a half-life of 23 hours at 40 °C (more than 99% of the original 
activity after 15 min) when measured for a period of 24 hours. The stability of the wtCPCR as 
reported by Steinsiek (2006) was very low when compared. The reported half-life of the 
wtCPCR at 4 °C was about 18 days but with increase in temperature from 20 to 25 °C, the 
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half-life decreased rapidly about three times (from 92 h to 32 h). The recombinant His-tagged 
CpSADH was much more stable at those temperatures (see Table 6). But from 28 °C 
onwards, the half-life of the recombinant CpSADH was decreasing comparatively faster. 
From 40 °C onwards the half-life fell to less than 24 hours but comparatively were higher 
than the wtCPCR as has been reported by Steinsiek (e.g. half-life at 37 °C of only 16.6 h, at 
40 °C of only 13.9 h and at 46 °C of only 10.9 h). The half-life of the recombinant CPCR 
(Bönitz, 2001) and the recombinant CPCR (X-Zyme) are not described. 
 
3.3.2 pH optimum and pH stability  
 
The pH optimum for reduction as well the stability of the recombinant His-tagged CpSADH 
were determined at different pH ranges using 100 mM TEA-HCl buffer. Figure 29 describes 
the results of the relative activities that had been determined at different pH values of the 
buffer and the stability of the CpSADH at different pH values calculated over the residual 
activity for a period of 24 hours. 
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                         Figure 29: pH optimum and pH stability of the recombinant His-tagged CpSADH. 
 
The highest activity of the enzyme was determined at pH 6. Between pH 5.5 and 6.8 as much 
as 84% and between pH 7 and pH 7.5 approximately 83% of the relative activity was retained. 
The relative activity decreased from pH 7.8 (approximately 60%), followed by a further 
decrease to as much as 34% at pH 8.8. The lowest relative activity of only 16% was measured 
at pH 10. As the activity was very low from pH 8.8 onwards, the stability of the enzyme in 
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different pH values was measured only between pH 5.5 and pH 8.5. The highest stability of 
the enzyme was found within the range of pH 7.5 and pH 8.5. The highest residual activity of 
99% was measured at pH 8. A residual activity of 87%, 91% and 98% were measured at pH 
values of 7.5, 7.8 and 8.5 respectively.  
 
 The pH optimum for reduction of the wild type CpSADH was stated to be within the range of 
pH 5.5- 6.5, the highest being at pH 6 (Kojima et al., 1995). The stability of the same enzyme 
was stated to be within the range of pH 8 to 10. The pH optimum of the recombinant 
CpSADH cloned by the same group was not determined. The pH optimum of wtCPCR 
(Steinsiek, 2006) was likewise determined also at pH 6 and the stability between pH 7.5 to 8, 
the same as has been determined for the recombinant His-tagged CpSADH. This shows that 
the recombinant CpSADH and the wtCPCR have very similar pH optimum and also similar 
pH stabilities. 
 
3.3.3 Stability in hexane 
 
In order to carry out enzymatic synthesis with the recombinant His-tagged CpSADH in 
aqueous-organic two-phase systems, the stability of the enzyme in the organic solvent 
(hexane) was very important to know. Many biocatalysts are known to be highly unstable 
(Gröger et al., 2003, Gröger et al., 2004) and inactivated by organic solvents, either through 
the solvent or through the interface in between the aqueous and organic phases (Ghatorae et 
al., 1994; Halling, 1994; Halling et al., 1998). Various groups studied the stabilities of alcohol 
dehydrogenases in organic solvents. Sensitivity of alcohol dehydrogenases with organic 
solvents is a very common phenomenon. This has been described for alcohol dehydrogenases 
like the YADH and the HLADH (Keinan et al., 1986) and also for an alcohol dehydrogenase 
from Lactobacillus minor (Gupta et al., 2004). 
 
 The stability of the recombinant CpSADH was studied in different percentages of the organic 
solvent (hexane). In order to be able to compare the results, the method of determination of 
the stability was however kept similar to the method described by Steinsiek (2006). The 
hexane phase consisted of 25%, 50% and 75% (v/v) of the total volume. The aqueous phase 
that consisted of 2 U of the enzyme dissolved in 100 mM TEA-HCl (pH 7.5) was overlaid 
with the organic phase in a total volume of 1 ml. The lower phase was mixed with a magnetic 
stirrer without intermixing the two phases. The stability of the His-tagged CpSADH in contact 
with organic solvent (hexane) was thereby determined in this aqueous-organic two-phase 
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system at a temperature of 25 °C. The stability of the enzyme calculated over the half-life in a 
two-phase system with different percentages of hexane is summarized in the following table. 
 
 Percentage of 
Hexane phase 
Half-life, τ (h) 
25% 188.4 
50% 133 
75% 77 
 
 
 
 
 
Table 7: Half-life of the recombinant His-tagged CpSADH in two-phase system consisting of buffer and hexane 
at 25 °C. 
 
The half-life of the recombinant His-tagged CpSADH decreased with an increase in the 
volume of the hexane phase. This could be explained by the fact that the ratio of the interface 
to the volume of the water phase increased with the rising portion of the hexane phase, since 
the total volume was kept constant (1 ml in each case). Therefore, with an increase in the 
volume of the hexane phase, the aqueous phase decreased and thus a more intensive contact 
between the enzyme and the organic solvent took place than with a larger aqueous phase, in 
which the enzyme came in contact with the interface more rarely. The recombinant His-
tagged CpSADH in 100 mM TEA-HCl (pH 7.5) had a half-life of 289 h at 25 °C without any 
contact with the organic solvent hexane (see section 3.3.1). In the presence of the organic 
solvent through the interface, the half-life decreased to 188.4, 133 and 77 hours in 25%, 50% 
and 75% of hexane phases respectively. That means a stability of approximately 65.2% (with 
25% hexane), 46.1% (with 50% hexane) and as low as 26.6% (with 75% hexane) of the 
original stability that the enzyme had at 25 °C and without any contact with the organic 
solvent was retained. This showed that the recombinant CpSADH had a high sensitivity 
against hexane. But the stability of the recombinant CpSADH was much higher than the 
wtCPCR in hexane under the same conditions. Steinsiek (2006) reported that the half-life of 
the wtCPCR in hexane was only 45 h (in 25% hexane), 42 h (in 50% hexane) and 22 h (in 
75% hexane). Some dehydrogenases are reported to be more stable in hexane than the 
recombinant CpSADH. Examples are a mutant of the recombinant FDH from C.biodinii that 
was reported to have a residual activity of as much as 92 and 90% in 10 and 20% (v/v) hexane 
respectively even after 60-69 h (Gröger et al., 2003). But the same enzyme was found to be 
highly unstable in other organic solvents. Gröger et al. (2003) also found the (S)-specific 
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alcohol dehydrogenase from Rhodococcus erythropolis to be stable for long periods under the 
same conditions (10-20% hexane). 
 
The half-life of the recombinant His-tagged CpSADH after incubation in pure hexane 
(without any water molecule) was also determined at 25 °C by using a lyophilized powder of 
the enzyme. It was found that the enzyme under these conditions had a half-life of as low as 
only 2.2 h. In direct contact with hexane, the enzyme therefore showed very high instability 
and just after 15 min approximately 90.3% and after 45 min approximately 78.5% of the 
residual activities was determined. The HLADH showed an exceptional stability in direct 
contact with pure hexane and as much as 90% of the residual activity was found after 20 
hours (Andersson et al., 1998). Steinsiek (2006) reported that the wtCPCR had a residual 
activity of about 87% after 15 min of incubation in pure hexane. The stability of the cofactor 
nicotinamide adenine dinucleotide is not affected by organic solvents (Adlercreutz, 1996). 
Therefore, despite the reduced half-life of the recombinant His-tagged CpSADH in the 
presence of hexane as organic solvent, the use of this solvent in two-phase system seems to be 
one of the alternatives to carry out synthesis of hydrophobic substrates, which otherwise are 
soluble in aqueous medium only partially or in small concentrations and therefore the overall 
productivity of the reaction medium is decreased.   
 
3.3.4 Inhibition study  
 
The inhibition of the recombinant CpSADH (with and without His6-tag) when exposed to 
various reagents was determined to find out their influence on the activity of the enzyme. Of 
the reagents tried, both the recombinant CpSADH (with and without His6-tag) were markedly 
inhibited by ZnCl2. The same was stated for the CpSADH (Kojima et al., 1995). Peters 
(1993), Kula et al. (1996), reported that the wtCPCR was strongly inhibited by Zn2+ as well. 
But Bönitz (2001) reported that the CPCR was not inhibited by low concentrations of Zn2+, 
only higher concentration (5 mM) showed some inhibition (72% residual activity). This result 
of course is different from those that had been stated by Peters, Kula and also Kojima. The 
recombinant CpSADH showed no inhibition by Fe3+ and also not by the chelator EDTA. But 
the chelator o-phenanthroline inhibited the enzyme. This showed that the enzyme needed an 
essential metal ion which is removed by o-phenanthroline (hence loss in activity) but not by 
EDTA (Kula et al., 1996). Kojima et al. (1995), Bönitz (2001) and Peters (1993, 1993a) also 
described similar results. In the presence of up to 10% DMSO, about 50% of the residual 
activity of the recombinant CpSADH was retained. Sulfhydryl-protective reagents like DTT 
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were stabilizing the recombinant CpSADH (both with and without His6-tag) and as much as 
100% of the original activity was retained even after incubation with 1 mM DTT at 30 °C. 
This result is very much different from what had been reported by Kojima (1995) for the 
wtCpSADH. Kojima (1995) stated that the wtCpSADH was significantly inhibited by DTT. 
Peters (1993), Kula (1996) and Bönitz (2001) reported that the wtCPCR was not inhibited by 
DTT and was similarly stabilizing the enzyme as had been found for the recombinant 
CpSADH in this research work. Steinsiek (2006) described also that DTT was stabilizing the 
wtCPCR. The results of the influence of different reagents on the recombinant CpSADH are 
summarized in the following table. 
 
Reagents CpSADH 
Residual activity (%) 
0.5 mM    1 mM    10 mM  
CpSADH (His -tagged) 
Residual activity (%) 
0.5 mM     1 mM    10 mM 
DTT 95.6        100           n.d. 96             100         n.d. 
EDTA 98          98             79     100            100         80 
o-Phenanthroline        23          14            n.d.      22             14           n.d. 
FeCl3       98.7       99             n.d.      99.6           100         n.d.  
ZnCl2     14.7          0              n.d.      12.9            0            n.d. 
5%     10%     15%     20% 5%     10%     15%     20% DMSO 
  59        50        36        13  58.5     56.9      32        10.4 
6
 
Table 8: Influence of different reagents on the activity of the recombinant CpSADH. n.d. = not determined. 
 
3.3.5 Substrate spectrum of recombinant CpSADH 
 
The substrate spectrum of the recombinant CpSADH (with and without His6-tag) was 
measured photometrically. It was found that there were some differences in the reaction 
conditions (particularly pH of buffers) that were used to determine the substrate spectrum of 
wtCPCR in the published results. Peters (1993) reported to use a pH of 7.5 (TEA-buffer), 
Kula et al. (1996) reported to use a pH of 7.8 also in TEA-buffer and Bönitz (2001) reported 
to use a pH of 7 (TEA-buffer). Other conditions like the concentration of substrate (8 mM) 
and that of the cofactor NADH (0.2 mM) that had been used in the assays were the same as 
described by each author. The conditions that had been used to determine the substrate 
spectrum of the wtCpSADH (Kojima et al., 1995) were not properly mentioned. Besides, the 
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concentrations of substrates were also not kept constant in each case. According to the data-
sheets of JFC, 35 mM of the substrates were used in 100 mM citrate buffer (pH 6.8). But 
many substrates that are mentioned in the data-sheets are not soluble in water up to that 
extent. Due to these differences in the published data, the activities of the commercially 
available purified wtCPCR (Juelich Fine Chemicals, Juelich, Germany) and the recombinant 
CPCR preparation (X-Zyme, Dusseldorf, Germany) in different substrates were also 
measured in parallel to the recombinant CpSADH to bring about a direct comparison under 
the same reaction conditions and also to minimize the errors caused by multiple handling.  
 
The reducing activities of the above-described enzymes are summarized in Table 9 as 
compared with the standard substrate ABEE reducing activity (100%). 
 
Substrates CpSADH CpSADH 
(His6-tagged) 
wtCPCR (JFC) Recombinant 
CPCR (X-Zyme) 
ABEE 100 100 100 100 
Acetophenone 52.1 52.1 48.1 12.3 
2’-Chloroacetophenone 8 8.37 -- 3.5 
3’-Chloroacetophenone 70.7 78.2 63.4 149.8 
4’-Chloroacetophenone 88.5 94 97.5 88 
2-Butanone 90 94.3 93.3 2 
2,4-Pentanedione 58.9 55.6 53.7 3.7 
Ethylacetoacetate  91.2 94 88.2 156.6 
Table 9: Comparison of the substrate spectrum of different enzymes (reducing activities). The results are 
expressed as relative activities (in %) as compared with the standard substrate ABEE set as 100%. The reaction 
mixture contained in a total volume of 1 ml, 100 mM TEA-HCl (pH 7), 8 mM of the substrate, 0.2 mM 
NADH+H+ and 1 unit of enzyme per ml. The activity was measured photometrically at 340 nm and 37 °C for 1 
min. (--) = Activity could not be measured. 
 
The pattern of reduction of different substrates with the recombinant CpSADH (with and 
without His6-tag) and the commercially available wtCPCR (JFC) were all within the same and 
very close ranges. It should be noted that the activity with 2’-chloroacetophenone (   ) could 
not be measured photometrically when an enzyme concentration of 1 U/ml was used in the 
reaction. The reduction of the substrate was initiated only when a high starting concentration 
of the enzyme was used (25 U/ml for recombinant CpSADH both with and without His6-tag; 
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and approximately 60 U/ml for recombinant CPCR preparation by X-Zyme). The 
concentration of the wtCPCR preparation from Juelich Fine Chemicals (JFC) was only about 
17 U/ml (as supplied form). The activity with the substrate was therefore not possible to 
measure for this enzyme preparation. Literature data of the wtCPCR is reported to have no 
activity with 2’-chloroacetophenone as well. The probable reason could be the initial start 
concentration of the enzyme (1 U/ml) that was used (Peters, 1993). Among the 
chloroacetophenone(s) examined, it was found that the position of the substituent (Cl) in the 
phenyl-ring possessed an influence on the rate of turnover. The highest reaction rate was 
reached with the para-substituted chloroacetophenone, followed by the meta-substituted 
chloroacetophenone. The lowest relative activity was found with the halogen on the ortho-
position. Steinsiek (2006) also reported of such increasing patterns of activities for the 
wtCPCR, though no activity was found for 2’-chloroacetophenone.  The relative activities of 
the recombinant CpSADH and the wtCPCR (JFC) with aliphatic ketones like 2-butanone 
were approximately 90-94%. With the keto acid ester (diketo-ester) ethylacetoacetate (EAA), 
approximately 91-94% relative activities were measured for the recombinant CpSADH (both 
with and without His6-tag) and about 88% with that of wtCPCR (JFC). With the diketone 
(2,4-pentanedione), approximately 55-58% relative activity with recombinant CpSADH and 
about 53% relative activity with wtCPCR (JFC) were determined. From the pattern of 
behaviour of the recombinant CpSADH and the commercially available wtCPCR (JFC) it 
could be possible to state that both these enzymes had very similar reaction rates with the 
examined substrates. In addition, the recombinant CpSADH (with and without His6-tag) 
showed similar relative activities with the substrates. 
 
The recombinant CPCR preparation (X-Zyme) as can be seen from the table, had very 
different reaction rates with the examined substrates. Very low relative activities of only 
12.3%, 3.7% and 2% were measured with acetophenone, 2,4-pentanedione and 2-butanone 
respectively. For measuring the activities with 2,4-pentanedione and 2-butanone an initial 
concentration of approximately 60 U/ml of the enzyme had to be used. Low activities with 
these three substrates were also reported in the research work of Müller (Müller, 2004) for the 
same recombinant CPCR. Further it was reported that this recombinant CPCR preparation 
required Mg2+ for the conversion of 2-butanone. Such dependence was not reported in any of 
the available literature data for the wtCPCR. For the chloroacetophenone(s), analogous to the 
pattern of increase in the relative activities according to the position of the halogen as 
described for the recombinant CpSADH and wtCPCR (JFC) and also as reported by Steinsiek 
  
3 Results and Discussion 101
(2006) for the wtCPCR, it was found that the recombinant CPCR (X-Zyme) had the highest 
reaction rate of 149.8% with 3’-chloroacetophenone followed by 4’-chloroacetophenone 
(88%). The enzyme had the maximum relative activity of 156% with EAA. 
 
The oxidation reaction in which an alcohol is converted to the keto-group was also examined 
using some aromatic and aliphatic alcohols and diols as substrates with the recombinant 
CpSADH (His6-tagged). These measurements were basically done to find out if the 
recombinant CpSADH was able to carry out the back-reaction as well. Some common 
alcohols that could be used for cofactor regeneration during the enzymatic synthesis were also 
used as substrates.  
 
The oxidizing activities of the said enzyme are summarized in Table 10 as compared with the 
(S)-2-butanol oxidizing activity (100%). As the product of the actual standard substrate, 
which is hydroxy-hexane-acid-ethyl-ester (HHEE), is not commercially available, the 
oxidation of (S)-2-butanol was therefore arbitrarily set as 100%. 
 
Substrates Relative activity (%) 
(S)-2-Butanol 100 
(S)-1-Phenylethanol 101 
(R)-1-Phenylethanol 3 
(S)-1,3-Butanediol 20 
Ethanol 2 
2-Propanol 82 
 
Table 10: Substrates of the oxidation reaction of recombinant His-tagged CpSADH. The reaction mixture 
contained in a total volume of 1 ml, 50 mM Tris-HCl (pH 9), 50 mM of the substrate, 2.5 mM NAD+ and 10 µl 
of enzyme solution. The activity was measured photometrically at 340 nm and 37 °C for 1 min. 
 
2-propanol is known to be used as cosubstrate for cofactor regeneration. It is described as the 
cosubstrate for the regeneration reaction of the CPCR (Peters et al., 1993a, b; Zelinski et al., 
1999; Laue et al., 2001) and also of the CpSADH (Endo and Koizumi, 2001; Matsuyama et 
al., 2002). The same was also used for the regeneration of cofactor in the enzymatic synthesis 
with recombinant His-tagged CpSADH and was found to be converted with good activity. 
The highest oxidizing activity of the recombinant His-tagged CpSADH was found with (S)-1-
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phenylethanol (101%) followed with 2-propanol (82%). Similar results were also described 
by Steinsiek (2006) for the wtCPCR. But in order to reach an efficient regeneration of the 
cofactor, it is necessary to use a high concentration of the cosubstrate (Steinsiek, 2006) in 
order to avoid the back reaction from (S)-1-phenylethanol to acetophenone because the 
activity of the His-tagged CpSADH with (S)-1-phenylethanol is somewhat higher than 2-
propanol.   
 
The wtCpSADH (Kojima et al., 1995) also showed higher activities with (S)-1-phenylethanol 
(about 89% when 50 mM was used) and with 2-propanol (60% when 100 mM was used).  
 
3.3.6 Conclusion of the characterization of recombinant CpSADH  
 
The recombinant CpSADH (mainly the His6-tagged) was characterized taking five main 
aspects into consideration: temperature optimum and stability, pH optimum and stability, 
stability in hexane, inhibition with different reagents and substrate spectrum. It was found that 
the recombinant His-tagged CpSADH had a temperature optimum for reduction of 50 °C and 
activation energy of 41 kJ/mol. The enzyme showed very high stability at low temperatures 
(up to 28 °C). At 25 °C the half-life of the enzyme was determined to be 289 h. This stability 
reduced to about 65.2% in presence of organic solvent (188.4 h with 25% hexane phase). The 
pH optimum for the reaction was found to be at pH 6 but the stability of the enzyme was 
found within the range of pH 7.5-8.5. The same temperature and pH optima were also 
reported for the wtCPCR (Steinsiek, 2006). Zn2+ and o-phenanthroline markedly inhibited the 
enzyme. But DTT did not inhibit the enzyme (this result is very different from those that had 
been described by Kojima). Fe3+ and EDTA also did not inhibit the enzyme. The enzyme 
could convert many substrates; examples are aliphatic, aromatic and cyclic ketones. Due to 
the differences with the literature data of wtCPCR, the commercially available wtCPCR (JFC) 
and the recombinant CPCR (X-Zyme) were also measured in parallel for direct comparison. 
Interestingly, the recombinant CpSADH (both with and without His6-tag) and the wtCPCR 
(JFC) showed a very similar pattern of conversion with the examined substrates. The 
recombinant CPCR (X-Zyme) which is based on the derived amino acids sequences by Bönitz 
(2001) behaved very differently.  
 
Based on the recent data for the characterization of the wtCPCR (Steinsiek, 2006), direct 
comparison with other closely associated enzymes [wtCPCR, (JFC) and recombinant CPCR, 
(X-Zyme)] and also certain similarities like the activation energy, inhibition study, with the 
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old published data for the CPCR (Peters et al., 1993, 1993a), it seems that the recombinant 
CpSADH and the CPCR (preparations from JFC, from Steinsiek) could be very similar (if not 
the same) alcohol dehydrogenase, both from C.parapsilosis. 
 
3.4 Computer modeling and simulation of CPCR and CpSADH  
Experimental conditions that had been examined to characterize the recombinant CpSADH 
showed that the enzyme was very similar to the recently characterized wtCPCR (Steinsiek, 
2006). Moreover, the examined conditions with regard to the substrate spectrum, inhibition 
study and activation energy that had been covered within this research work also showed that 
the recombinant CpSADH behaved very similar to that of the wtCPCR but very differently to 
the recombinant CPCR preparation (X-Zyme)[in case of substrate spectrum]. In order to try 
and identify the “Real CPCR” and to have a better understanding to which of the two 
enzymes that are now known (and also proved) to exist in C.parapsilosis DSMZ 70125 strain 
is actually the “Real CPCR”; both these enzymes were modeled. Computer modeling and 
simulation of the two enzymes were done by Dr. Paolo Braiuca (University of Trieste, Italy), 
co-operation partner of the working group “Biocatalysis”, RWTH-Aachen, Germany. The 
modeling was based on the derived amino acids sequences of the two enzymes namely 
CpSADH (Kojima et al., 1995) and CPCR (see Figure 20 and Figure 10 respectively) using 
the NAD-dependent alcohol dehydrogenase (EC 1.1.1.1) from Sulfolobus solfataricus 
(Esposito et al., 2002) as the template molecule. According to the model, it was found that 
though the two enzymes were very different in their amino acids compositions, they had very 
close similarities in their active sites and therefore an initial comparison of the active sites of 
the CpSADH and the CPCR was done. Moreover these structures are more conserved among 
the ADHs. The active sites comparison of the two enzymes according to the model is shown 
in Figure 30.  
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Figure 30: Comparison of the active sites of CpSADH and CPCR. 
 
From the figure it can be seen that the CpSADH has a leucine (LEU) marked in orange at 
position 119. In contrast, CPCR has a tyrosine (TYR) marked in yellow at position 175 
instead. The big red sphere in the center is the zinc ion showing that both the enzymes are 
zinc-dependent. The green structure on the left side is the NADH molecule. In CPCR, the 
presence of tyrosine instead of leucine in the active center is an important difference, since the 
larger tyrosine seems to close a cleft of the active site, which on the contrary is available in 
CpSADH. It was therefore predicted from the model, that the CpSADH is able to bind 
somewhat larger substrates.  
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Another aspect of the model was to examine substrate selectivity of the two enzymes. From 
the lists of published data available for the broad substrate spectrum (Peters 1993; Peters 
1993a; Kula et al., 1996; published data sheets of JFC) that are known to be converted by 
wtCPCR or tried for conversion with the enzyme, some potential substrates were predicted by 
the model, which should be converted by the CpSADH and not/very slowly by the CPCR and 
thus would indicate the identity of the real CPCR. Here the CpSADH is meant by the 
recombinant enzyme that had been cloned and expressed in this research work using the 
published amino acids sequences of the same enzyme (Kojima et al., 1995). The CPCR used 
for comparison was the recombinant CPCR preparation (X-Zyme) which is based on the 
derived amino acids sequences by Bönitz (2001), the commercially available purified 
wtCPCR (JFC) and also the wtCPCR preparation by Steinsiek (Steinsiek, 2006). A few of 
these potential substrates as predicted by the model were used to check for their conversions 
with the above-mentioned enzymes (recombinant CpSADH, recombinant CPCR preparation 
by X-Zyme and wtCPCR preparation by JFC and Steinsiek). The conversion rates were 
measured photometrically at 340 nm. ABEE was used as the standard substrate and was 
arbitrarily set as 100%. The relative activities hence determined are summarized in the 
following table. 
 
Substrates CpSADH 
without 
His6-tag 
CpSADH 
with 
His6-tag 
wtCPCR 
preparation 
(JFC) 
wtCPCR 
(Steinsiek, 
2006) 
Recombinant 
CPCR 
(X-Zyme) 
ABEE 100 100 100 100 100 
Methyl-3-oxovalerate 30 27 19 25.2 0 
Ethyl benzoylacetate 24.1 23.7 13 28.6 5.6 
3-Benzoylpropionic acid 0 0 0 0 0 
 
Table 11: Comparison of some potential substrates as predicted by the model with different enzyme 
preparations. The results are expressed as relative activities (in %) as compared with the standard substrate 
ABEE set as 100%. The reaction mixture contained in a total volume of 1 ml, 100 mM TEA-HCl (pH 7), 8 mM 
of the substrate, 0.2 mM NADH+H+ and 10 µl of enzyme per ml. The activity was measured photometrically at 
340 nm and 37 °C for 1 min. 
 
As can be seen from the table, the CpSADH and the wtCPCR (both preparations by JFC and 
by Steinsiek) again showed similar patterns of conversion rates. An important thing to be 
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pointed out here is that the keto acid ester methyl-3-oxovalerate, which is reported to be 
converted by wtCPCR even in the known and published literature data (18% relative activity 
as reported by Peters 1993; Peters 1993a; Kula et al., 1996; JFC data sheets), was not 
converted by the recombinant CPCR (X-Zyme) which was cloned using the published amino 
acids sequences (Bönitz, 2001), but was converted by the recombinant CpSADH and also by 
the wtCPCR preparations. According to the published data, ethyl benzoylacetate that was not 
converted by wtCPCR, showed conversions with all the enzymes including the CPCR 
preparation from JFC. This substrate showed the lowest conversion rates with that of the 
recombinant CPCR (X-Zyme). The keto acid 3-benzoylpropionic acid was not converted by 
any of the enzymes.  
 
3.4.1 Conclusion of the modeling data 
 
The CpSADH and the CPCR was modeled (courtesy: Dr. Paolo Braiuca) and the active sites 
of these two enzymes were described in details. It was found that the CpSADH had a leucine 
residue whereas the CPCR had a comparatively larger tyrosine residue in the active center 
thus making the former accept more bulky substrates. The model also predicted some 
potential substrates that should be converted by the CpSADH and not/very slowly converted 
by CPCR. Accordingly, substrate specificity studies of the recombinant CpSADH, 
recombinant CPCR (X-Zyme) and wtCPCR preparations (JFC and Steinsiek) showed that a 
potential substrate methyl-3-oxovalerate was converted by the recombinant CpSADH and 
also by wtCPCR (JFC and Steinsiek) but not by the recombinant CPCR (X-Zyme). According 
to the literature data available, methyl-3-oxovalerate was described to be converted by the 
wtCPCR as well (Peters 1993; Peters 1993a; Kula et al., 1996; JFC data sheets).  
 
These data that were predicted by the model and also verified by experiments confirmed that 
though both the enzymes were present in the C.parapsilosis DSMZ 70125 strain, CpSADH 
should be the “Real CPCR” with a broader substrate spectrum than the recombinant CPCR 
(X-Zyme). 
 
3.5 Biocatalytic synthesis in different systems 
With the IMAC purified recombinant His-tagged CpSADH, enzymatic syntheses were carried 
out in different systems. Acetophenone was used as the model substrate. The recombinant 
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CpSADH as native forms, were used in a pure aqueous system and also in aqueous-organic-
two-phase system (the aqueous phase was overlaid with the organic solvent). Furthermore, 
biocatalytic syntheses with the recombinant CpSADH (His6-tagged) were also carried out in 
immobilized forms (section 3.6). Enzymatic substrate-coupled cofactor regeneration was 
carried out with 2-propanol as cosubstrate. 
 
3.5.1 Enzymatic synthesis in an aqueous system 
 
Substrate-coupled cofactor regeneration 
 
The conversion of acetophenone in a buffered aqueous system (100 mM TEA-HCl, pH 7.5) 
was carried out with the regeneration of the cofactor NADH+H+ by 2-propanol. The solubility 
of acetophenone, which was used as the substrate, in water/buffer is approximately up to 45 
mM. A maximum of this concentration was therefore used for conversions in purely aqueous 
medium. In order to determine the influence of this cosubstrate, different concentrations of 2-
propanol were used within a range between 5 and 20% (v/v). The conversions were 
approximately between 87.5 to 96.1%. The highest conversion was obtained with 2-propanol 
concentration of 10% (v/v). The maximum phenylethanol concentration that was formed 
amounted to 43.2 mM. The results are shown in Figure 31.  
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Figure 31: Production of phenylethanol in substrate-coupled reaction with different concentrations of 2-
propanol. The reaction was carried out at 30 °C and the reaction mixture consisted of five different 
concentrations of 2-propanol, 45 mM acetophenone, 1 mM NADH+H+ and 0.5 U/ml of recombinant His-tagged 
CpSADH. 
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Peters et al. (1993c) described that an optimal substrate conversion by CPCR was achieved 
with 5% of 2-propanol, whereas Steinsiek (2006) reported that highest substrate conversion 
by CPCR was achieved with 10% of 2-propanol . As can be seen from the results (Figure 31), 
the highest conversion with CpSADH was obtained with 10% (v/v) of 2-propanol and thus 
agreed with the results described by Steinsiek for CPCR. Peters et al. (1993a) reported that 
the stability of the CPCR was not affected with up to 10% 2-propanol. This was also clearly 
observed here from the results that had been obtained with the same concentration of 2-
propanol. At a concentration of 15% and 20% of 2-propanol approximately 94.8% and 92% 
conversion was determined respectively. These percentages of conversions were still higher 
than those obtained with 5% and 7.5% of 2-propanol. The decrease in the conversion rates 
with 2-propanol concentrations above 10% could be due to the overall decrease of the 
reductase activity (Steinsiek, 2006) of the recombinant CpSADH, because at such a high 
concentration of 2-propanol, the back reaction would be favored.  
 
3.5.2 Enzymatic synthesis in a liquid two-phase system 
 
Due to the poor water solubility of many hydrophobic substrates including acetophenone, 
which was used as the model substrate in the reaction system with recombinant His-tagged 
CpSADH, the enzyme catalyzed synthesis with acetophenone was carried out in liquid-liquid 
two-phase system in which the aqueous phase consisted of the enzyme with the cofactor and 
the organic phase consisted of hexane with the substrate. With this two-phase system a high 
concentration of the substrate could be used and therefore a better volumetric productivity of 
the reaction system was achieved. Many alcohol dehydrogenases are described to need a little 
amount of water in order to be active and be able to convert substrates and just a single water 
molecule could be sufficient (Zaks and Klibanov, 1988). But usually a higher concentration is 
needed in order to have a functional two-phase biocatalytic system depending upon the 
solvent used and/or the enzyme particularly when immobilized by adsorption to the carrier 
material (Adlercreutz, 1996). In a general way, more the solvent is hydrophobic; higher will 
be the initial enzymatic activity at low water content (Halling, 1994). Deetz and Rozzell 
(1988) reported that the minimum quantity of water required for the HLADH and also for the 
YADH and TBADH is only 0.1% (v/v) in the organic solvent hexane. In the organic solvent 
n-heptane, the HLADH needed 2.5% of water content in order to exhibit maximum activity 
(Itozawa and Kise, 1995). The wtCPCR showed activity with just 1% of water content in 
hexane as organic solvent (Steinsiek, 2006). Depending upon the type of solvent, the activity 
of the TBADH was between 6 and 30 times better in water than in organic solvent (Jönsson et 
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al., 1999). In the presence of 0.5% water in isopropyl ether, the activity of the HLADH was 
approximately one quarter of that in aqueous solution (Zaks and Klibanov, 1988).  
 
If enzyme powder is directly used in organic solvents, its own hydration level could be 
regarded as a molecular water phase. In order to determine the activity of the recombinant 
His-tagged CpSADH in hexane with little or no water content, the enzyme (1 U) was 
lyophilized together with the cofactor NADH+H+ for about 20 h in order to be sure that there 
was no water molecule left and to check if the hydration level after lyophilization was 
sufficient for catalytic active conformation of the CpSADH (method is described in section 
2.4.13). The activity of the enzyme was then examined in four different reaction sets. One of 
the sets contained no additional water/buffer solution. In the other three sets, buffer was added 
in a concentration of 0.1, 0.5 and 1% (v/v) of hexane (total volume of the reaction was 1 ml). 
All the four sets were made in pairs- to one of each pair, 1% (v/v) of 2-propanol was added 
for the regeneration of the cofactor, while in the other this cosubstrate was not added. The 
results thus obtained are summarized in Table 12. 
 
(S)-1-Phenylethanol produced (mM) Percentage  
of buffer (%) With 1% (v/v) 2-propanol Without 2-propanol 
0 0 0 
0.1 2.4 1.9 
0.5 15.4 3.3 
1 29.2 4 
 
Table 12: Production of (S)-1-phenylethanol in hexane with 0-1% of buffer. The synthesis was carried out at 25 
°C using 200 mM acetophenone as substrate in hexane. 
 
It was found that with no additional buffer (both with and without 2-propanol), the CpSADH 
did not convert the substrate. But, with as low as 0.1% buffer, there was conversion of the 
substrate and 1.9 mM of (S)-1-phenylethanol was produced. This concentration of the product 
increased to 2.4 mM when 2-propanol was added for cofactor regeneration. With 1% buffer in 
hexane, 4 mM (S)-1-phenylethanol was produced and increased further to as much as 29.2 
mM when 2-propanol was added for cofactor regeneration. This amount is more than one-half 
of what had been obtained in a pure aqueous system (43.2 mM phenylethanol), though a 
lower substrate concentration (45 mM) had to be used due to poor solubility of the substrate 
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in aqueous solution. It was therefore determined that the lyophilized CpSADH without any 
water molecule was not active in hexane. But just 0.1% of buffer was enough for the 
CpSADH to receive a catalytically active conformation and be flexible enough to bind and 
convert the substrate. For the HLADH it was described that only with addition of very little 
water or with a water-saturated solvent, the enzyme showed activity when lyophilized 
together with the cofactor (Grunwald et al., 1986 and Larsson et al., 1991). Some alcohol 
dehydrogenases are reported to change their stereospecificity by the organic solvents. This is 
particularly true for the TBADH (Jönsson et al., 1999; Keinan et al., 1984). The recombinant 
His-tagged CpSADH showed no change in the stereo-selectivity in hexane because only (S)-
1-phenylethanol was produced. 
 
Further synthesis in aqueous-organic two-phase system with recombinant His-tagged 
CpSADH was carried out in a larger volume of the aqueous (buffer) phase. The reactions 
were carried out with 25, 50 and 75% of hexane phase in a total reaction volume of 1 ml. This 
therefore produced a definite interface. The organic phase consisted of hexane with the 
substrate while the aqueous phase consisted of the cofactor (NADH, 1mM) together with the 
enzyme (0.5 U/ml) (see 2.4.13). For cofactor regeneration, 10% (v/v) 2-propanol was used 
and this concentration was always calculated over the aqueous phase. After 24 hours of 
synthesis at 25 °C the product formation was analyzed by GC (for the organic phase) and by 
HPLC (for the aqueous phase). The substrate acetophenone was used in a concentration of 
100 mM and 200 mM. This concentration was calculated always over the aqueous-organic 
phases. Because of its solubility, acetophenone remained mostly in the organic phase, which 
serves therefore as the substrate reservoir. The substrate diffuses into the aqueous phase, is 
converted into the product, which is then extracted into the organic phase. After the extraction 
of the product in the organic phase, the substrate can further diffuse again into the aqueous 
phase. The concentration of phenylethanol thus produced with the recombinant His-tagged 
CpSADH in such a two-phase system using 100 and 200 mM of acetophenone as substrate is 
shown in Figure 32. 
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Figure 32: Production of phenylethanol after 24 h with acetophenone concentration of 100 and 200 mM in 
different volume percent of hexane. 
 
The highest product concentration was found at 25% of hexane phase. 61.5 mM of 
phenylethanol was produced with 100 mM start-concentration of the substrate whereas as 
much as 103 mM of phenylethanol was produced with 200 mM start-concentration of the 
substrate. This yield is relatively better than those that had been described by Steinsiek (2006) 
for the wtCPCR in which under the same conditions, only 55 mM and 92 mM of 
phenylethanol was produced (with 100 and 200 mM substrate concentration) after 48 hours. 
Furthermore, the production of phenylethanol in case of recombinant His-tagged CpSADH 
was calculated only after 24 hours of synthesis. In the preliminary tests with two-phase 
system, further conversions after 24 hours of synthesis were not examined though. The lowest 
product formation took place with 75% hexane phase obviously due to a higher instability of 
the enzyme, as had been shown earlier, in this percentage of hexane. In comparison to the 
pure aqueous medium where with the same percentage of 2-propanol for cofactor 
regeneration, as much as 96% conversions were reached, a worse product formation was 
determined here. The reason of course could be explained by the inactivating effect of the 
organic solvent. The larger the organic phase, the greater is the instability of the enzyme. 
Despite the instability of the enzyme in such a two-phase system, one advantage of such a 
system is the overall volumetric productivity of the system. In a pure aqueous system, even 
though about 96% conversion was obtained, only a maximum of 45 mM of acetophenone 
could be used. Therefore, a maximum of 43.2 mM of phenylethanol was produced. 
Comparatively, in this two phase system where 100 and 200 mM start-concentrations of the 
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substrate were used, as much as 61.5 and 103 mM of phenylethanol (with 25% hexane) and, 
38 and 58.5 mM of phenylethanol (with 75% hexane) were produced. Product yields in this 
order of magnitude would not have been possible in a purely aqueous system. 
 
3.5.3 Conclusion of the enzymatic synthesis in different liquid systems 
 
Conversion of acetophenone with the recombinant CpSADH was carried out in different 
liquid systems. In pure aqueous system, a maximum of 96% (43.2 mM phenylethanol) 
conversion rate was determined with 10% (v/v) 2-propanol that was used for cofactor 
regeneration. But one drawback of the pure aqueous system was that, due to the partial 
solubility of the acetophenone in aqueous solutions, the maximum start-concentration of the 
substrate (acetophenone) that could be used was only up to 45 mM. This drawback was 
overcome by using a liquid-liquid two-phase system consisting of hexane and buffer. The 
hexane served as the reservoir of the substrate and the product could be continuously 
extracted in the organic phase. Under these conditions, with 25% (v/v) hexane phase, 103 mM 
phenylethanol was produced with 200 mM start concentration of acetophenone and 61.5 mM 
of phenylethanol was produced with 100 mM acetophenone. The overall product yields were 
much higher in comparison to the purely aqueous system. Furthermore, the enzyme showed 
no activity in the pure organic solvent hexane without any additional buffer, but with just 
0.1% (v/v) of buffer the enzyme showed activity and 2.4 mM phenylethanol was produced. 
With 1% of buffer, as much as 29.2 mM phenylethanol was built. 
 
3.6 Immobilization of recombinant His-tagged CpSADH and 
enzymatic synthesis with the immobilisate  
Immobilization of the enzyme was carried out with two different methods: with entrapment 
and with covalent binding through adsorption. In the first method, polyvinyl alcohol (PVA) 
was used because this hydrogels are well characterized and are known to be functional with 
some alcohol dehydrogenases (Steinsiek, 2006; Metrangolo-Ruiz de Temino et al., 2005). In 
the second method, ready-to-use enzyme carriers SEPABEADS® EC-SERIES (Resindion 
S.r.l., Italy) were used. The beads were kindly donated by the company for carrying out 
preliminary experiments with the recombinant CpSADH and check for their functionality 
with the said enzyme.  
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3.6.1 Immobilization in PVA and enzymatic synthesis thereof 
 
Immobilization and extensive characterization of the wtCPCR with polyvinyl alcohol beads 
was successfully accomplished by Steinsiek (2006). Good results and high stability were 
obtained with an alcohol dehydrogenase from Lactobacillus kefir (LKADH) immobilized in 
the same matrix (Metrangolo-Ruiz de Temino et al., 2005). The entrapment method is useful 
particularly when an enzyme shows high sensitivity against organic solvents. The 
immobilized system consists of a gel-stabilized two-phase system, with PVA hydrogel beads 
and hexane as organic phase. Using this system, the recombinant CpSADH could be used 
successfully for the reduction of acetophenone. 
 
Enzyme entrapment in PVA was performed by a process of freezing and thawing (Ariga et 
al., 1987). Gelation of the polyvinyl alcohol solution took place by introducing the solution in 
drops in cold silicone oil (-70 °C) and then a slow thawing process. During freezing process, 
phase separation is built through the formation of ice crystals. In the unfrozen low-moisture 
regions of the system, this remains liquid and the concentration of the polyvinyl alcohol is 
strongly increased and it forms during the warming-up process, hydrogen bonds between the 
polymer chains and the free hydroxyl groups. During the slow thawing process the bonds 
between the PVA chains strengthen. By addition of polyethylene glycol (PEG) and with 
freezing and thawing, firm hydrogel beads are formed. Complete saponification of the 
polyvinyl alcohol is required for the stability of the beads (Prüsse, 2000) otherwise the 
remaining acetate groups would obstruct the formation of hydrogen bonds between the 
polymer chains (Lozinsky and Plieva, 1998) during gel formation. This saponification was 
done by addition of sufficient amount of sodium hydroxide in the solution of PVA and PEG 
prior to gelation (i.e. before adding the solution in silicone oil).  
 
Steinsiek (2006) had done extensive characterization of the wtCPCR immobilized in PVA 
beads. The recombinant His-tagged CpSADH immobilized in PVA was therefore used for 
conversion of substrate without further characterization in order to determine the functionality 
of the immobilisate. In the gel-stabilized two-phase system, consisting of the PVA 
immobilized biocatalyst and hexane as organic solvent, a fixed ratio of 1:3 of the hydrogel 
phase to the organic solvent was used such that the immobilisates were completely 
surrounded by the solvent and thereby a good exchange of substrate and product between the 
phases was ensured. Due to the high solubility of acetophenone in hexane, the organic solvent 
served as the substrate reservoir. Enzymatic synthesis was carried out with 200 mM 
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acetophenone as substrate dissolved in hexane. This start-concentration of the substrate was 
used because it showed better conversion rates in liquid-liquid aqueous-organic two-phase 
system. For cofactor regeneration, 2-propanol was used in a concentration of 5 and 10% (v/v), 
which was calculated over the hydrogel phase. The results are hereby shown in Figure 33. 
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Figure 33: Phenylethanol produced with different cosubstrate concentration. Reaction composition: 2 U/g beads, 
1 mM NADH+H+, 200 mM acetophenone and 25 °C, pH of the hydrogels were 7.5. 
 
The substrate concentration used amounted to 200 mM, accordingly a conversion of 44.1 mM 
with 10% (v/v), and of 32.9 mM with 5% (v/v) of 2-propanol was obtained that were detected 
only with the outgoing concentrations in the organic phase. The difference in the product 
formation with different 2-propanol concentrations is very much comparable to that of the un-
immobilized soluble enzyme in aqueous system. The highest conversion took place with 10% 
cosubstrate. From the course of the curve, it is evident that there was no inactivation or 
inhibition of the recombinant CpSADH with the cosubstrate within the examined 
concentrations. 
 
Apart from the activities of the immobilisate that was determined, there are some other 
parameters that play a role during the substrate acceptance and product formation. The mass 
transfer is particularly important since the substrate must first diffuse into the beads and after 
conversion, the product must diffuse out. The exact concentrations in the beads are not 
detectable thereby. But by the solubility of the product and substrate in the gel phase, it can be 
measured how much will remain in it. According to the distribution of the product between 
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gel and solvent phase, it can be estimated, in which concentrations the product/substrate will 
remain in the beads. The distribution of phenylethanol between aqueous phase i.e. the 
hydrogel phase (PVA beads) and organic phase is shown in Figure 34. 
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Figure 34: Balanced distribution of phenylethanol between the aqueous and organic phase, determined with a 
volume ratio of 1:3 (hydrogel phase: organic solvent hexane). 
 
In the examined concentration range (between 2.5 to 52 mM), the concentration of 
phenylethanol was approximately 1.3 times more in the hydrogel phase than in the hexane 
phase. When determining the production of phenylethanol with the enzyme immobilized in 
PVA beads, this distribution was not considered, since the yield was referred to which is 
actually available. 
 
3.6.2 Immobilization in Sepabeads and enzymatic synthesis thereof 
 
The activity and functionality of the recombinant His-tagged CpSADH were determined in 
two different types of ready-to-use enzyme carriers SEPABEADS® EC-SERIES namely EC-
EP and EC-HFA. Brief characteristics of these two types of beads are described in the 
following table (source of information: Resindion S.r.l., Italy). 
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Characteristics SEPABEADS® EC-EP SEPABEADS® EC-HFA 
Matrix Polymethacrylate Polymethacrylate 
Active Group Epoxide Amino Epoxide 
Functional Group density Minimum 110 µmol/g wet Minimum 50 µmol/g wet 
Particle Size range 150-300 µm 150-300 µm 
Pore Diameter (for target 
enzyme size: normal) 
30-40 nm 30-40 nm 
Porosity > 25% > 25% 
Water Retention 55-65% 50-60% 
Table 13: General characteristics of the EC-EP and EC-HFA beads. 
 
EC-EP and EC-HFA perform covalent fixation by a nucleophilic attack of the amino groups 
of the enzyme on the epoxy groups of the carrier. EC-EP is unpolar and will not adsorb 
typical enzymes in the absence of high buffer concentration. EC-HFA is more polar allowing 
enzymes also to adsorb, but later they are immobilized via the epoxy groups. In the EC-EP, 
first a very slow intermolecular covalent immobilization takes place between the enzymes. 
The enzyme thereby is bound to the carrier by mild physical adsorption through hydrophobic 
adsorption plus very fast intramolecular covalent binding (Mateo et al., 2000a; Mateo et al., 
2002). In the EC-HFA, a high density of amino-epoxy groups is present. Due to this, the 
enzymes are adsorbed into the carriers through fast physical adsorption. After the physical 
adsorption, a very strong covalent immobilization takes place between the epoxy-amine 
groups (Mateo et al., 2003).  
 
Immobilization with the EC-EP and EC-HFA enzyme carriers 
 
The recombinant His-tagged CpSADH was successfully immobilized on the carriers with the 
methods described earlier (see section 2.5.2). Since the immobilization method with EC-EP 
needed a high concentration of buffer, a concentration between 100, 200, 500 and 1000 mM 
was used to examine the optimal buffer conditions for the immobilization of the enzyme. For 
the immobilization with EC-EP (and also EC-HFA), potassium phosphate buffer instead of 
TEA-buffer was used during the immobilization methods and also during syntheses. This was 
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because, triethanolamine (TEA) has a free electron pair, which could perform a nucleophilic 
attack on the epoxy group and thereby reduce the overall immobilization yield with the 
enzyme. It was found that the adsorption of the enzyme on the Sepabeads (EC-EP) was about 
80% during the first two hours of incubation with 100 mM phosphate buffer, pH 8. With the 
other three concentrations of the buffer (200, 500 and 1000 mM) at pH 8 that had been used, 
the adsorption efficiency was the same (> 99% of bound activity) during the first 2 hours. But, 
increase in the concentration of the phosphate buffer resulted in a terrible decrease in the 
stability and activity of the soluble enzyme. This might be owing to the conformational 
changes in the enzyme caused by the substantial increase in ionic strength leading to loss of 
enzyme activity. Similar effects of decrease in diastase activity with increasing salt 
concentrations were observed by Bajpai and Sachdeva (2002). When compared between 200-
1000 mM phosphate buffer, the activity and stability of the enzyme was found to be the 
highest at 200 mM (pH 8) of the phosphate buffer. This concentration was therefore used for 
the immobilization method since the immobilization yield was the same when compared with 
the other two concentrations (500 and 1000 mM) of the phosphate buffer. The effect of 
increasing ionic strengths of the phosphate buffer on the stability of soluble CpSADH and 
immobilization efficiency on the EC-EP Sepabeads is shown in Figure 35. It was found that at 
100 mM phosphate buffer concentration, about 99% of residual activity was retained. This 
decreased to about 3% at 200 mM buffer concentration. At 1 M buffer concentration, the 
stability of CpSADH was highly affected and only 56% residual activity was determined. 
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Figure 35: Effect of concentrations of phosphate buffer on the stability of CpSADH and immobilization 
efficiency on EC-EP Sepabeads. 
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Due to the high polarity of the EC-HFA, no buffering is usually required. But, the 
recombinant CpSADH needed a small buffering in order to be stable for a longer time. A very 
low concentration of 20 mM of phosphate buffer, pH 7.6 was used for the immobilization, 
which showed to be enough for a long-term stability of the enzyme.  
 
With the optimized conditions for immobilization, it was found that the recombinant 
CpSADH was completely adsorbed in the EC-HFA Sepabeads within the first 1 hour at 25 °C 
(> 99% bound activity). The adsorption of the enzyme in the EC-EP was a bit slower; it was 
only after the first 2 hours of incubation that > 99% bound activity was found.  After the 
adsorption was completed, further incubation was done at 5 °C (in order to prevent thermal 
degradation of the enzyme) for 48 h by stirring in an over-head shaker. This second 
incubation was done in order to facilitate covalent binding of the adsorbed enzyme to the 
Sepabeads. After the immobilization was completed, the supernatant was eliminated after 
checking the residual activity. The course of immobilization with the EC-EP and EC-HFA 
Sepabeads are shown in Figure 36. 
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Figure 36: Course of immobilization of the recombinant His-tagged CpSADH on EC-EP and EC-HFA 
Sepabeads during the first 2 hours. Protein/enzyme loading: 10 units of the enzyme (0.5 mg protein) per gram 
beads. 
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From the course of the curve, it is evident that the immobilization was approximately two 
times faster on the EC-HFA than on the EC-EP. This was checked particularly during the first 
two hours of immobilization so as to determine the adsorption efficiency of the two kinds of 
Sepabeads. After the initial two hours when adsorption was completed (> 99% bound activity 
determined), a second incubation for 48 h was done to ensure covalent binding as because the 
process of covalent binding is comparatively slower than that of adsorption. No desorption of 
the enzyme was found after the immobilization was completed when using 200 mM 
phosphate buffer at pH 8 for the EC-EP and 20 mM phosphate buffer at pH 7.6 for the EC-
HFA and with protein loading of 0.5 mg protein/gram beads. A comparatively rapid 
immobilization rate particularly during the first two hours with the EC-HFA Sepabeads could 
be explained by the fact that in the epoxy-amino Sepabeads, the presence of amino groups 
allows a very rapid ionic adsorption of the proteins onto the support at low ionic strength 
(here 20 mM phosphate buffer, pH 7.6). On the other hand, using epoxy Sepabeads (EC-EP), 
enzyme adsorption requires high ionic strength (here 200 mM phosphate buffer, pH 8) and 
proceeds via the hydrophobic interaction between the external hydrophobic pockets of the 
enzyme and the hydrophobic surface of the support, which yielded a lower immobilization 
yield during the first two hours. This greater binding capacity and higher immobilization rates 
with the EC-HFA Sepabeads were also reported by Mateo et al. (2003) and Torres et al. 
(2003) for several examined enzymes.  
 
Protein loading 
 
To determine the carrier capacity, increasing amounts of protein was loaded within a range of 
0.0001 to 0.001 mg/mg beads. The ratio of the beads to the enzyme/protein solution for 
immobilization was always kept constant (1:4). A saturation of the surface of the beads with 
the protein was not found within the studied range and an adsorption rate of > 99% was 
accomplished within the first 1 hour of immobilization (with EC-HFA) and within the first 2 
hours (with EC-EP) under the optimized immobilization conditions. This showed that the 
examined range of protein was obviously not the maximum capacity of the carriers. It might 
have been possible to load with higher amounts of protein, but the preliminary synthetic 
experiments with the immobilized enzyme were carried out only with 10 units of the enzyme 
(0.5 mg protein) per gram beads. Synthetic reactions were carried out in a total volume of 4 
ml. For such small-scale synthesis (in 4 ml reaction volume), a higher amount of 
enzyme/protein loading was not required. This low protein load was also chosen to prevent 
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diffusion problems. No desorption of enzyme from the beads was found when loaded up to 
0.001 mg protein/mg beads. This was verified by washing the immobilized beads with buffer 
very thoroughly and afterwards checking the activity as well as the amount of protein in the 
solution. Therefore the total immobilization yield obtained was > 99% in each case. 
 
Synthesis with the enzyme immobilized on Sepabeads in pure aqueous system 
 
Unlike the PVA beads, it was not possible to co-immobilize the cofactor NADH+H+ along 
with the enzyme in the Sepabeads. The NADH has to reach the active center, which will be 
only possible with free or homogenously enlarged cofactor e.g. PEG-NADH. To check the 
functionality of the enzyme immobilized on Sepabeads, initially all syntheses were carried out 
in pure aqueous medium (50 mM potassium phosphate buffer, pH 7.6) and NADH+H+ was 
supplied into the bulk phase so as to rule out the possibility of cofactor limitations. The 
compositions of the reaction mixtures for both the EC-EP and EC-HFA Sepabeads had been 
described in section 2.5.2 (Reaction set-up for aqueous system). The ratio of the immobilized 
biocatalyst to that of the reaction volume was always kept at 1:16 (250 mg sepabeads in 4 ml 
of total reaction volume). Acetophenone was used here also as the model substrate in order to 
be able to compare different reaction systems. Since the solubility of acetophenone in aqueous 
medium is only up to 45 mM, therefore this concentration was also used for the synthesis. 
Cofactor regeneration was done with 10% (v/v) of 2-propanol because the highest activity of 
the recombinant His-tagged CpSADH was always found at this concentration of the 
cosubstrate. The phenylethanol that had been produced by the enzyme immobilized on EC-EP 
and EC-HFA are shown in Table 14. 
 
 Phenylethanol produced (mM) Time (h) 
With EC-EP With EC-HFA 
24 3.4 34.3 
48 5.1 39.4 
 
 
 
 
 
 
Table 14: Production of phenylethanol with enzyme immobilized on Sepabeads in pure aqueous medium. 
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The highest conversion was found with EC-HFA Sepabeads. Since 45 mM acetophenone was 
used as substrate as much as 87.5% conversion (39.4 mM phenylethanol) was achieved. In a 
pure aqueous system with soluble enzyme, the percentage of conversion was about 96%. But, 
a remarkably very low conversion of only 5.1 mM phenylethanol (11.2%) was obtained with 
the epoxy-linked EC-EP Sepabeads. Additionally, it was found that the material balance 
(concentration of substrate and/or product) that had been analyzed with the HPLC was very 
different. It was presumed that after immobilization some of the epoxy groups might remain 
unconverted and the substrate and/or product when used showed some affinity towards them. 
Loading with as much as 30 mg protein/gram beads did not change the difference. This 
material imbalance was true also in the case of EC-HFA but the difference was very less 
when compared to the EC-EP. 
 
In order to determine how much have the substrate and/or product bound to each of the two 
kinds of Sepabeads, enzyme-free beads were used and after equilibration was reached (48 
hours), the adsorption of the substrate and/or product into the beads was determined. The ratio 
of beads to reaction volume was always kept at 1:16 (250 mg enzyme-free beads in 4 ml 
reaction volume). The results are shown in Figure 37 (a-d). 
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Figure 37: Balanced distribution of acetophenone and phenylethanol between the aqueous medium and the 
Sepabeads, determined with a volume ratio of 1:16 (Sepabeads: aqueous medium). 
(a): Distribution of acetophenone in EC-EP Sepabeads. 
(b): Distribution of phenylethanol in EC-EP Sepabeads. 
(c): Distribution of acetophenone in EC-HFA Sepabeads. 
(d): Distribution of phenylethanol in EC-HFA Sepabeads. 
 
In the examined concentration ranges, it was found that for EC-EP, the concentrations of 
acetophenone bound to the beads was as much as 16 times more and that of phenylethanol 
was as much as 7 times more than in the reaction medium. For EC-HFA, the concentration of 
acetophenone bound was 2.8 times more and that of phenylethanol was 1.7 times more than in 
the reaction medium. A comparatively very high affinity of acetophenone towards the EC-EP 
Sepabeads could be because of its unpolar characteristics. As acetophenone is very 
hydrophobic, therefore it had more affinity towards the beads than towards the buffer. 
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Comparatively, phenylethanol is more hydrophilic. Therefore it had a lower affinity towards 
the EC-EP Sepabeads. On the other hand, EC-HFA Sepabeads is more polar; therefore 
acetophenone and phenylethanol had lower affinities towards it. Due to this huge material 
imbalance with the EC-EP Sepabeads, and also very low enzymatic conversions, this was 
obviously not the right enzyme carrier particularly when carrying out enzymatic synthesis in 
pure aqueous system. 
 
Synthesis with the enzyme immobilized on Sepabeads in aqueous-organic two-phase 
system 
 
The functionality of the enzyme immobilized on Sepabeads was examined in an aqueous-
organic two-phase system in order to have the possibility of using a higher starting 
concentration of the substrate acetophenone and thereby have better yields at the end of the 
synthesis. A small aqueous phase had to be included in the synthetic reactions to supply the 
cofactor NADH+H+. This aqueous phase varied from 0.5 ml and 1 ml in a total reaction 
volume of 4 ml (the remaining volume consisted of hexane with the substrate acetophenone). 
Accordingly, two sets of reaction probes were established: SET A and SET B (see section 
2.5.2). SET A consisted of 1 ml aqueous phase containing 1 mM NADH+H+ in 50 mM 
phosphate buffer, pH 7.6 and 3 ml of hexane phase containing 200 mM acetophenone 
(concentration was calculated for the aqueous-organic phases). SET B consisted of 0.5 ml 
aqueous phase containing 1 mM NADH+H+ in 50 mM phosphate buffer pH 7.6 and 3.5 ml of 
the hexane phase with 200 mM substrate acetophenone (concentration calculated for aqueous-
organic phases). Cofactor regeneration was carried out with 10% (v/v) of 2-propanol 
(concentration was calculated for the aqueous phase only). The ratio of the enzyme 
immobilized on Sepabeads to the total reaction volume (including the aqueous-organic 
phases) was kept constantly at 1:16 (250 mg Sepabeads in 4 ml of total reaction volume). 
Synthesis was carried out at 25 °C and proper mixing of the reaction system was ensured by 
shaking in an end-to-end shaker. When using Sepabeads, it is very important to take care of 
the stirring method for proper mixing of the reaction system. Sepabeads being very fine 
particles, care should be specially taken not to use magnetic stirrers, as these would cause 
grinding of the Sepabeads. If magnetic stirrers cannot be avoided, triangular sticks or sticks 
with wheels at its ends could be used as these would not cause grinding of the beads. In any 
case, round sticks should never be used. The substrate consumption and product formation 
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were analyzed at regular time intervals via HPLC (aqueous phase) and GC  (organic phase). 
The results obtained thereby are shown in Figure 38 (a-b). 
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Figure 38: Production of phenylethanol with enzyme immobilized on Sepabeads in a varied aqueous-organic 
two-phase system. 
(a): Enzymatic synthesis with EC-EP Sepabeads. 
(b): Enzymatic synthesis with EC-HFA Sepabeads. 
 
In the aqueous-organic two-phase system, the highest conversion was found with the EC-
HFA Sepabeads as had been found also in the pure aqueous system. But, among the two 
reaction sets that had been studied, it was found that the conversion was better when an 
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aqueous phase of 1 ml to 3 ml hexane phase was used rather than 0.5 ml to 3.5 ml (aqueous 
phase to organic phase). With the first instance (SET A composition) consisting of 1 ml 
aqueous phase, as much as 57.6 mM phenylethanol (28.8% conversion) was formed from 200 
mM acetophenone. With the second instance (SET B composition) 36.2 mM phenylethanol 
(18.1% conversion) was built from 200 mM acetophenone. The concentration of the product 
that was bound in the Sepabeads was not taken into consideration since they were not 
extracted in the said experiments. The reason behind a comparatively lower conversion rate 
with the SET B was obviously due to the inactivation/instability of the enzyme in close 
contact with the organic solvent hexane. Since, in this composition, a ratio of 1:7 in a total 
reaction volume of 4 ml (1 part aqueous medium to 7 parts organic medium) was used, the 
contact of the enzyme immobilized on Sepabeads with hexane was more intensive due to an 
increased ratio of the interface and the aqueous phase. This resulted in a faster 
instability/inactivation of the enzyme. Comparatively, in the SET A composition, a larger 
aqueous phase was used (1:3 aqueous to organic phase in a total reaction volume of 4 ml). 
Therefore, the contact of the enzyme immobilized on Sepabeads with hexane was less 
intensive, and hence the enzyme was more stable/active, which in turn resulted in a better 
conversion. With the gel-stabilized two-phase system (enzyme immobilized in PVA beads 
and hexane in 1:3 ratio) after 356 h, a maximum of 132 µmol phenylethanol (44.1 mM 
phenylethanol in 3 ml hexane) was produced that was detected only with the outgoing 
concentrations in the organic phase and therefore was considered to be the final yield 
achieved at the end of the synthesis. In contrast, with the enzyme immobilized on EC-HFA 
Sepabeads in an aqueous-organic two-phase system (in 1:3 ratio of aqueous to organic phase) 
after 356 h, as much as 230 µmol phenylethanol (57.6 mM phenylethanol in 4 ml reaction 
volume) was produced. This value was also calculated taking into consideration only the 
available amounts in the aqueous and organic phases and hence was the final yield. The 
concentration of phenylethanol bound to the Sepabeads was not considered. Under these 
conditions, approximately 100 µmol more of phenylethanol was produced with the enzyme 
immobilized on Sepabeads than with the enzyme immobilized in PVA beads. 
 
With the EC-EP Sepabeads, conversion was very less in the aqueous-organic two-phase 
system. However the conversion was similar to that of the pure aqueous system. The substrate 
concentration used amounted to 200 mM, accordingly a conversion of only 3.5 mM 
phenylethanol with SET A composition and 2.5 mM phenylethanol with SET B composition 
was obtained. The material balance with the EC-EP Sepabeads in aqueous-organic two-phase 
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system was again studied (beads to reaction volume ratio was 1:16). It was found that for 
phenylethanol, similar concentrations were bound to the Sepabeads like those that had been 
found in the pure aqueous system (about 7 times more than in the reaction medium). With 
acetophenone it was found that when a starting concentration of 200 mM was used, after 
equilibrium, about 185 mM was staying in the solution of hexane and buffer and about 15 
mM was staying in the beads. Therefore enough of the substrate was still left in the solution to 
be converted by the enzyme. But the enzyme was simply not active/stable enough in the EC-
EP Sepabeads in order to carry out a good conversion reaction. This different effect on the 
enzyme activity of the immobilization when using different supports (even though both of 
them have epoxy groups as reactive group) may be related to different orientations of the 
enzyme on the support. This implies that the enzyme likely reacts with the support via 
different areas (the areas of the protein surface that have more hydrophobic residues or the 
areas of the protein that have more negative charge) with co-occurrence of different effects on 
enzyme activity. Moreover, the different nature of the support (hydrophobic or ionic) may 
also have some relevance to explain the difference in the enzyme activities. A negative effect 
(less activity) of the hydrophobicity of the support could be because the close presence of a 
hydrophobic surface (of the enzyme) near the support can promote some unstabilizing effect, 
similarly like the presence of any other hydrophobic interfaces like organic solvents phase 
(Mateo et al., 2002). 
 
Stability of the enzyme immobilized on Sepabeads 
 
After determining the functionality with regard to activity of the enzyme immobilized on 
Sepabeads, it was interesting to know the stability of the immobilized enzyme. Due to the 
poor conversion rates that had been achieved with the EC-EP Sepabeads, these were not used 
in the further experiments. But the immobilized EC-HFA Sepabeads showed a very good 
conversion rate and was even better when compared to the conversion obtained with the PVA 
beads. The stability (thermo-stability) of the recombinant His-tagged CpSADH immobilized 
on EC-HFA Sepabeads was therefore necessary to know. Figure 39 shows the residual 
activities that had been measured with the immobilized enzyme after incubation at different 
temperatures in an aqueous-organic two-phase system (method described in section 2.5.3). 
The ratio of the immobilized enzyme to the total aqueous-organic volume was kept at 1:16 
[250 mg beads to 4 ml of reaction volume; buffer (1 part; 50 mM phosphate buffer, pH 7.6) 
and hexane (3 parts)]. 
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igure 39: Thermo-stability of the recombinant His-tagged CpSADH immobilized on EC-HFA Sepabeads. 
Residual activity was measured after storage of the immobilisate at different temperatures. 
he half-life of the immobilized enzyme in EC-HFA decreased with an increase in the 
Table 15: Comparison between the half-lives of the soluble and the immobilized CpSADH. 
t lower temperature (here 25 °C), the half-life of the immobilized CpSADH on the EC-HFA 
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temperature. At the lowest temperature that had been studied here, the immobilized enzyme 
had a half-life of approximately 284 h. At 30 °C the half-life reduced to 91.2 h followed by a 
further decrease to 55 h at 37 °C. In Table 15, a comparison of the half-life of the soluble 
enzyme (in one phase and two-phase) to that of the immobilized one is shown. 
 
T (°C) τ (h), soluble enzyme in 
pure aqueous medium 
τ (h), immobilisate 
(1:3 phase ratio) 
τ (h), soluble enzyme in two-
phase system (1:3 phase ratio) 
25 289 284 77 
30 68.6 91.2 Not determined 
37 34.2 55 Not determined 
 
A
Sepabeads was more or less the same as in the soluble form in one phase. But at higher 
temperatures, the stability of the immobilized enzyme increased significantly. The half-life of 
the soluble CpSADH in aqueous-organic two-phase system was comparatively very less (see 
3.3.3). It was found that under the same phase ratio of buffer to hexane (1:3), the soluble 
enzyme had a half-life of only 77 h at 25 °C. In a two-phase system, the half-life of the 
  
3 Results and Discussion 128
immobilized enzyme on Sepabeads therefore increased to approximately 3.6 times when 
compared to that of the soluble enzyme in a similar two-phase system consisting of the same 
phase ratios (Table 15). Similar increase in the stabilities of the amino-epoxy immobilized 
enzymes was also reported by Mateo et al. (2003). 
 
3.6.3 Conclusion of the immobilization  
he recombinant His-tagged CpSADH was successfully immobilized with two different 
 
T
methods: entrapment and covalent binding via adsorption. In the first method, the enzyme 
was entrapped in PVA beads. Without further characterization, the functionality of the 
immobilized enzyme in PVA beads was determined. The immobilized enzyme in PVA 
remained protected against the organic solvent and was active within the hydrogels. 
Acetophenone was converted by the immobilisate and about 132 µmol phenylethanol was 
produced. In the second method, the enzyme was covalently bound on two different types of 
Sepabeads: EC-EP and EC-HFA. The former has epoxy group as reactive group and the latter 
has epoxy-amino group as the reactive group. The immobilized enzyme showed activity both 
in pure aqueous system and also in aqueous-organic two-phase system. The use of two-phase 
system is particularly important for substrates (here acetophenone), which otherwise exhibit 
only very small water solubility. Here the organic phase serves as reservoir for the 
hydrophobic substrate and leads for an extraction of the product and therefore lead to higher 
yields. The small aqueous phase contained the cofactor, which unlike the PVA beads was not 
possible to co-immobilize together with the enzyme. Under these conditions, the enzyme 
showed very good conversion with the EC-HFA Sepabeads and about 230 µmol 
phenylethanol was built. The conversion with the EC-EP Sepabeads was very poor and as low 
as only 14 µmol phenylethanol was produced. The stability of the immobilized enzyme on 
EC-HFA Sepabeads was 284 h which was approximately same like that of the soluble enzyme 
(in one phase) at a temperature of 25 °C. But with an increase in temperature (30 and 37 °C), 
the stability of the immobilized enzyme got higher than that of the soluble enzyme 
(approximately 1.5 times). Furthermore, when compared to the half-life of the native enzyme 
in aqueous-organic two-phase system with the same phase ratio of 1:3 (buffer: hexane), it was 
found that the immobilized enzyme on the EC-HFA Sepabeads was much more stable under 
the same phase ratios and the half-life increased to approximately 3.6 times. 
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4 Summary 
The (S)-specific NADH-dependent carbonyl reductase from C.parapsilosis DSMZ 70125 
strain (CPCR) is a very versatile biocatalyst and because of its broad substrate spectrum, the 
possibility of cofactor-regeneration and high stereo-selectivity, very much interesting for the 
chemoenzymatic synthesis of pharmaceuticals and agrochemicals. However, the wtCPCR was 
present in the yeast cells only in very small amounts (< 0.03% of the total cell proteins). In the 
year 2001, Bönitz identified the partial amino acids sequences of the wtCPCR and thereby 
cloned and expressed this protein in E.coli. But the recombinant enzyme did not show similar 
substrate spectrum like the wtCPCR (results obtained from JFC). Another (S)-specific 
NADH-dependent secondary alcohol dehydrogenase that was first isolated from 
C.parapsilosis IFO 1396 (CpSADH) by a Japanese research group showed also broad 
substrate specificities. However, the recombinant CpSADH was not characterized and was 
basically employed for whole-cell biocatalysis for the oxidation of 1,3-butanediol.  
 
This research work was aimed at cloning and expression of the carbonyl reductase from 
C.parapsilosis (CPCR) followed by characterization and immobilization of the recombinant 
enzyme. With this view, the first step was to identify which of the two alcohol 
dehydrogenases that were described to be present in two different strains of C.parapsilosis 
was the real CPCR. For this, using the information of the partial amino acids sequences 
available for the wtCPCR, the gene coding for the CPCR was amplified by PCR based 
genome walking from the gDNA library of C.parapsilosis DSMZ 70125 strain. The derived 
amino acids sequence showed that it contained a total of 403 amino acids, which were 54 
additional amino acids on the N-terminal as compared to the amino acids sequences of the 
CPCR that had been described before. Analysis of this additional amino acids sequence on the 
N-terminal showed that it was not a signal-peptide sequence but rather a part of the mature 
protein. Interestingly it was found that the recombinant CPCR was not active in E.coli 
expression strains just after 2 expression cycles. Changes of expression parameters gave no 
positive results. Inclusion bodies were not found either. The enzyme showed no activity. Due 
to this problem in the expression of the recombinant CPCR (cloned in this work) in E.coli, a 
recombinant CPCR preparation (X-Zyme) which is also based on the available partial amino 
acids sequences of the wtCPCR was used for necessary comparison. The CpSADH gene was 
amplified also from the same gDNA library of C.parapsilosis DSMZ 70125 strain via 
conventional PCR with primers deduced from the published sequences. The amplification of 
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the CpSADH and the CPCR genes from the same strain of C.parapsilosis confirmed that at 
least these two ADHs were present in the same strain (“CPCR” type strain of C.parapsilosis). 
Further identification was done by modeling the active sites of the CpSADH and the CPCR 
(based on their amino acids sequences) which showed that the CpSADH would accept more 
bulky substrates than in comparison to the CPCR. Experimental analysis of some potential 
substrates based on the prediction of the model, showed that methyl-3-oxovalerate (described 
to be converted by CPCR) was converted by the recombinant CpSADH (both with and 
without His6-tag) and also by the wtCPCR (JFC) but not by the recombinant CPCR (X-
Zyme). Comparison of the substrate spectrum of the recombinant CpSADH showed that the 
enzyme had very similar conversion rates like the commercially available wtCPCR (JFC), but 
a very different conversion rate with the substrates were observed with the recombinant 
CPCR (X-Zyme). The modeling information, substrate spectrum, special characteristics of the 
recombinant CpSADH identified that it was indeed the CpSADH which was the “Real 
CPCR”. 
 
The His-tagged CpSADH showed higher specific activities than the one without any His6-tag, 
and possessed a specific activity of 653.7 U/mg, 82.3% yield (after IMAC purification and 
ultrafiltration). Enzymatic syntheses with the recombinant His-tagged CpSADH were carried 
out in one-phase system, aqueous-organic two-phase system, gel-stabilized two-phase system 
and also with immobilized enzyme in Sepabeads in two-phase system. In all the systems, 
acetophenone was used as the model substrate and the cofactor NADH+H+ was regenerated 
with 2-propanol. The highest product concentration was obtained in a liquid two-phase 
system with 25% (v/v) hexane as substrate reservoir, and 103 mM of (S)-1-phenylethanol was 
produced (51.5% conversion). In gel-stabilized two-phase system with PVA-immobilized 
biocatalyst, 44.1 mM (S)-1-phenylethanol was formed. Among the epoxy-carrier Sepabeads 
(EC-EP and EC-HFA), the immobilized enzyme in a two-phase system showed a very high 
activity on the EC-HFA (57.6 mM phenylethanol produced) but a very low activity on the 
EC-EP (3.5 mM phenylethanol produced) due to the hydrophilic and hydrophobic natures of 
the respective Sepabeads. The stability of the enzyme immobilized on EC-HFA (in two-phase 
system) was higher than the soluble enzyme (in pure aqueous medium) at higher temperatures 
(30 and 37 °C) and also higher than that of the soluble enzyme with the same aqueous-organic 
phase ratios at 25 °C. Therefore concerning the productivity, the EC-HFA Sepabeads was 
indeed better than that of the PVA matrix though the stability of the latter was not studied. 
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